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ABSTRACT
The work presented here was an attempt to chai’acterise some properties of a 
rat erythroleukaemic cell line (REL), in particular, the ability of these cells to undergo 
erytliroid differentiation following exposure to dimethylsulphoxide (DMSO).
Erytliroid differentiation was readily demonstrated by the appearance of 
haemoglobin in REL cells, using the benzidine reaction. Although it required some 72 
hours exposure to DMSO before significant numbers of haemoglobinized cells could 
be detected, it appeared that some cells became committed to differentiate after as 
little as 8 hours exposure. It was possible to propose a sequence of events when REL 
cells were exposed to DMSO. After 4 hours of DMSO, DNA synthesis was down- 
regulated and REL cells started to shift out of S-phase of the cell cycle (i.e. 
proliferative) and stai'ted to accumulate in GQ/G%(i.e. quiescent). This loss of 
proliferative ability was reflected in a reduction in cloning efficiency, i.e. some cells 
could no longer divide. Cells became committed to differentiation by 8 hours and by 
24 hours, gross morphological changes could be observed, e.g. a significant reduction 
in cell size, cells adopting a smooth surface appearance as demonstrated by scanning 
electron microscopy (SEM). Cells producing haemoglobin could be detected by 72 
hours of DMSO and the number of cells rose to a maximum after about 96 hours. It 
would appear that haemoglobin production is a relatively late event in DMSO-induced 
erytliroid differentiation of REL cells.
To try to identify the biological activities that regulate differentiation, REL 
cells were adapted to a chemically defined, serum-free (SF) medium. Although the 
growth and division of these cells was not significantly different from cells grown in 
serum-containing medium, without serum, REL cells could not be induced to 
differentiate. Even when SF medium was supplemented with combinations of known 
growth factors / cytokines, no significant erytlu'oid differentiation was obtained.
It is because of this ability to differentiate along an erythroid pathway that the 
REL cells are regarded as erythroleukaemic. However, imder certain culture
■■I
'-i-conditions, REL cells developed characteristics associated with monocyte / 
macrophage maturation as demonstrated by morphology, appearance under SEM, 
cytochemical analyses, and expression of a macrophage-associated surface antigen.
It would appear that REL cells are not restricted to the erythroid lineage, but, in fact, 
they retain the potential to mature along additional lineages.
Brief cytogenetic analysis revealed the presence of a chromosomal abberation, | |
namely, the translocation of the major portion of chromosome 3 to the terminal region
Îof chromosome 1. The area of the breakpoint on chromosome 3 contains the proto- y
oncogene, c-abl. It may be that this translocation subverts the normal expression of c- 
abl and this aberrant expression contributes to the unregulated growth of REL cells.
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SECTION 1
INTRODUCTION
1.1 Historical Perspective
The vital importance of blood was probably recognised from earliest times. 
Certainly, in the Old Testament "to shed blood" meant "to kill", i.e. if enough blood 
is lost, life ceases. Although blood was recognised to be essential for life, its 
nature, by necessity, remained obscure until relatively recently. It was not until the 
advent of the microscope that a means became available to study the nature of 
blood. One of the most sldlful of the early microscopists was Antonj van 
Leeuwenlioek (1632-1723) of Delft, Holland. It is generally Leeuwenlioek who is 
credited with first describing the red blood cell (1) although his contemporaries, 
Jan Swammerdam (1637-1680) and Marcello Malpighi (1628-1694) also recorded 
their observations on the cellular nature of blood. Some hundred years later, 
William Hewson (1739-1774) reported the presence of the relatively much less 
numerous "colourless" blood cells, i.e. white blood cells (2).
From Leeuwenhoek's first letter to the Royal Society in April 1673, it was 
nearly two hundred years (i.e. 1868) before the origins of the blood cells were first 
recognised. Ernst Neumarm (1834-1918) (3,4) and, almost simultaneously, Giulio 
Bizzozero (1849-1901) (3,4) demonstrated that, in the adult organism, the main site 
of red blood cell formation is the bone marrow. Subsequently, they both reported 
that, in the case of adult humans, red blood cell production is limited to the bone 
marrow (3). It is interesting to note that these earlier reports were highly 
controversial and evoked great scepticism amongst many of the contemporaries of 
Neumaimand Bizzozero. It was not until the end of the century, a period of some 
twenty odd years, that the bone marrow was universally accepted to be the site of 
haematopoiesis in adult man.
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It is worth mentioning that up until this time there was a general 
assumption that blood cells, once formed in the embryo, persisted in the body 
tlu'oughout life. However, it was Neumann who recognised that this was not so (3), 
that in fact blood formation was a continuous process occurring during post-natal life.
It was Artur Pappenheim (1870-1916) who first proposed that all the different 
types of blood cells arose from one common ancestor. Using staining methods, he 
noted that various transition forms of cells could be traced back to a relatively 
featureless type of mononuclear cell, which he termed the "lymphoidocyte"(4).
From a morphological point of view this cell appeared so primitive that he 
considered it to be the common ancestor of all blood cells. This monophyletic theory 
of Pappenheim's was based solely on morphological criteria. The severe limitations 
of this morphological analysis could not be overcome until some new 
experimental tools became available, viz, radiation biology.
The first step forward came in Chicago where Jacobson and co-workers 
demonstrated that mice given otherwise lethal whole-body irradiation could be 
protected by partial shielding of haematopoietic tissue -they exteriorized the 
spleen and excluded it from the radiation (5,6). Although there was some controversy 
over whether this haematological recovery was due to a humoral factor or due to 
living intact cells, the matter was resolved in 1956 in Harwell by Ford and co-workers 
who used a chromosome marker to clearly demonstrate that this radioprotective effect 
was cellular, i.e. intact viable cells in the graft were responsible for the restoration 
of the haematopoietic tissue (7). This was amply confirmed by several other groups 
working independently (8, 9, 10).
The watershed came in 1961 when Till and McCulloch, working in Toronto, 
reported on the radiation sensitivity of normal mouse bone marrow cells (11). They 
reported an assay in which mice were lethally irradiated and then injected with low 
numbers of bone marrow cells (lO^-lO^). This low number of cells is not sufficient 
to ensure long-term survival of the recipient. However, when the surviving animals 
were sacrificed after 10 or 11 days, discrete macroscopic nodules were clearly visible
11
on the surface of their spleens. Histologically, each nodule consisted largely of 
proliferating recognisable haematopoietic cells and their preciusors. In addition, the 
number of spleen colonies was found to be directly proportional to the number of 
marrow cells injected, and granulopoiesis, erytlii'opoiesis and megakaryocytopoiesis 
could be observed in the nodules. Their results were compatible with the 
assumption that single viable cells from the marrow graft were able to give rise 
to colonies in the spleen. However, because of their uncertainty over the identity 
of the cells, they proposed the term "Colony-Forming Unit" (CFU) to designate the 
cell (or cells) which gave rise to a single colony.
The clonality of these spleen colonies was soon demonstrated by more direct 
evidence from several groups working independently. Becker et al used marrow 
cells that had been irradiated to produce chromosomal aberrations (12). Eleven days 
after these cells were injected into irradiated mice, individual spleen colonies were 
removed and subjected to chromosomal analysis. This analysis showed that the 
same chromosomal markers were present in 95-99% of the cells of colonies that 
had chromosomal markers. Since the clu’omosomal aberration was produced by a 
random process, it was highly improbable that an identical abnormality should occur 
in each cell and this provided good evidence for the clonal origin of the splenic 
nodules. Fowler et al examined 14-day colonies and found that 83%-98% of the cells 
from each marked colony contained the characteristic marker cliromosome of that 
colony (13). In addition, Welshons transplanted a mixed suspension of marrow cells 
from normal and chromosomally marked donor mice and found that none of the 
spleen nodules in the host had a mixed karyotype (14).The only explanation for these 
observations was that the original cell carrying the marker was the parent of all the 
other cells in that colony. Furthermore, these colonies could consist purely of one 
cell lineage (erythroid, granulocytic or megakaryocytic) or a mixture of two, or 
even all tlu’ee of them (13, 15,16).
By now, compelling evidence had accumulated for the concept that there was 
a pluripotential stem cell that could give rise to all the morphologically identifiable
12
cells of the blood and bone marrow. However, the natui'e of this relationship 
remained to be elucidated. The picture began to take shape with the introduction of 
techniques that allowed the in vitro culture of bone maiTow cells.
1.2 In Vitro Culture of Bone Marrow
The earliest report of the in vitro culture of bone mai row cells appears to be the work 
of Carrel and Biurows in 1910 (17). The cells were cultured over a relatively short 
term of between 6 and 24 hours. Some years later, Osgood and Muscovitz introduced 
a rather complicated cell suspension method for culturing bone marrow for 
haemato logic and metabolic studies (18).
However, the modern era of bone marrow culture dawned some thirty-odd 
years ago when two reports appeared in quick succession describing the in vitro 
cultui'e of mouse haematopoietic cells. In Israel, Pluznik and Sachs cultured adult 
mouse spleen cells on a feeder layer of mouse embryo cells. The concluded 
(mistakenly) that the colonies formed were composed of "mast" cells (19). Shortly 
after this report, Bradley and Metcalf described their technique for the growth of 
colonies from single cell suspension of mouse bone marrow (20). They correctly 
identified the nature of the cells that made up the colonies, viz, neutrophilic 
granulocytes and macrophages. Pluznik and Sachs subsequently showed that the 
cells of the feeder layer could be replaced by "conditioned medium" (21). This 
consisted of mouse embryo cells sustained in tissue culture medium for 7 days. The 
resulting supernatant contained the factors necessary for spleen cell growth. The 
term "Colony Stimulating Activity" (CSA) was coined to denote the factor or 
factors present in conditioned medimn, or secreted by feeder cells, which 
stimulated the proliferation in vitro of granulocytes/macrophages.
The clonal nature of the colonies formed was implied by the 
demonstration of a linear relationship between the number of cells plated and the 
number of colonies grown. This clonality was later confirmed by colony mapping 
and single cell cloning experiments (22). The cell of origin of these colonies was
13
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termed the "colony forming unit in culture" (CFU-C) as opposed to the previously 
discussed colony forming unit in spleen (CFU-S). In the fulness of time this feeder 
layer teclmique was adapted to allow the growth of human bone marrow cells (23).
With the demonstration that colonies of granulocytes and/or macrophages 
could be grown in semi-solid medium Axelrad and colleagues, working in 
Toronto, succeeded in growing erytliroid colonies from mouse foetal liver cells (24). 
They argued that the rather vague term, CFU-C, should be further dissected to CFU- 
G- for granulocytic colonies and CFU-E for these erythrocytic colonies. The clonal
nature of these erytliroid colonies was demonstrated by direct observation using time- 
lapse cinemicrography (25).
It became clear that this CFU-E was a relatively matui’e cell (26). 
Subsequently, it was shown that when the erythi'opoietin concentration was 
increased and the period of incubation prolonged, more immature cells could be 
grown which produced small colonies which were not distributed homogeneously 
in the cultures but rather occurred in bursts (27). The previous operational 
nomenclatui'e was again used, with a slight modification, and the cell that gave rise 
to an erytlu'oid bui'st was called a "bmst forming unit-erythroid" (BFU-E)
"0
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Reports of additional colony-forming cells continued to emerge. Eosinophils 
were successfully cultured from both human peripheral blood cells and bone 
marrow cells (28,29). Metcalf et al reported a teclmique for growing 
megakaryocytes from mouse bone marrow (30). A few years later, human 
megakaryocyte colonies were grown from both peripheral blood cells and bone 
marrow cells (31,32).
The colony-forming cells so far described are "committed" in that they are 
restricted in their development to only one cell lineage (or two in the case of the 
granulocyte / macrophage progenitor cell). Subsequently, an assay became available 
for a multipotential haematopoietic progenitor in both the mouse and the human 
system (33,34). The haematopoietic colonies generated in these cultures contained 
terminally differentiated cells of several lineages,e.g.granulocyte/macrophage,
14
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erythrocyte and megakaryocyte.This progenitor cell is variously known as the "CFC- 
Mix" (Colony-Forming Cell-Mixed), "Multi-CFC" (Multipotential Colony- 
Forming Cell) or"CFU-GEMM" (Colony-FormingUnit-Granulocyte,Erythrocyte,
Macrophage, Megakaryocyte).
For the sake of accuracy it should be kept in mind that the terms 
"haematopoietic stem cell" and "CFU-S" are not, strictly speaking, 
synonymous.Although some CFU-S are stem cells, as demonstrated by their 
pluripotential nature and self-renewal ability (35), there is evidence to indicate that 
CFU-S represent a heterogeneous population of cells differing in their ability to 
self-renew (36). It would appear that there is a primitive stem cell which gives rise
to CFU-S (37). In support of this, Hodgson and Bradley proposed a class of
-primitive haematopoietic stem cell, "pre-CFU-S", which accumulates in the bone
marrow to give rise to cells capable of growing in the spleen (38).
Based on the colony assays it is convenient to represent the hierarchial 
nature of haematopoiesis in the form of a lineage diagram (Fig I). Lest this 
representation be misleading, it should be remembered that considerable 
amplification takes place within the differentiating cell populations. For example, 
if a particular stem cell is committed to differentiate along the erythroid pathway, 
i.e. BFU-E, it retains considerable growth capacity, i.e. it may divide several times 
as a BFU-E. Subsequently, when these cells have matured to morphologically 
recognisable cells, e.g. normoblasts, they still possess considerable proliferative 
ability (39). This amplification can be represented diagrammatically (Fig 2). dm
1.3 Regulation of Haematopoiesis
From the earliest experiments where murine haematopoietic cells were 
successfully cultured in vitro, it was obvious that proliferation and colony 
formation required the continued presence of factors elaborated from the cells of the 
feeder layers (19,20). Subsequent work showed that the feeder cells need not be 
capable of proliferation and indeed could be replaced by medium harvested from
15
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Figure 2
Amplification within the haematopoietic system.
pluripotent stem 
cell
\ \
17
1 BFU-E
2® CFU-Es
2^’ mature
erythrocytes
■i
I
a
vS
■
'1
Î
'1
4
liquid cultures of feeder cells, i.e. conditioned medium (21). Other studies showed 
that small volumes of mouse serum (40), human serum (41), or human urine (42) 
could be incorporated into the agar medium and serve as a suitable stimulus for 
colony formation in vitro by haematopoietic cells.
Various descriptive terms were proposed to describe this activity:- "colony 
stimulating factor (CSF)" (43), "colony stimulating activity" (CSA) (44), "inducer 
of colony formation" (45), "conditioning factor activity" (46), "macrophage and 
granulocyte inducer" (MGI) (47). By convention, the term "CSF" was most 
commonly used to describe this stimulatory activity. The tissues that produced CSF 
were many and variedi-spleen (48), embyro kidney (49), vascular cells (50), lung 
(51), placenta (52). In addition, a variety of human cell lines have been established 
which elaborate CSF, e.g. the T-lymphoblast cell line (Mo) which was derived 
from a patient with a T-cell variant of hairy-cell leukaemia (53), the monocyte-like 
cell line GCT which was isolated from a lung metastasis of a fibrous histiocytoma 
(54), a pancreatic carcinoma cell line (55), a cervical carcinoma cell line (56), and T- 
cell lines from normal individuals (57) or leukaemia-lymphoma patients (58), This 
apparent ubiquity of sources of CSF has lead to speculation that maybe all tissues in 
fact produce varying amounts of CSF, some more easily detectable than others (59).
Interestingly, CSF levels were elevated in tissues and serum in situations 
where increased production of granulocytes and monocytes would be required, e.g. 
during infections (60,61,62,63) or after injection of bacterial products (64).This 
seemed to indicate that CSF was indeed a genuine regulator in vivo of granulocyte - 
marcrophage populations and therefore its characterisation became a priority.
It soon became apparent that CSF was not a single entity, and, in fact, there 
appeared to be several distinct CSF's with overlapping actions on granulocyte- 
macrophage populations.
By 1975, the first CSF had been purified, in this instance from human urine 
(65). It should be remembered that these activities were originally identified 
tlii'ough colony formation in in-vitro culture systems. This is reflected in the
18
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nomenclature used to describe individual CSF's, i.e. a prefix is used to indicate the
major cell populations produced as a consequence of the action of a particular 
.CSF.This CSF isolated by Metcalfs group stimulated macrophage colony formation 
in cultures of mouse bone marrow cells. Although originally known by the trivial 
name of "urinary CSF", it is now properly referred to as "macrophage - colony 
stimulating factor" (M-CSF), i.e. a CSF that preferentially stimulates the formation 
of colonies of macrophage cells.
Conditioned media provided rich sources of CSF’s, allowing the purification 
of murine (66) and human (67) granulocyte-macrophage colony stimulating factor 
(GM-CSF), murine (68) and human (69) granulocyte colony stimulating factor (G- 
CSF). The fourth and final CSF that was isolated was found to be less restrictive in its
activity, possessing the ability to stimulate the formation of megakaryocytes (70)
erythroid and multipotential colonies in cultures of murine bone marrow (71). This 
activity was subsequently puiified by Metcalfs group (72) and given the name 
multipotential CSF (Multi-CSF). However, this activity had already been isolated 
(73). Ihle et al had identified an activity in WEHI-3 conditioned medium that 
induced the enzyme 20 o^-hydroxysteroid dehydrogenase in murine splenic 
lymphocytes. They had named this molecule interleukin-3 (IL-3). Multi-CSF and IL- 
3 are now accepted as synonyms for the one activity.
The problem which arose now was that, although all 4 CSF's had been
■I
purified, the amounts of starting materials available were far too small to permit even
the simplest clinical study thus making it impossible to determine if the CSF's did
indeed possess any regulatory function in vivo.
All this changed with the application of molecular biological techniques.
Within a 3 year period (1984-7) complementary DNA's (cDNA's) were cloned for
each of the 4 murine and human CSF's (128). The characteristics of the human
.haematopoietic growth factors are summarised in Table 1. (74).
These colony stimulating factors are the classic haematopoietic growth 
factors. However, there are other, many and varied, molecules which have a
Ir
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regulatory function in haematopoiesis. The most obvious one is erythropoietin 
(Epo) which has its predominant effect on committed erythioid cells, promoting 
their proliferation and differentiation into proerythroblasts (75). Its importance in 
regulating red cell production in vivo has been clearly established (76).
A major group of regulatory molecules is the ever-increasing"Interleukins" 
(IL's), presently numbering fifteen (IL-15) (77). Some of these interleukins have their 
primary effect on the development of lymphoid cells. For example, IL-2 is a T-cell 
derived cytokine which stimulates growth and differentiation of T cells, B cells, 
Natural Killer (NK) cells and Lymphokine Activated Killer (LAK) cells (78). IL-7 is a 
growth factor for progenitor B cells and T cells (79).
Other interleukins can influence myelopoiesis. IL-5 is somewhat restricted in 
its activity, being a powerful stimulus for the proliferation of eosinophils (80). IL-1 
has a number of effects on a variety of cell types. Within the haematopoietic system, it 
can act either directly on early stem / progenitor cells to prolong their survival (81) or 
indirectly by influencing the release of CSF's from accessory cells (82, 83). IL-3 
stimulates growth and differentiation of a broad spectrum of haematopoietic cell 
lineages. It supports growth of multilineage colonies (84, 85) as well as all the 
committed progenitors (86). However, many of the activities of IL-3 are entranced or 
depend upon co-stimulation with other cytokines. For example, IL-6 has activity on 
megakaryocytes and platelets (87, 88) especially in combination with IL-3 (89). 
Similarly, IL-11 can synergize with IL-3 to stimulate haematopoiesis in vitro (90).
Many other activités have been reported, notably Stem Cell Factor (SCF) (also 
known as kit ligand (KL)), Transforming Growth Factor-beta (TGF-p), Macrophage 
Inflammatory Protein-1 alpha (MIP-la), and Leukaemia Inhibitory Factor (LIF). SCF 
has a wide range of activities and appears to act on early myeloid cells where it can 
have a potent synergistic effect in conjunction with other growth factors (91). TGF-p 
is considered to be a negative regulator and can down-modulate the expression of 
receptors for G-CSF, GM-CSF, and IL-3 (92). In addition, TGF-p appears to maintain 
early progenitors in a non-proliferative quiescent state, thereby preventing them
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entering the cell cycle (93). M IP-la can also have a suppressive activity on early 
haematopoietic cells (94) and can be myeloprotective (95). In combination with IL-3, 
LIF can potentiate the stimulation of megakaryocyte precursors (96). It also has a 
somewhat unique effect on embryonic stem (ES) cells. ES cells exhibit a 
predisposition in culture to differentiation commitment with loss of totipotentiality. 
However, incubation with LIF prevents this differentiation commitment and allows 
the cells to retain their totipotentiality (97).
This interacting network of various regulatory molecules is a feature of 
haematopoiesis, and synergy is often observed using a wide range of growth factor 
combinations (98). The fine control of haematopoiesis is a highly complex 
phenomenon requiring a subtle balance between stimulatory activities (like the CSF's) 
and suppressive influences (like M IP-la and TGF-P).
For all practical purposes, the stem cells are immortal (99) in that they persist 
thr oughout the lifespan of the organism. In fact, there is a vast proliferative reserve 
built into the system that would be sufficient to last several times the normal lifespan. 
This is elegantly demonstrated in transplantation studies where relatively few donor 
cells are required to reconstitute fully the haematopoietic system of the recipient 
(100). For example, infusion of as few as 10^-10^ marrow cells into an irradiated 
mouse is sufficient to restore haematopoiesis. Since a normal mouse has about 3x10^ 
marrow cells, the infused amount represents only 0.01% of this total. Furthermore, 
these transplant recipients have a normal lifespan and their haematopoietic system 
shows no evidence of decline with age (101). In addition, it has been amply 
demonstrated in murine studies that bone marrow cells from a transplant recipient can 
themselves be used successfully in further transplantation procedures (102), although 
with repeated serial transplantation, the ability of the donor marrow to reconstitute the 
recipient mice is eventually lost ( 103, 104, 105).
The scale of this process is quite remarkable when one considers that every 
day some 2 x 10  ^1 erythrocytes, 1 x lOl^granulocytes and 4 x 10  ^^platelets enter 
the circulation, in addition to lymphocytes and monocytes (3). With a production
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system of this magnitude, one might expect malfunction to be a common event. 
However, the regulation is so exquisite, that, in fact, the system seldom fails. 
Nevertheless, failures do occur and when a stem cell escapes these fine control 
mechanisms, then unregulated cell proliferation may produce a vast overproduction of 
abberant cells - as in leukaemia.
l A  LEUKAEMIA
1.4.1 Historical Perspective
It seems reasonable to assume that leukaemia has been around as long as 
mankind himself. However, the disease was not properly described until the 
nineteenth century. The first record of a case of leukaemia is generally attributed to 
Alfred Valpeau in 1827 (106, 107, 108). The patient was a 63 year old florist who 
became ill in 1825 with a pronounced swelling of the abdomen, accompanied by fever 
and weakness. He died soon after admission to the hospital and at autopsy was found 
to have a greatly enlarged spleen. The blood was "thick, like gruel". Unfortunately, no 
microscopic studies were carried out, so, strictly speaking, these macroscopic changes 
camiot be attributed to an increased white blood cell count. The cause of this 
"paleness" of the blood remained unloiown for almost twenty years, until cases of 
leukaemia with clinical, post-mortem, and microscopic findings were independently 
and almost simultaneously published in Edinburgh and Berlin.
In the Edinburgh Medical and Surgical Jouinal of October 1st 1845, two case 
reports appeared. In the first, David Craigie described a patient who had been under 
his care in 1841 (106). Autopsy revealed "globules of purulent matter" in the blood 
and massive hepatosplenomegaly. The second case was reported by John Hughes 
Bennett (1812-1875) (106). He noted that parts of the blood clot were unusually 
yellow, opaque, and dull in appearance and that material resembling thick pus could 
be squeezed from the cut ends of many veins. Both the spleen and liver were greatly 
enlarged. Microscopic examination of the blood clot revealed the presence of 
colourless corpuscles.
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Some six weeks after Bemiett's publication, Rudolph Virchow (1821-1902) 
reported from Berlin a patient whose blood vessels contained a "yellowish-white, 
almost greenish mass" (108). Microscopically, it contained "besides a very few red
blood corpuscles the same colourless or white cells which also occur in normal
blood". The relationship between red and white cells was the reverse of normal, so 
much so that Virchow coined the term "white blood" (weisses Blut) to describe the 
condition.
Despite the similarity of their findings, Bennett and Virchow chose to interpret 
them differently. Bemiett thought that the colourless corpuscles were pus cells rather 
than white blood cells, and concluded that the disease was a "suppuration of the 
blood". Virchow, on the other hand, could find no inflammation that might have led to 
the formation of pus and was reluctant to call the condition "pyemia" (i.e. blood 
containing pus). Instead, he contented himself with the descriptive term "white 
blood". Some months later, in August 1846, having reviewed the current literature, 
Virchow rejected the pyemic theory of leukaemia (still called white blood). Instead, 
he took the view that the "pus corpuscles" were identical to the colourless bodies 
normally occurring in the blood, and that in leukaemia there was merely an increase in 
the normal number of these cells (108). The following year, in 1847, he proposed a 
new name for the disorder, namely "white blood" translated into Greek, i.e. 
"leukaemia" [Xskoct (leucos = white), a ip a  (haema = blood)]. This name did not 
meet with universal approval. Indeed, Bennett objected to the name "leukaemia" as a 
misnomer since the blood was not itself white. Instead, he proposed "leucocythaemia" 
(white-cell-blood) as a more satisfactory descriptive term. It is ironic, perhaps, to note 
that in retrospect "leucocythaemia" is probably the more accurate name, particularly 
since these colourless corpuscles came to be Imown as "leucocytes".
1.4.2 The Nature of Leukaemia
In simple terms, leukaemia is a cancer of the haematopoietic system. For one 
reason or another, a cell (or cells) escapes the complex controls that regulate normal
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are genetically almost pure, i.e. identical. In some strains of mice, leukaemia can 
occur spontaneously in almost every individual. In other strains, leukaemia is rare. 
Clearly, some strains of mice have a genetic predisposition to developing leukaemia.
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haematopoiesis. Some leukaemogenic event(s) occurs which endows a cell with a 
particular growth advantage which allows it to dominate over normal haematopoiesis.
Leukaemic cells do not develop fully to functionally normal end cells. Rather, 
they appear to undergo a "maturation arrest" at some point in their differentiation, and 
consequently accumulate as immature cells.
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However, these immature forms do not necessarily display a phenotype that is
' .identical to some normal counterpart (109). In a significant number of cases, a rather 
bizarre phenotype can be demonstrated whereby individual leukaemic cells co-express ÿâ:
markers which are normally restricted to a single lineage - so called "lineage 
infidelity" (110). For example, there have been several reports of patients with acute
■‘Himyeloid leukaemia (AML) whose cells expressed nuclear terminal deoxynucleotidyl i
transferase (TdT) - TdT is normally expressed on early lymphocytic cells (111, 112, 
113). In the majority of cases, however, it is possible to identify the predominant 
lineage and cell type involved, and so designate the leukaemia to a particular 
category, e.g. myeloid or lymphoid, acute or clironic.
1.4.3 The Aetiology of Leukaemia
■It would be an over-simplification to speak of "the cause of leukaemia". Ai
Certainly, several diverse factors have been implicated in its aetiology and it is likely 
that some interaction between these factors will prove to be the effective cause.
(a) Heredity
It would appear that genetic factors may influence susceptibility to 
leukaemogenesis. This has been implied from experimental leukaemia in mice (114). ..1Strains of mice have been developed by intensive inbreeding to produce animals that
■;=i
Corroborating evidence has come from human studies. One study estimated 
that among first-degree relatives of patients with either acute leukaemia or cln'onic 
lymphatic leukaemia, the incidence of leukaemia was 2 .8-3 times higher than 
expected (115). The evidence suggested that the excess incidence was primarily due to 
a genetic predisposition in these families. In addition, the incidence of acute 
leukaemia in the identical twin of an afflicted patient is considerably higher than in 
the general population, and is extremely high if one twin develops the disease before 
the age of three (116). Fur thermore, in children with some congenital defects, notably 
Down's syndrome, the incidence of leukaemia can be 20-fold higher than in 
unaffected children (117). Some rare hereditary diseases which are associated with 
chromosome breakage (e.g. Bloom's syndrome, Fanconi's anaemia, or ataxia- 
telangiectasia) carry a high risk of leukaemia (114,118).
It would seem, therefore, that although leukaemia is not inlierited in a 
Mendelian fashion, nevertheless there can be some genetic predisposition. The overall 
contribution of this must, for the present, be regarded as small.
(b) Radiation
The most powerful demonstration of the leukaemogenic potential of ionizing 
radiation can be seen in the aftermath of the atomic bombs dropped on Hiroshima and 
Nagasaki in Japan in 1945. The high incidence of leukaemia in survivors of the 
explosions was ample evidence for a causative role for radiation in leukaemogenesis 
(119). In addition, there appears to be some evidence that patients receiving 
radiotherapy (e.g. for cervical cancer) may run a risk, albeit very small, of developing 
leukaemia (120).
(c) Viruses
Viruses were first implicated as a cause of leukaemia by Vilhelm Ellermann 
and Oluf Bang in Copenhagen in 1908 when they reported the cell-free transmission 
of chicken leukaemia (114). Although these studies were confirmed and extended, it
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was over 40 years before similai' successful experiments were performed on 
mammals. In 1951, in New York, Ludwik Gross showed for the first time that 
leukaemia could be transmitted to newborn mice by means of cell-free extracts, hence 
the Gross AKR leukaemia virus (121). Subsequently, viruses have been identified in a 
number of species; e.g. cats (feline leukaemia virus, FeLV (122)), cattle (bovine 
leukaemia virus, BLV (123)), and primates (gibbon ape leukaemia virus, GaLV 
(124)).
Although viruses can frequently be the causative agent in animal leukaemias, 
to date, in humans only two haematological malignancies have a viral association. 
Adult T-cell leukaemia (ATL) is associated with a C-type retrovirus, human T-cell 
lymphotropic virus type 1 (HTLV-1) (125) and Burkitfs lymphoma is associated with 
a large DNA virus, Epstein Barr virus (EBV) (126).
The precise way in which viruses may cause leukaemia in animals is still 
unclear, but it is likely that they will act in concert with other factors like radiation or 
chemicals. In common with most other cancers, leukaemia is multifactorial in its 
aetiology, and a succession of events will be necessary for the evolution of the 
malignant clone.
(d) Chemicals
There is a great belief that in our modern industrialized society, our polluted 
enviromnent harboms many toxic substances. However, in hiunans, only benzene has 
been shown beyond reasonable doubt to be able to induce leukaemia (127). Its 
leukaemogenic potential was observed in an occupational setting (127). There is also 
some evidence that patients receiving cytotoxic drugs, like melphalan, for the 
treatment of cancer may show an elevated incidence of acute leukaemia (128),
1.4.4 Chemical Carcinogenesis
The first report of a possible connection between enviromnental chemicals and 
the induction of cancer appeared over two hundred years ago. In 1761, Jolm Hill
26
(1716-1775) observed that nasal cancer occurred in people who used snuff excessively 
(129). Some years later, in 1775, Percival Pott (1713-1788) reported a high incidence 
of scrotal skin cancer in men who had spent their childhood as chimney sweeps and 
he correctly attributed this to their constant contact with coal tar and soot (130). A 
hundred years later, Bell observed skin cancer in the workers of the Scottish shale oil 
fields whose skin was in continuous contact with tar and paraffin oils (which we now 
know contain polycyclic aromatic hydrocarbons (PAH)) (131). By necessity, the 
nature of this relationship between chemicals and cancer remained obscure until the 
early part of this century.
One of the first successful attempts to chemically induce cancer in animals 
was made by Yamagiwa and Ichikawa in 1915 (132). Benign tumours (skin 
papillomas) and highly malignant carcinomas were evoked by painting the ears of 
rabbits with coal tar every 2-3 days for many months. In 1932, at the Research 
Institute of the Royal Cancer Hospital (Free) in London, the group led by Ernest 
Laurence Kennaway (1881-1958) demonstrated that a pure chemical compound of 
Imown molecular structure could cause cancer (133). The first pure hydrocarbon to be 
identified as a carcinogen was dibenz(a,h)anthracene. Subsequently, over the next six 
years, several other potent carcinogens were isolated, e.g. benzo(a)pyrene in 1933 
(134), 3-methyIcholanthrene in 1935 (135). In 1938, Bachmami and Chemerda 
succeeded in synthesizing 7,12-dimethylbenz(a)anthiacene (DMBA) (136) and later 
that year Baclrmaim and Kennaway reported DMBA to be highly carcinogenic when 
skin-tested on mice (137). Even now, DMBA is still one of the most potent 
carcinogens Imown.
1.4.5 Experimental leukaemia
Although leukaemia is not one of the most common neoplastic diseases, it has 
nevertheless commanded an enormous amount of research into its causes and 
treatment. Indeed, the incidence of leukaemia is only of the order of 10 cases per
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100,000 population (cf. breast 70 per 100,000; lung 45 per 100,000) (138). This figure 
represents only ~3% of all cancers (139).
Leukaemia has attracted much scientific attention because it represents a 
neoplastic disease of a rather unique organ - blood. The ease of access to the blood has 
made it a most convenient system to study. Individual cells are easily available. 
Normal / leukaemic cells can be readily identified, enumerated and manipulated. 
Information accrued from the study of leukaemia may have general application to 
other neoplastic disorders.
Obviously, leukaemia in humans does not lend itself to experimentation. There 
is an obvious attraction in any system which can reproducibly induce leukaemia in 
high yield in experimental animals. Such a system would offer a unique opportunity 
to study the leukaemogenic process.
Chemicals have been used for many years to induce experimental leukaemia in 
animals. One of the earliest reports was the induction of leukaemia in rats of the 
Wistar strain by tube-feeding them with the polycyclic aromatic hydrocarbon, 3- 
methylcholantlirene (140).
The work that will be presented here is concerned with particular aspects of a 
model developed almost thirty years ago, namely, the induction of leukaemia in rats 
of the Long Evans strain by multiple intravenous injections of the polycyclic aromatic 
hydrocarbon - 7,12 dimethyl-benz(a)anthmcene (141).
In 1966, Huggins and Sugiyama (132) demonstrated that DMBA could elicit 
leukaemia in high yield in rats of the Long Evans strain given 4 intravenous injections 
at bi-weekly intervals. Several kinds of leukaemia were produced, but the most 
common type (-80%) was a diffuse hepatic form, often associated with 
erytlu'oblastosis. Diagnosis was normally made by liver biopsy where the first sign 
was an infiltration of the sinusoids by densely staining basophilic cells. As the disease 
progressed, the infiltration became more pronounced until massive infiltration brought 
about liver failure and, subsequently, death. At autopsy, characteristically the liver 
was greatly enlarged and had an unusual, mottled appearance. Often, the spleen, as
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well, was enlarged. The leukaemia was shown to be transplantable. Wlien whole 
blood from a leukaemic animal was injected intraperitoneally into Long Evans babes 
(24-4Sin' old), leukaemia developed in about 85% of the recipients.
It is possible to establish permanent cell lines from these leukaemic animals 
using either blood or spleen. Leukaemic blood, when injected subcutaneously into 
newborn rats of the same strain, may produce tumours which histologically resemble 
erytlnosarcomas (142). By removing pieces of tumour, disrupting the tissue and 
suspending the cells in culture medium, permanent cell lines can be obtained (143).
1.4.6 in vitro studies using permanent cell lines
Cell studies in vitro have made a major contribution to our understanding of 
the cellular events in normal and leukaemic haematopoiesis. As well as allowing the 
characterization and enumeration of the various haematopoietic progenitors, cell 
culture teclmiques have also helped to delineate the regulatory factors controlling both 
normal and leukaemic haematopoiesis.
Leukaemic cells appear to undergo maturation arrest, i.e. normal 
differentiation is blocked (109). A variety of leukaemic cell lines have been 
established both from humans and rodents, and these have provided a means for 
directly analysing the factors that influence proliferation and differentiation of these 
cells. This list of cell lines is extensive, but it would be inappropriate to review these 
data here. Among the most extensively studied human cell lines are HL-60, which 
was derived from a patient with acute promyelocytic leukaemia (144) and K-562 
which was established from the pleural effusion of a patient with CML in blast crisis 
(145). Rodent cell lines include MELC, which are murine erytlrroleukaemic cells 
transformed by Friend virus (146), and WEHI-3B which were derived from murine 
myelomonocytic leukaemia cells (147). These cell lines have been used in many 
studies of the differentiation process. Indeed, MEL cells have several similarities with 
the REL cells under study in this work. It was a serendipitous discovery by Charlotte 
Friend in 1971 that showed that these MEL cells could be induced to differentiate
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along an erytliroid pathway following exposure to dimethylsulphoxide DMSO (148). 
Subsequently, Rifldnd and Marks' group showed that this inductive effect could be 
reproduced by a variety of chemicals, including N-methyIformamide and N- 
methylacetamide (149), the common feature of the molecules being that they were 
polar-planer in their configuration. In a further study, they reported a new group of 
potent inducers, the most effective being hexamethylenebisacetamide (HMBA) (150). 
Using this model, an impressive body of knowledge has accumulated about the 
process by which proliferating precursor cells can be induced to withdraw from the 
cell division cycle and, instead, express those characteristics of the differentiated 
phenotype.
Similarly, HL-60 cells can be induced to differentiate by a variety of agents 
such as DMSO (151) and retinoic acid (152), however the induced phenotype is 
granulocytic rather than erytliroid. Furthermore, on exposure to agents such as 
phorbol myristate acetate (TPA) (153) or cytosine arabinoside (ara-C) (154), HL-60 
cells can differentiate into macrophage- or monocyte-like cells, demonstrating a 
bipotentiality. In addition, there is some evidence that HL-60 cells, maintained in 
slightly alkaline medium, can develop granules characteristic of eosinophils (155), 
suggesting that they may even be tripotential. HL-60 cells, therefore, provide a model 
for investigating the mechanisms that regulate differentiation, especially the "decision 
-making" process that determines which lineage will be persued.
The validity of using these established cell lines to elucidate the nature of the 
leukaemic lesion is indicated by the fact that they can be induced to differentiate into 
cells with many of the characteristics of normal mature leukocytes (156).
Furthermore, this suggests that these leukaemic cells have retained much of the 
cellular apparatus required to express the mature end-cell phenotype. Therefore, the 
aberrations of this maturational programme fomid in these cell lines are likely to be 
similar to the dysregulation that occurs in vivo.
From a clinical point of view, the goal of all this work is to exploit the 
experimental findings so that patient care may be improved. This indeed has proved to
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be the case. Differentiation therapy has been applied effectively to achieve complete 
remission (CR) in cases of acute promyelocytic leukaemia (APL) using all-trans- 
retinoic acid as the inducing agent (157). Similarly, HMBA has been used to achieve 
partial or complete remissions, in terms of measurable tumour regression, in 5 of 33 
patients with solid tumours (158), and in 6 of 20 patients with myelodsplastic 
syndrome (MDS) or acute myeloid leukaemia (AML) (159). These sorts of data are 
the ultimate demonstration that these experimental systems can make a valid and 
worthwhile contribution to our understanding of the regulation of haematopoiesis.
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SECTION 2
MATERIALS AND METHODS 
2.1 Induction of Leukaemia
Leukaemia was elicited in randomly-bred, weanling (4-6 weeks) rats of the 
Long Evans strain by serial administration of the polycyclic aromatic hydrocarbon, 7, 
12-dimethylbenz (a) anthiacene (DMBA) (Upjohn, Kalamazoo, Michigan, USA) 
(141), Rats received 4 intravenous injections of a lipid emulsion of DMBA 
(3 5mg/kg) at bi-weekly intervals. Prior experience showed that about 40% of the rats 
developed leukaemia, often within a short period of time (<100 days). The diagnosis 
of leukaemia was made by histological examination of liver, obtained by open biopsy 
under brief ether anaesthesia, commencing two weeks after the last dose of earcinogen 
and repeated at 14 day intervals. The earliest evidence for the induction of leukaemia 
was the appearance of aggregates of basophilic cells in the liver sinusoids. Over 
subsequent days and weeks, this infiltration became extensive and frequently involved 
the spleen.
2.2 Preparation of Culture Medium
The culture medium used throughout this study was Ostertag's modification 
of Eagle's Medium i.e. Modified Eagle's Medium-Ostertag i.e. MEM-0.
The overall formula for MEM-O was:-
MEM Amino acids (50x) (MEM A A) : 40ml/litre
MEM Non Essential Amino Acids (lOOx) (MEM NEAA) : 20ml 
MEM Vitamins (lOOx) : 20ml
MEM Sodium Pyruvate (100 mM) : 10 ml
Penicillin (5000U/ml)-Streptomycin Solution (500pg/ml) ; 20 ml 
Sodium Bicarbonate (7.5%) : 25 ml
L-glutamine (200 mM) ; 20 ml
Foetal bovine serum (FBS) : 100 ml
All the reagents were obtained from Life Teclmologies, Paisley, UK.
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The volume was made up to 1 litre with Earle's Balanced Salts Solution (EBSS) (i.e. 
745ml).
Because of their instability in solution at temperatures above -lO^C, L- 
glutamine and FBS were normally omitted when preparing batches of medium. L- 
glutamine and FBS were stored at -20°C and thawed out and added to the culture 
medium as required.
In practice, it was more convenient to prepare the medium by adding, 
aseptically, the appropriate volumes of ingredients to a commercially produced 500 
ml bottle of EBSS.
To a 500 ml bottle of EBSS was added: - 
MEM A A : 26.8 ml
MEM NEAA :13.4ml
Vitamins :13.4ml
Pyruvate : 6.7 ml
Pen/Strep :13.4ml
Na HCOg :16.8ml
The pH was adjusted to pH 7.2-7.4 by dropwise addition of 4N NaOH. Since 
this preparation lacked L-glutamine and FBS it was referred to as MEM-0=.
Complete medium, i.e. MEM-0++, was prepared by adding to 135ml of MEM-0= in 
a sterile medium bottle :-
L-glutamine : 3 ml
FBS : 15 ml
This gave a final volume of 150 ml of complete medium, MEM-0++. The 
final FBS concentration was 10% (v/v) (see 3.1). In addition, MEM-0± was 
occasionally prepai'ed. This consisted of MEM-0= with added L-glutamine, but no 
added FBS, i.e. MEM-0±. This was used, for example, in the preparation of methyl 
cellulose for the in vitro clonogenic assay (see Section 2.5.1).
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2.3 Establishment of Cell Lines
Rats diagnosed as being leukaemic were sacrificed by cervical dislocation 
and, under sterile conditions, the spleen was removed to a 90 mm Petri dish (Sterilin). 
Using a 23G needle (VA, microlance Becton Dickinson) and syringe (Plasti-Pak, 
Becton Dickinson), the spleen was perfused with 20 ml of MEM-0++. Aliquots of 
the resulting cell suspension were seeded into a number of 25 cm^ tissue culture 
flasks (Nunclon, Life Technologies, Paisley, UK) at various cell concentrations:- 1 x 
lO^/ml; 1 X lO^/ml; 1 x lO^/ml. The culture medium was MEM-0++.
The cultures were routinely maintained at a cell density between 0.05 x 
10^/ml and 2 x 10^/ml at 37®C/5% CO2 in a fully humidified atmosphere. These 
wild cells were used to clone cell lines.
2.3.1 Cloning of cell lines
Wild cells were prepared in MEM-0++ at a nominal concentration of 5 
cells/ml. Aliquots of lOOpl were added to each well of 96-well, low - evaporation 
tissue culture plates (flat bottom) (Costar). This represented aliquots of, nominally, 
"0.5 cell/well". The plates were incubated for 4 days at 37^0/5% CO2 in a ftilly 
humidified atmosphere.
Individual wells were examined using an inverted microscope (Labovert, 
Leica). Positive wells (i.e. containing cells) were easily identified and the contents of 
individual wells were each transferred by Pasteur pipette to a 25 cm^ tissue culture 
flask containing MEM-0++, These cultures were maintained under the usual 
conditions until the cell concentration was of the order of 1-2 x 10^/ml. At this point 
the cloning procedure was repeated. Only then were cells from a positive well 
deemed to be a clone. Clone REL-C7 was used throughout this work (Rat, 
erytliroieukaemia - clone number 7}. This particular clone was chosen for its ability to 
undergo erytlu’oid differentiation on incubation with dimethylsulphoxide (DMSO).
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2.4 Cryopreservation of clones
The many cell lines produced by the cloning procedure were conveniently 
cryopreserved and may be stored for long periods of time (>5 years) in liquid 
nitrogen.
Cells from exponential-growing cultures were gently centrifuged 
(lOOg/lOmin) (Centra 3, Damon/IEC). The resulting cell pellet was resuspended in 
1 ml MEM-0++ and then additional medium was added to adjust the cell 
concentration to 10 x 10^/ml. The cells were placed on ice.
Dimethylsulphoxide (DMSO, Sigma) was used as cryoprotectant. DMSO 
was prepared at 20% (v/v) in MEM-0++ on ice. Equal volumes of cell suspension and 
DMSO solution were mixed and 2ml aliquots dispensed into Cryotubes (Nunc, Life 
Teclmologies, Paisley, UK) on ice. The final DMSO concentration was now 10% and 
the final cell concentration was 5 x 10^/ml. The cryotubes were transferred to a 
polystyrene container and placed in a -80^C freezer overnight. The aliquots were 
subsequently transferred to the vapour phase of a liquid nitrogen storage system (K 
Series, Cryostorage System, Jencons). In this particular case, the polystyrene 
container consisted of two polystyrene trays in which 15 ml centrifuge tubes (Bibby, 
UK) had been supplied. The cryotubes were placed in the slots of one tray and the 
second tray was placed on top to form an enclosed box. The two trays were secured 
together with labelling tape (Whatman, UK). This simple procedure avoided the need 
for a controlled rate freezer for cryopreservation (160).
2.4.1 Recovery of cryopreserved cell lines
There is not "one right way" to recover cells from cryopreservation. 
Depending on the cell type and method of freezing, different laboratories have 
developed teclmiques that are appropriate for their own use.
Aliquots were recovered from the vapour phase of liquid nitrogen and rapidly 
thawed by placing in a 37®C water bath. Immediately, the cryotube was removed 
from the water bath and the contents transferred to a 15 ml centrifuge tube (Bibby,
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UK) containing 1ml cold MEM-0++. The subsequent steps in cell recovery were 
performed on ice. A total of 10 ml of cold medium was added in a stepwise fashion 
of 10 X  1ml aliquots given at intervals of 2-3 minutes. This addition of medium over 
20-30 minutes allows the intracellular DMSO to leave the cell slowly, thus reducing 
the level of DMSO-induced membrane damage.
Wlien the rehydration process was complete the cells were centrifuged (lOOg 
/ lOmin). The resulting cell pellet was resupended and washed in MEM-0++ (lOOg / 
10m). After resuspension, these cells were ready for use.
Cell viability was determined by Trypan Blue exclusion (Life Technologies). 
Cells and Trypan Blue were mixed in the proportions 4:1, e.g. 4 drops of cell 
suspension and 1 drop of Trypan Blue were deposited in a bijou bottle, and left to 
stand at room temperature for 5 min. A small volume of culture/dye was removed and 
introduced into a haemocytometer counting chamber. Simultaneous counts were 
made for non-viable cells (staining blue, since the dye had penetrated the cell 
membrane) and for viable cells (colourless, since the intact cell membrane prevented 
penetration of the dye). A total of 400 (approx) cells was counted and the percent 
viable was calculated:- No. of viable cells counted x 100%
(No.of viable cells) + (No.of non-viable cells) 
Generally, there was some variation in the percentages of viable cells recovered from 
cryopreservation. This ranged from 10%-40% viability, perhaps reflecting the fragile 
nature of cultured cells.
2.5 Invitro clonogenic assay
A semi solid culture system was developed for clonogenic studies. This 
involved suspending cellsin MEM-0± containing 0.9% methylcellulose (Methocel, 
Fluka) and 20% FBS.
2.5.1 Preparation of methyl cellulose
Methyl cellulose (High Viscosity, USP Methocel, 3000-5000 mPa.s, Fluka) 
was prepared in batches of approximately 500 ml by adding 10.725g to a 1 litre
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Erlenmeyer flask containing a large (e.g. 60mm) magnetic stirring bar. The flask was 
sealed and autoclaved (15 psi, 20m). As a sterilisation check, an indicator tube was 
always included with the flask ( Sterilizer Control Tube Type 1, Albert Browne Ltd., 
Leicester). Two hundred and fifty millilitres of sterile double distilled water was pre­
heated to 90°C and added to the flask, stirring continuously. To avoid formation of 
clumps and ensure proper dispersion of the methyl cellulose, the suspension was 
stirred constantly.
Stirring was continued until the flask had cooled to hand-hot (~50°C) (1.5- 
2h). An equal volume (-250ml) of double strength MEM-0± was added. The flask 
was then transferred to the cold room and kept overnight at 4^C, stirring continuously. 
After stirring overnight, the medium appeared perfectly clear. If it was at all turbid, it 
was discarded. The medium was now viscous (e.g. the stirring bar was no longer able 
to turn). From the flask, aliquots of 20 ml were poured into sterile Universal 
containers (Sterilin). As a precaution, these Universals were stored in the dark at 
room temperature for 1 week. If there were no signs of contamination, the methyl 
cellulose was stored at -20^C mitil required (< 1 year). Wlien required for use, the 
methyl cellulose was thawed in a 37^C water bath. Once thawed, the methyl cellulose 
was used within one week, then discarded.
2.5.2 Clonogenic Assay
Depending on the number of tests to be set up, appropriate volumes of 
methyl cellulose and FBS were mixed in the proportion 2:1. Using a 2 ml syringe, 
aliquots of 1.8 ml were dispensed into 12 x 75 mm tubes (Falcon 2058) and the 
volume made up to 2.4 ml with MEM-O+H- containing cells. The tubes were capped, 
shaken vigorously and the contents allowed to settle for 2 min (no longer than 5 min). 
Using a 1 ml syringe, aliquots of 1 ml were dispensed into each of 2 suspension 
cultures dishes (35mm) (Lux Suspension Culture Dishes, Flow Laboratories). These 
were then placed inside a larger Petri dish (90mm) (Sterilin) together with a third 
small dish (30mm) (Sterilin) containing 4 ml sterile distilled water to reduce
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evaporation. The plates were incubated at 37^C / 5%C02 / humidified atmosphere 
for 4 days. Colonies were enumerated under an inverted microscope (Diavert, Leica). 
Usually, the entire plate was examined, using a grid to facilitate counting.
Example : For 4 tests:-
FBS : 3 ml
I
methyl cellulose : 6 ml
Total : 9 ml 4 x 1.8 ml aliquots in Falcon tubes.
Each tube still requires a further 600 pi to make the final volume 2.4 ml.
REL-C7 cells at 0.2 x 10^/ml. To each tube, add 12 pi (= 2.4 x 10^) of cells. 
Each tube now requires to be made up to 2.4 ml. For example, the control tube would 
receive 588 pi of MEM-0++ to make up the final volume to 2.4 ml. Alternatively, if 
"substance x" was being tested (at, say, 10% concentration) then that tube would 
receive 240 pi of substance x + 348 pi of MEM-0++. The final cell concentration, in 
this example, is 1 x 10^/ml. Routinely, this cell concentration was found to be the 
most convenient for subsequent colony counting. Clearly, the ingredients of each 
tube can be readily adjusted to investigate different cell concentrations, different 
factors, etc...
Ï2.6 In vivo Tumourogenic assay
The malignant nature of the cell lines was investigated in an in vivo 
tumourogenic assay. The recipient rats were Long Evans babes between 3 and 7 days 
old. Each animal received a sub-cutaneous injection (Becton Dickinson,
Microlance,"brown needle", 26G,3/8) of cells in a volume of 0.1 ml, administered 
under the loose skin behind the head in the scruff of the neck. A positive result was 
deemed to be the development of a tumour (tumour size, -10mm) at the site of 
injection. As soon as tumour formation was confirmed, the animals were destroyed 
by exposure to ether in a closed container until they succumbed. For numbers of cells 
required, time talcen for tumour formation, etc, see Results, Section 3.3.
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2.7 Chemically-induced differentiation
For the differentiation studies, tissue culture flasks containing medium were 
pre-equilibrated by incubating them at 37°C/5%C02/humidified atmosphere for 2-3 
hours before use. Several compounds were tested for their ability to induce 
differentiation in REL-C7 cells.
2.7.1 Dimethyl sulphoxide IDMSQXSigmal
Routinely, DMSO was used at a concentration of 1.5% (v/v) (equivalent to 
211 mM) (see Results Section). The appropriate volume of DMSO was always added 
to the culture medium prior to the addition of cells. This precaution was taken to 
prevent any damage to the cells from the rise in temperature due to the Heat of 
Solution, released when an aqueous phase (medium) and a non-aqueous phase 
(DMSO) are mixed. For example, to 5 ml of equilibrated medium, 75 pi of DMSO 
were added (i.e. 1.5%). Subsequently, cells were added (say 5 x lO^cells into 5 ml 
medium/DMSO to give 1 x lO'^/ml).
2.7.2 Hexamethylene bisacetamide (HMBA) (Aldrichl
A stock solution of HMBA was prepared at 50mM prior to each experiment
(HMBA M.Wt.200). Test concentrations investigated were in the range l-SmM.
HMBA was dissolved in MEM-0++ and filter sterilised (Millex-OR, 0.22 pm pore 
size, Millipore). Since HMBA has a tendency to become hydrated in aqueous 
solution and consequently lose its activity, it was prepai'ed fresh as required and used 
immediately.
2.7.3 all trans-Retinoic Acid (ATRA) (Sigma)
A stock solution of ATRA (M.Wt. 300.4) was prepared in ethanol (Analar, 
Burroughs) at 10"^ M. ATRA was examined for its ability to induce differentiation 
over the range 10“^ M - 10"^M. To avoid any possible toxic effects of ethanol on the
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cell cultures, the volume of ATRA solution added was kept to a minimum, e.g. 5pl 
ATRA into 5 ml cell cultures (1:1000).
2.7.4 Sodium butyrate (NaBuJ (BDHI
A stock solution of NaBu was prepared at 20mM in MEM-0++ (M.Wt.
110.09), and filter sterilised before use. The concentration range investigated was
0.05.M~5niM.
2.7.5 N-Methvl Formamide TNMFIIBDHJ
NMF (M.Wt. 59.07) is supplied at 17.12M. Appropriate dilutions were made 
in MEM-0++ to investigate the range 10"^M - lO'^M.
2.7.6 Cytosine Arabinoside fara-O tSigma)
Ara-C (M.Wt. 243.21) is supplied in a vial of 100 mg. This was dissolved in 
4.12 ml of the diluent provided to give a stock solution of lO'^M. Subsequent 
dilutions were made in MEM-0++. Ara-C was tested over the range 10"^M - lO'^M.
2.8 Assessment of differentiation
Differentiation could be assessed by:-
1. Morphology.
2. Demonstration of the appearance of haemoglobin by the benzidine reaction.
2.8.1 Morphology
After appropriate exposure to the inducing agent (eg DMSO), a Cytospin 
prepai'ation was made of the cells. Routinely, a small aliquot of cells was removed 
from culture and resuspended in HBSS to a concentration of 1 x lO^/ml. A 0.5ml 
aliquot (= 5 x 10  ^ cells total) was dispensed into the slide holder of a Cytospin 
(Cytospin 2, Shandon). The cell preparations were spun at 500 rpm for 5min. Cell 
lines in general, and these differentiated cells in particular, are rather fragile and slow
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speeds must be employed with the Cytospin to minimise cell damage (see Section 
2.4.1, recovery of cryopreserved cell lines). The slides were recovered, allowed to air- 
dry and were then stained with Wright's Stain in a staining machine (Hematek, Ames). 
The slides were mounted in DPX and the cells examined by light microscopy (Dialux, 
Leica) at low (lOOx) and high power (400 x).
2.8.2 Benzidine Reaction
The benzidine reaction is the oxidation of benzidine by the peroxide 
peroxidase system to a blue or brown product (161):-
■2H
• ««««*■ N H
2H
A CNH, NH
NH
NH
colourless blue brown
The intermediate compound, benzidine blue, is unstable and is oxidised to 
the brown colour without enzymatic intervention. However, benzidine blue can be 
stabilised by acidification of the benzidine-peroxide medium, resulting in a colour that 
is predominantly blue rather than brown. Since haemoglobin is a catalyst for the 
oxidation of benzidine, then the appearance of benzidine blue is a rapid and sensitive 
indicator of haemoglobin production.
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The benzidine stain for the detection of haemoglobin was used to determine 
the percentage of erythroid differentiated cells. At daily intervals 1 ml of culture was 
removed and transferred to an Eppendorf tube (1.5ml, Sarstedt) and centrifuged at 100 
g for 5min. The supernatant was carefully aspirated and the pellet gently resuspended 
in 0.2ml HBSS. To this was added an equal volume of the benzidine reagent.
The benzidine reagent consisted of benzidine hydrochloride and hydrogen 
peroxide (H2O2). Benzidine hydrochloride (Sigma) is supplied in an Isopac bottle 
containing 1 mg. To this was added 50ml of 0.5% acetic acid. Benzidine and 
^2^2(30%  solution, Sigma) were mixed in the ratio 1 part H2O2 to 99 parts 
benzidine in a bijou bottle (Sterilin).
After the addition of benzidine reagent to the cells, the percentage of 
haemoglobinized cells was determined within 5 minutes. A small aliquot was taken 
up in a capillary tube (Scotlab) and both chambers of a haemocytometer were filled 
(Improved Neubauer, Hawksley). The cells were examined under low power (lOOx) 
light microscopy (Dialux, Lieca). Benzidine +ve cells were characterised by a strong 
blue colouration; benzidine -ve cells appeared yellow. Routinely, at each assessment, 
both chambers of the haemocytometer were counted, approximately 400 cells per 
chamber. The percentage of benzidine positive cells was calculated.
2.8.2.1 Safety aspects of benzidine
Benzidine has been officially classified as a carcinogen (The Carcinogenic 
Substances Regulations 1967, Statutory Instrument No. 879). Although the use of 
benzidine is not actually prohibited, its use is restricted in accordance with the Health 
and Safety at Work etc. Act (1974). For the purpose of this study, a certificate of 
exemption from this restriction was obtained from the Flealth and Safety Executive 
Inspector of Factories (Exemption Licence No CAR/1985/1). This required that 
certain standards be met in the handling and disposal of benzidine.
Briefly, benzidine was stored under lock and key and its use was restricted to 
necessary personnel only. Benzidine was handled in a fume cupboard and the
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DMSO to differentiate, or whether a brief exposure to DMSO was sufficient to 
commit the cells to differentiate in the subsequent absence of inducer. In any given 
experiment, multiple flasks of culture were set up, one flask for each time point.
Routinely, DMSO was used as the chemical inducer. The optimal 
concentration of DMSO that produced the highest percentage of haemoglobinized 
cells was 1.5% (v/v). Concentrations above 1.5% resulted in excessive cell death (See 
Results Section 3.5.1). Cultures were established by adding cells to medium/DMSO 
at a final concentration of 5 x lO^/ml (see Section 2.7.1, Chemically-induced
centrifuging for 5 min at 100 g. The supernatant was poured off and the cell pellet
operator wore protective clothing, the minimum being impervious gloves. Ehrlich's 
reagent (p-dimethylamino-benzaldehyde in methanolic hydrochloric acid) was used 
for routine decontamination of equipment and work surfaces as required, including 
counting chambers and microscope. Eluiich's reagent was prepared by adding 25 g of 
-dimethylaminobenzaldehyde and 125 ml of 10 N hydrochloric acid to 2.5 litres of 
methanol (1% solution of p-dimethyl aminobenzaldehyde, 0.5 N hydrochloric acid).
i
pj
Wlien Elirlich's reagent was used, e.g. to decontaminate counting chambers, a 
bright red-brown precipitate was produced. All gloves, tissues, bijou bottles etc used 
with benzidine were collected in plastic containers (Sharpsafe, Frontier Medical 
Products) and a specialist company was contracted to dispose of the waste safely 
(Leigh Environmental Ltd., Norwood Industrial Estate, Rotherham Road, Killamarsh, 
Sheffield, S31 8DR).
2.9 Commitment to differentiate by exposure to DMSO
When REL-C7 cells were exposed to 1.5% DMSO, maximal numbers of
.benzidine +ve cells were obtained on day 4 (see Results Section 3.4.1). Experiments 
.were set up to investigate whether REL-C7 cells required to be exposed continually to
.11
.1 7
differentiation, DMSO). At appropriate time intervals, cultures were terminated by
'transferring the contents of a flask to a sterile 15 ml centrifuge tube (Corning) and I
gently resuspended in 1 ml of MEM-0++ (i.e. no DMSO). The volume was made up
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to 10 ml and the cells centrifuged as before. This washing procedure was repeated 
one more time and the cell pellet was resuspended in 1 ml of MEM-0++ and counted 
in a semi-automatic coimter (model M530. Coulter Electronics). Depending on this 
cell count, a portion of the cells was aspirated and the cell concentration adjusted to, 
nominally, 5 cells/ml (about 20-30 ml were usually prepared). Aliquots of 100 pi 
were dispensed into flat-bottomed 96-well tissue culture plates (Cel-Cult), i.e. "0.5 
cell/well". The plates were incubated at 37®C/5%C02/humidified atmosphere, and 
were assessed 5 days later. Wells positive for growth were identified by light 
microscopy (Diavert, Leica). From these wells, as much of the culture supernatant as 
possible was carefully aspirated. Usually, about 90pl of supernatant could be 
removed without disturbing the cells. To each well, 100pi of the benzidine reagent 
was carefully added and the nmnber of benzidine positive cells counted within 5 
minutes by inverted light microscopy.
2.10 ^H-Thymidine Incorporation following DMSO exposure
Cells were exposed to DMSO for various periods of time, then DNA 
synthesis was assessed by ^H-thymidine incorporation.
Initial experiments investigated DMSO exposui'e times of 241ir, 48hr, 721ir, 
and 961ir. The experiments were planned so that all the cultui'es were harvested at the 
same time. Thus, flasks of culture were set up on consecutive days. To measure the 
rate of proliferation, cultures were exposed to ^H-thymidine for the last 18hr of 
culture, prior to harvesting. The plan of the experiments can best be laid out thus :- 
Day 0 : Time 10.00. Flask A : 1 flask of 10ml of REL-C7 set up at O.OlxlO^/ml
in MEM-0++ / DMSO 1.5%.
Time 10.00 : Flask B : As above.
Time 10.00 : Flask C : As above.
Time 10.00 : Flask D : As above.
Time 16.00 : The contents of each flask were each transferred to a 
centrifuge tube and the cells spun down (lOOg / 5min).
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Day 1 :
Day 2 :
Day 3 :
:3i
The culture supernatants were aspirated and retained 
for subsequent use. The cell pellets were resuspended 
and a small aliquot of each was removed to perform a 
cell count. Using the appropriate previously retained 
culture supernatant, the cell concentration for each 
sample was adjusted to 0.5 x lO^/ml. Aliquots of 
200pi were dispensed into the wells of a 96-well flat 
bottomed tissue culture plate (Cel-Cult). Using a 
Hamilton Syringe (Capacity, 1 OOpl) and a dispenser 
adaptor (50 strokes), aliquots of 2pl of ^ H-thymidine 
(TRA 120, Amersham) were dispensed into each 
well. ^H-thymidine was supplied at 74 MegaBequerel
I
i
:
(MBq) in a volume of 2ml. A stock solution was 
prepared : 0.2ml of ^ H-thymidine was added to 4.8ml
of MEM-0++ to give 5ml of 1.48 MBq / ml. Each well 
.received 2pi, which was equivalent to O.OOSMBq.
Day 4: Time 10.00 : All cultures were terminated by harvesting the cells
onto glass fibre discs using a Titertek Cell Harvester 
530 (Flow Laboratories).
Thus, the cells from Flask A were cultmed for a total of 961u", continually in the ^
ïlpresence of DMSO (Day 0, 10.00 Day 4, 10.00). Similarly, the cells from
Flask B were exposed to DMSO for 72hr ; the cells from Flask C were exposed for 
48hr ; and the cells from Flask D were exposed to DMSO for 241ir. For the final 18hr 
of these cultures, ^H-thymidine was also present.
The discs were allowed to air-dry and then each disc was deposited 
into a numbered glass vial. Five millilitres of Ecoscint A scintillation solution 
(National Diagnostics) were added to each vial. The vials were then tightly capped 
and counted for 5 min on a Packard 300C P-counter. Control wells were included
;î
1
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which contained culture medium only. These control wells gave a measure of the 
background counts.
Results were expressed as counts per minute (cpm). The background cpm 
were deducted from all the test samples. Additional controls were set up which 
exactly duplicated these culture conditions, except that no DMSO was used. These 
cultures gave a measure of the amount of ^ H-thymidine taken up by normally 
proliferating cells. The cells in flask A, for example, were cultured for a total of 961ir 
without any replenishment of the medium. Although the starting cell concentration 
was low (0.01 X  10^/ml), it is conceivable that some essential nutrients may become 
depleted over a 961ir culture. This would likely have an effect on the proliferative 
status of the cells, i.e. their growth would be retarded. Thus, parallel cultures 
(containing no DMSO) were set up to ensure that the level of proliferation was not 
adversely affected by the culture conditions themselves.
A second series of experiments was set up, investigating shorter DMSO 
exposure times, e.g. 21u*, 41u*, 61ir, and 81u\ The method outlined previously was 
modified to accomodate these shorter exposure times. Again the experiments were set 
up so that all the cultures were harvested at the same time. Thus, flasks of culture 
were set up at staggered time intervals, every 2 hours. In these experiments the 
cultures received a 90 min pulse of ^ H-thymidine (cf. 18hr pulse in the previous 
experiments). The plan of the experiments was:-
Day -1 : 10 flasks of 9ml of MEM-0++ were incubated overnight to allow
the medium to equilibrate to the culture conditions.
Day 0 : Time 9.00 : Flask A : 1 flask of REL-C7 set up at 0.05 x
106/ml in MEM-0++ / DMSO 1.5%,
: 1 flask of REL-C7 set up at 0.05 x 
10^/ml in MEM-0++ alone (i.e. control)
: Time 11.00 : Flask B : As above.
; Time 13.00 : Flask C : As above.
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: Time 15.00 : Flask D : As above, then immediately the contents of
each flask were each transferred to a centrifuge tube 
and the cells spun down (lOOg / 5min). As before, each 
cell pellet was resuspended in the appropriate cultui'e 
supernatant and the cell concentration was adjusted to
0.05 X  10^/ml. Aliquots of 200ql were dispensed into 
the wells of a 96-well flat-bottomed tissue culture plate 
(Cel-Cult).
: Time 15.30 : All wells received 2|ul of ^ H-thymidine (as before).
: Time 17.00 ; All cultures were terminated by harvesting the cells
onto glass fibre discs as described eaiiier. Thus, the cells from Flask 
A were cultur ed for a total of 81n’, continually in the presence of 
DMSO (9.00->-»17.00). Similarly, the cells fi'om Flask B were
exposed to DMSO for 61ir; Flask C for 4hr; and Flask D for 21ir. For
the final 90min of the cultures, ^H-thymidlne was also present.
The samples were counted as described earlier.
2.11 Cell Cycle Analyses
The cell cycle status was assessed by measuring the uptake and incorporation 
into DNA of a thymidine analogue, bromodeoxyuridine (BrdU). Cells can be pulse 
labelled with BrdU and those cells that are synthesizing DNA (i.e. in S-phase of cell 
cycle) will incorporate BrdU into the DNA. An appropriate anti-BrdU antibody is 
used to identify those cells undergoing DNA synthesis at the time of the pulse. The 
total DNA content of cells was assessed by propidium iodide (PI) uptake.
Reagents : 1. Normal S aline
2. Phosphate buffered saline (PBS)
3. Bovine serum albumin, 10% in PBS.
4. Tween 20, 0.5% in PBS.
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5. Bromodeoxyuridine, (BrdU), ImM stock solution in PB S, stored
at -20OC.
6 . Anti-BrdU (Becton Dickinson, Cat. No.7580).
7. Fluoroscein isotliiocyanate (FITC) conjugated F(ab')2 rabbit anti­
mouse IgG (RAM IgG)
8. Propidium iodide, 20 pg/ml in PBS.
9. Hydrochloric acid, 4N.
10. Sodium Hydroxide, 0.07N.
11. Ethanol, 70% at -20^C.
12. Sodium tetraborate (Na2 B4 O7), 0.1 M, pH 8.5.
Cells were cultured in the presence of DMSO as detailed earlier, except that
the cell concentration was 0.1 x 10^/ml. Wlien the cells had been exposed to DMSO 
for the appropriate time, they were transferred to a 15 ml centrifuge tube, washed 
twice with MEM-0++ as before, and then seeded into 25 cm^ tissue culture flasks 
containing 10 ml of equilibrated MEM-0 ++ with BrdU at 10 pM.
After a 30 min incubation, the cells were transferred to a centrifuge tube, and 
washed twice with PBS (Gibco) (100g/5min). The final supernatant was poured off 
and the cells resuspended in the small residual amount of supernatant remaining in the 
centrifuge tube (approx 100 pi). The cell suspension was chilled on ice (for about 5 
min) and made up to 2 ml with cold 70% ethanol with vigorous mixing. The cells 
were fixed at 4^C for 30min.
To denature the cellular DNA and produce single stranded molecules, 2 ml of 
4N HCl was added and the cell suspension was further incubated for 30min at room 
temperature. At this stage, the fixed cells become very sticky and great care was 
taken to avoid cell aggregates forming. For example, addition of HCl to the cell pellet 
will aggregate all the cells. The cells were centrifuged (100g/5min) and the pellet 
resuspended in 1 ml of 0.1 M Na2B4 0 7  to neutralize the acid. Aliquots of 1 x 
lO^cells were dispensed into Falcon tubes (Falcon 2058) and centrifuged 
(100g/5min). The supernatants were carefully aspirated and the pellets resuspended in
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50 pi of 0.5% Tween 20/PBS. To each aliquot was added 20pl of anti-BrdU (Becton
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Dickinson Cat No 7580). Following a 30min incubation at room temperature, the ?€■icells were spun down (lOOg for 5min), then re suspended in 50 pi of 0.5% Tween
20/PBS. To each cell suspension were added 100 pi of a 1:10 dilution of FITC 
conjugated-RAM IgG (Dako). The cells were incubated for 30min at room A
temperature, spun down (lOOg for 5min) and the resulting pellets resuspended in 1 ml 
of PBS containing 5 pg/ml of propidium iodide (PI) (Sigma).
• T-For each sample, 10,000 cells were analysed on the FAC Scan Flow 
Cytometry Analyzer (Becton Dickinson) using 488 nm excitation light. For two
-îïï-colour fluorescence, band pass filters 530/30 (for FITC) and 620/35 (for PI) were used
■v'Nin combination with a dichroic mirror 570. Cells were analyzed for their positivity to 
the BrdU antibody (FLl) and for their PI uptake (FL2). If
In addition, control cells were analyzed to allow baseline settings to be
entered into the FAC Scan prior to analyzing the test samples. Routinely, these control
cells were peripheral blood lymphocytes from normal donors (e.g. laboratory 
personnel). Since lymphocytes in the circulation are normally non-proliferative, BrdU f |
uptake should be minimal.
i
2.12 Assessment of cell size
All the flow cytometry was kindly performed by Mr. Charles Pearson, 
Haematology, GRI. Flow cytometry, for example using a FACScan, can be used both I
for analysis and separation of cells in suspension (162). As well as measuring the |.
fluorescence of individual cells as they flow, single file, in a stream past a laser 
illumination system, flow cytometry can also measure cell size. FACS has a detector 
for forward light scatter (FLS) - this essentially measures cell size.
FACS uses the amount of light scattered at a small forward angle (IO-I30) as 
an index of cell size. This measure is mainly due to diffraction and is not strictly 
proportional to cell size because it is influenced by such cell properties as asymmetry, 
reflectivity, refractive index, granularity, and nuclear size. Nevertheless, there is a I
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strong positive correlation between cell size as measured by the FACS scatter detector 
and cell size as measured by sedimentation at unit gravity (163) or with the Coulter 
Counter (164).
REL-C7 cells were exposed to DMSO for various time intervals as detailed 
before (24hr, 481ir, 72hr, and 96hr). Cultures were set up at a concentration of 0.05 x 
10^/ml in a 5ml volume of MEM-0+4-/DMSG 1.5%. After the appropriate period of 
exposure to DMSO, the contents of the flasks were each transfeiTed to a 15ml 
centrifuge tube and the cells spun down (lOOg / 5min). The pellets were resuspended 
and washed in 5ml of Sheath Fluid (Becton Dickinson) (lOOg / 5min). This washing 
procedure was repeated and the cell pellet was resuspended and made up to - 1ml with 
Sheath Fluid. The cells were analyzed on a FACScan (Becton Dickinson).
For each sample, 10,000 cells were acquired and the FLS signal analyzed. 
FLS was amplified on a linear scale. The histogram profiles generated fi’om each 
sample were overlaid together on the one display to allow direct comparison of
relative cell sizes. Thus, any shift in cell size could be clearly demonstrated.
2.13 Scanning Electron Microscopy (SEMI
SEM was kindly provided by Mr J Anderson of the Department of
Pathology, Glasgow Royal Infirmary. Briefly, following exposure to DMSO for
various periods of time, REL cell suspensions were passed over a Millipore filter (25
mm diameter, 0.45 pm pore size) and the cells were retained on the filter surface.
With the filters still in the filter holders, the cells were fixed in 4%
glutai'aldehyde for 15min, rinsed briefly in distilled water, then dehydrated through 3
X  10 minutes changes of 100% ethanol. The filters were removed from the holders,
.mounted on card and transferred to a critical point drier (CPD) (Bio-Rad) for the final
-drying proceduie in liquid C02- When the filters were completely dry, they were
. '■ kremoved from the CPD, cut into strips, mounted onto copper stubs and coated with 
gold in a sputter coater (Bio-Rad). SEM was performed on a Joel 1200EX 
transmission microscope with a scanning attachment using an accelerating voltage of
■
;r
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80 kV. Images were recorded on Ilford FP4 film and processed using conventional 
darki'oom techniques.
2.14 Adaptation of REL-C7 cells to serum- free culture.
Routinely, cells were cultured in MEM-0++ (i.e. MEM-0 supplemented 
with 10% FBS). Flowever, cultures could be readily adapted from serum- containing 
medium to serum- free medium.
Experiments were performed with two commercially available preparations :-
(a) SF-1 (Northumbria Biologicais)
(b) High Protein Hybridoma Medium (HPHM) (Gibco/BRL). 
However, most of the data were generated using an in-house preparation which 
consisted of MEM-0= supplemented with ITS-Premix (Insulin; Transferrin;
Selenious Acid) (Collaborative Research) at 0.1 % and bovine serum albumin (ESA) 
(Sigma) at 1%.
ITS-Premix comes as a lyophilised powder, supplied in a vial sufficient for 5 
litres of medium. Each vial contained 25mg of insulin, 25 mg of transferrin and 25 pg 
of selenious acid. The powder was reconstituted with 5 ml of appropriate sterile 
serum- free culture medium. This stock solution was at 1000 X strength. Aliquots of 
200 pi were dispensed into Nunc cryotubes and stored at -20®C until required. As 
stated above, the final working concentration of ITS-Premix was 0.1% (i.e. 1/1000- 
fold dilution) i.e. insulin 5 pg/ml, transferrin 5 pg/ml and selenious acid 5 ng/ml as 
per manufacturer's recommendations.
Bovine serum albumin (BSA) was de-ionized using analytical grade mixed 
bed resin beads (type AG501-X8(D), Bio-Rad). Ten grammes of BSA were dissolved 
in 44 ml of double distilled water. Approximately 1 gm of resin beads was added, and 
the solution was gently mixed on a Roller Mixer (Model CB 5150, Denley) for 1 hour. 
The resin beads changed colour from blue to yellow. The exhausted beads were 
removed by centrifugation (400 g/lOmin). The de-ionization procedure was repeated 
by again adding 1 gm of resin beads and mixing gently for 1 hour. Usually at this
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stage the de-ionization procedure was complete as demonstrated by the fact that while 
some beads were exhausted (yellow), others remained blue. As before, the resin 
beads were removed by centrifugation. To this de-ionized BSA was added an equal 
volume of double strength MEM-0±
MEM AA : 4.0ml
MEM NEAA : 2.0
Vitamins : 2.0
Pyruvate : 1.0
Pen/Strep : 2.0
Na HCO3 : 2.5
L-glu : 2.0
EBSS(lOx) : 8.45
Distilled water : 26.05
Total : 50.0
The resulting solution was approximately 10% BSA (w/v). The solution was 
sterilised tlirough a Millipore disposable filter ("Millex-OR", Pore size 0.22 pm). 
Aliquots of 5 ml were dispensed into sterile bijou bottles and stored at -20^C until 
required.
Cells were adapted to serum- free conditions by stepwise reduction of the 
serum concentration in the culture medium. For example, cells originally maintained 
in MEM-0++ were spun down (100 g for 5min) and washed twice with a mixture of 
MEM-0+-I- and, say, SF-1 in the ratio 1:9 (i.e. 1%FBS). After the second wash, the 
cells were resuspended in this medium mixture at an appropriate concentration (5 x 
lO^/ml) and were maintained under the usual culture conditions for 48 h to allow the 
cells to adjust to this reduction in FBS. After this time interval, the process was 
repeated using a medium mixture of MEM-0++: SF-1 of 0.5:9.5 (i.e. 0.5% FBS).
This procedure was repeated tlirough several cycles to bring the FBS concentration 
down consecutively to 0.25%, 0.10% and finally 0.05% FBS (i.e. a 200 fold reduction
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in the FBS concentration from the original culture conditions). At this stage, the cells 
were washed twice, as before, with serum-free medium (eg SF-1) and resuspended at 
5 X lO^/ml in that serum-free medium.
Î2.15 Determination of doubling-time for REL-C7 cells
After cells had been weaned off serum and adapted to serum free culture 
conditions, it was important to ensure that cells could still proliferate at an acceptable 
level. For this reason, grovrth curves were constructed for cells grown under various 
cultiue conditions.
From established cultures, growing exponentially, cells were aspirated (5- 
10ml) and spun down (100 g for 5min). The supernatant was poured off and the cell 
pellet gently resuspended in the residual supernatant (0.3 ml approx). A small portion
of this was counted in a Coulter Counter. An appropriate volume of cells was added 
to duplicate flasks of equilibrated medium to give a final concentration of 0.05 x 
10^/ml. At various time intervals thereafter, a small portion of the culture was
Cell doubling : 0.08 x lO^/ml. 
0.16 
0.32 
0.64
1.28 X lO^/ml. 
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in 62 hr (84-18)
J
1 
'1
I I
aspirated and introduced into a haemocytometer counting chamber. All four "corner 
squares" were counted and the cell concentration calculated. This procedure was 
repeated over five days to build up a graph of increasing cell nuiubers versus time.
Doubling times were calculated for various culture conditions.
For example:
Time 0 : cultures established at 0.05 x 10^/ml
Time 18 h : cell count 0.08 x 10^/ml
Time 84 h : cell count 1.3 x 10^/ml.
‘
-
?
y  4 doublings of cell numbers
i.e. 4 doublings in 62 hr = doubling time of 15.5 lir. The calculation of these 
doubling times allowed direct comparisons to be made between various media for 
their ability to support cell proliferation.
loss of viability or extension to their doubling time (see Section 3.6.4).
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2.16 Substitution of FBS by various sera
To fiu'ther investigate the role of serum in the maintenance of REL-C7, 
cultures were adapted from the usual FBS containing medium to MEM-0 containing 
alternative sera. These sera were:- |
a) Mouse
b) Rat
'I:c) Rabbit 'I,
Td) Horse lü
e) Human
Blood from mice and rats was obtained by cardiac puncture of anaesthetised 
animals (Animal Unit, University Department of Pathology, GRI). Rabbit blood was ,
obtained by ear-bleed. In all cases, the bloods were dispensed into serum bottles . |
(L.I.P.Ltd., Shipley, West Yorkshire), allowed to clot and spun down (400g for i:
lOmin). Serum was carefully aspirated, filter sterilized (Millipore, "Millex-OR, pore #1
,size, 0.22pm) and stored at -20°C until required. S
Horse serum was commercially available (Life Technologies). Human serum
'Îwas available from an "in-house" pool of sera from normal donors, namely, laboratory
'•"IIpersomiel. Cells were adapted to these alternative sera in a similar fashion to the 
adaptation to serum- free conditions, i.e. progressively reducing the FBS 
concentration in the culture medium, while simultaneously increasing the 
concentration of the particular alternative serum. The total serum concentration was
:
maintained at 10% at all times. Cells readily adapted to alternative sera without any f
The cytokines investigated were
(a) human Interleukin-6 (IL-6),
(b) human Interleukin-11 (IL-11),
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2.17 Modification of FBS by heat treatment
In a further attempt to define more precisely the role of FBS in the 
proliferation of REL-C7 cells, FBS was modified by 2 methods of heat treatment.
2.17.1 Heat inactivation
Aliquots of 20 ml of FBS were dispensed into sterile Universal containers 
(Sterilin). These were then placed in a water bath and incubated at 56°C for 30min.
This FBS was then deemed to be "heat inactivated". ■
1
2.17.2 Dénaturation
Aliquots of 10 ml of FBS were dispensed into sterile glass Universal
.containers (McQuilkin). These were then plunged into boiling water in a Dental 
.Steriliser ( Surgical Equipment Supplies Ltd., London) for 5 min. Some pale 
floccules often precipitated out. This precipitate was allowed to settle out and the 
FBS supernatant, now pale yellow, was aspirated and used in subsequent 
investigations. This FBS supernatant was deemed to be "denatured FBS".
2.18 Addition of recombinant growth factors to serum-free medium
To try to identify some of the crucial activities that regulate commitment and 
differentiation, serum-free media were prepared (Section 2.14) which were 
supplemented with a range of cytokines / growth factors. The basic serum-free
medium was the in-house preparation, MEM-0±/ITS, BSA. Prior to investigating the
effects of added cytokines, the REL-C7 cells were adapted to this serum-hee medimn 
.as outlined in Section 2.14.
(c) human granulocyte colony stimulating factor (G-CSF),
(d) human macrophage colony stimulating factor (M-CSF),
,(e) murine granulocyte-macrophage colony stimulating factor (GM-CSF),
1Us
56
I(f) murine kit ligand (KLS),(g) human macrophage inflammatory protein-1 alpha (MIP~la).
Note that these cytokines were of either human or murine origin rather than rat. This 
reflected the difficulty in obtaining rat recombinant cytokines. Wliere possible, murine 
cytokines were used since they would be most likely to be active on rat cells. Wliere 
murine cytokines were unavailable, human cytokines were used.
Some cytokines are species specific. Others show some cross species activity. 
For example, mouse and human IL-6 have 42% amino acid homology. Although 
murine IL-6 has no activity on human cells, human IL-6 is functional on murine cells 
(165). Thus, human IL-6 was presumed to be appropriate for use on rat cells.
Similarly, human IL-11 is active on murine cells (166).
For G-CSF, there is about 73% amino acid homology between the human and 
murine proteins, and both act across species (167)
For M-CSF, there is about 82% amino acid homolgy between human and 
murine proteins in the N-terminal region. With this degree of homolgy it is rather 
surprising that murine M-CSF is not active on human cells. However, human M-CSF 
is active on murine cells (168).
For GM-CSF, there is about 56% amino acid homology between human and 
mouse, and no cross species activity (169). Fortunately, a source of murine GM-CSF 
was available.
For KLS (Stem Cell Factor), there is 79% amino acid homology between 
human and mouse. Although human KLS has only very weak activity on mouse cells, 
murine KLS is active on human cells (170). In any event, a source of murine KLS was 
available.
For M IP-la, there is about 73% amino acid homolgy between human and 
mouse. The human and mouse proteins show cross-species activity (171).
2.18.1 Interleukin-6 (IL-6)
E.coli derived recombinant human IL-6 was obtained from Genetics Institute, 
Cambridge, Mass.,USA at a concentration of 22|ag/ml. A stock solution was prepared 
by adding 0.5ml of IL-6 (22|Lig/ml) to 10.5ml of PBS/0.1%BSA to give a final 
concentration of 1 pg/ml. This was dispensed into aliquots of 1ml in Nunc cryotubes
6 were prepared the recommended concentration; a preparation which was a 10-fold
final volume of 20ml.For example,
400pl of IL-6 (1 pg/ml)
20ml of IL-6 at 20ng/ml.
19.6ml of MEM-0±/ITS, BSA
and stored at -20^C rmtil required. From the manufacturer's data sheet, the optimal 
working concentration was in the region of 20ng/ml. Thus, tlnee concentrations of IL-
dilution of this; and a preparation which was 10 times more concentrated than the 
recommended, viz., 2ng/ml, 20ng/ml, and 200ng/ml. These were all prepared by 
adding the appropriate volume of IL-6 (1 pg/ml) to MEM-0±/ITS, BSA to obtain a
ÎI
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2.18.2 Interleukin-11 (IL-11)
E.coli derived recombinant human IL-11 was obtained from Genetics Institute,
Cambridge, Mass., USA. As above, a stock solution of 1 pg/ml was prepared in 
PBS/0.1% BSA, and aliquots of 1ml were stored at -20°C until required. The 
recommended concentration was lOng/ml from the manufacturer's data sheet. As 
before, a concentration higher, and a concentration lower than the recommended dose 
were both prepared, all in a final volume of 20ml of MEM-0±/ITS, BSA. Thus, the 
concentrations were 1 ng/ml, lOng/ml, and lOOng/ml.
2.18.3 Granulocyte colony stimulating factor (G-CSFl
Recombinant human G-CSF was a generous gift from Dr. T.L.Holyoake,
Beatson Institute for Cancer Research, Glasgow. It was supplied as a conditioned 
medium (CM) from a Chinese Hamster Ovary (CHO) cell line engineered to express
S
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human G-CSF. Optimal biological activity was obtained by using the CM at a final
a
I
concentration of lOpl/ml. As before, tliree concentrations were prepared Ipl CM /
ml, lOpl CM/ml, and 50pl CM/ml. All dilutions were made into MEM-0±/ITS, BSA.
It was felt inappropriate to prepare the highest concentration at 1 OOpl CM/ml 
.of cell culture, and instead, 50pl CM/ml of culture was prepared. This was because
the culture medium in which the CHO cells had been maintained was supplemented
with FBS at a final concentration of 10% (v/v). Had lOOpl of this CHO conditioned 
.medium been added to 900pl of MEM~0±/ITS, BSA, then the final product would 
.have contained FBS at 1% (v/v). Earlier studies (Section 3.6.3) indicated that medium 
supplemented with FBS at 1% could support a low level of DMSO-induced erythi'oid 
differentiation. It was possible to get round this problem by preparing the highest 
concentration of G-CSF at 50pl CM/ml, resulting in a final FBS concentration of
0.5%. From previous results, this value was acceptable.
: l
2.18.4 Macrophage colony stimulating factor fM-CSF)
Recombinant human M-CSF was obtained from Genetics Institute, 
Cambridge, Mass., USA. From the data sheet, the recommended working 
concentration was lOng/ml. As before, tliree concentrations were prepared, each in 
20ml of MEM~0±/ITS, BSA :-lng/ml, lOng/ml, and lOOng/ml.
2.18.5 Granulocyte-macrophage colony stimulating factor fGM-CSFI
Recombinant murine GM-CSF was obtained from Genetics Institute, 
Cambridge, Mass., USA as a conditioned medium (CM) prepared from cultures of 
COS-1 cells engineered to express murine GM-CSF. The activity of GM-CSF in the 
CM supplied was 16,300U/ml. A stock solution of l,OOOU/ml was prepared by taking
0.613ml of GM-CSF (16,300U/ml) and making it up to 10ml with MEM-0±/ITS, 
BSA. This stock solution was used to prepare a range of concentrations :- 0.5U/ml, 
5U/ml, and 50U/ml.
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but, instead, formed an adherent monolayer (Section 3.7). Under light microscopy, the
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2.18.6 Kit Ligand (KJ.S)
Recombinant murine KLS (also known as Stem Cell Factor / Mast Cell 
Growth Factor / Steel Factor) was a generous gift from Dr. T.L.Holyoake, Beatson 
Institute for Cancer Research (BICR), Glasgow. It was supplied as a medium 
conditioned by CHO cells expressing soluble kit ligand. Titration studies at Genetics 
Institute indicated that 20pl of this CM had the equivalent activity of 12ng of 
recombinant purified material. Other cell culture studies at BICR indicated that a 
working concentration of 20ql of KLS-CM/ml culture (equivalent to 12ng/ml) 
produced maximum activity. For the studies here, three concentrations were prepared 
2 |l i 1 KLS-CM/ml ( = 1.2ng/ml), 20ql KLS-CM/ml (= 12ng/ml), and 50pl KLS- 
CM/ml (= 30ng/ml).The highest concentration was 50ql/ml and not 200pl/ml so as to 
avoid the problem of FBS carry-over explained above in Section 2.18.3.
2.18.7 Macrophage inflammatory protein-l alpha (MIP-lal
Recombinant human M IP-la was a generous gift from Dr. T.L.Holyoalce,
■BICR, Glasgow. It was supplied as a conditioned medium prepared from cultures of
COS-1 cells engineered to express human M IP-la. Titration studies indicated that the
.concentration of M IP-la was approximately lOpg/ml. In ongoing culture studies at
"I#
?
%
BICR, a concentration of 200ng/ml gave maximum biological activity. As before, 
three concentrations were prepared in MEM-0±/ITS, BSA :- 20ng/ml; 200ng/ml; and 
500ng/ml. The highest concentration of M IP-la was 500ng/ml rather than 2,000ng/ml 
to avoid the potential effects of FBS carry-over.
2.19 Staining of adherent REL-C7 cells
Methods have previously been described for adapting REL-C7 cells to culture 
conditions that were serum-free, or contained serum at a reduced level (Section 
2.14). When the concentration of FBS was reduced from 10% to 0.5%, a chance 
observation was made that REL-C7 cells no longer proliferated in suspension culture.
1
gross morphology of these adherent cells appeared different from suspension culture 
cells. Specialized staining procedures were performed to try to characterize these 
adherent cells
(a) Periodic Acid-Schiff (PAS),
(b) Sudan Black B,
(c) alpha-Naphthyl Acetate Esterase (a-NAE).
The stains were kindly set up by Mr.C.Pearson, Haematology, GRI, according to the 
routine departmental protocols. A brief description is given below.
2.19.1 REL-C7 cells from suspension culture
These were cells that had been routinely maintained under standard conditions 
in MEM-0++ as outlined earlier.
2.19.2 REL-C7 cells from adherent monolayer cultures
As described previously (Section 2.14), by a progressive step-wise reduction 
in the concentration of FBS, REL-C7 cells could be adapted to grow in MEM-0± 
/0.5% FBS. Prior to staining, the cells were recovered from the plastic surface of the 
tissue culture flask by vigourous pipetting. With a sterile, glass Pasteur pipette (Long 
form; McQuilkin, Glasgow) and a rubber pipette bulb, an amount of culture 
supernatant was drawn up into the pipette. This was then forcibly expelled at the 
adherent cells, thus releasing them from the plastic. An appropriate volume of 
supernatant, now containing cells in suspension, was removed for staining purposes.
2.19.3 Normal rat bone marrow ceils
As a control, normal rat bone marow cells were set up. A rat of the Long 
Evans strain was sacrificed by cervical dislocation, and a femur excised. Femoral 
marrow cells were obtained by coring the shaft of the femur with a needle (25G) and 
syringe, and flushing out the marrow with 5ml of HBSS into a bijou bottle. The cells 
were disaggregated into a single cell suspension by repeated pipetting.
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2.19.4 Preparation of Cytospins
Prior to staining, Cytospin preparations were made of each lot of cells 
(Cytospin 2, Shandon). In all cases, the cell concentration was adjusted to 2 x 10^/ml 
in HBSS. The Cytospin chambers were assembled and an aliquot of 0.5ml of cell 
suspension was added to each (i.e. equivalent to 1 x lO^cells per slide). To minimize 
any structural damage as the cells were deposited on the slides, slow speeds were used 
500rpm for 5 min. The slides were then removed from the chambers and the cell 
"spots" allowed to air-dry.
2.19.5 Periodic Acid-Schiff tPASl
The reagents used were mainly from the Sigma Kit 395-B.
1. Slides were placed in a rack and fixed in cold methanol for 15min, then 
washed for 5min in rumiing tap water.
2. A solution of 1% periodic acid was prepared, and the slides were immersed in 
this for lOmin. Again, they were washed in rumring tap water.
3. The slides were immersed in Schiff s reagent for 30min, washed in running tap 
water for 5min, and then air-dried.
4. The slides were counterstained with Haematoxylin for 5min, then "blued" by 
immersion in Scots Tap Water for 30sec (Scots Tap Water : 3.5g of sodium 
bicarbonate, 20g magnesium sulphate, dissolved in 1 litre of distilled water).
5. After the slides were air-dried, they were mounted in Depex.
2.19.6 Sudan Black B
The reagents used were mainly from the Sigma Kit 3 8OB
1. Fixative was prepared by adding 25ml of acetone to 75ml of glutaraldehyde 
solution.
2. Slides were immersed in fixative for Imin on ice, with gentle agitation, and 
then washed in distilled water.
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3. Slides were immersed in Sudan Black B Staining Reagent for 5min with 
intermittent agitation.
4. Slides were rinsed tlrree times in 70% ethanol, or additional times until no 
more dye was washed out. They were then thoroughly rinsed in distilled water.
5. The slides were counterstained in Haematoxylin Solution (Gill No.3, GHS-3) 
for 5min, and then rinsed in tap water.
6. After air-drying, the slide were mounted in Depex.
2.19.7 alpha-Naphthyl Acetate Esterase (a-NAE1
The reagents used were mainly from Sigma Kit 91-A. Fixative was made up 
fresh before use. One millilitre of citrate concentrate solution was diluted in 9ml de­
ionised water. Four millilitres of this citrate was added to 6ml of acetone. After
thorough mixing, 9ml of this citrate:acetone was added to 1ml of methanol.
1. Slides were immersed in the above fixative for 30sec at room temperature,
washed in de-ionised water and allowed to air-dry.
2. TRIZMALTM pH 7.6 buffer concentrate was diluted 1:10 by adding 5ml of
buffer to 45ml of de-ionised water. To this 50ml of diluted buffer was added
1 capsule of Fast Blue BB Salt with constant stirring.
.3. Two millilitres of a-naphthyl acetate were added to the mixture prepared in
step 2 .
4. This solution was then filtered through Whatman No.4 filter papers into a 
Coplin jar.
5. Slides were then immersed in this staining solution and incubated for 30min at 
370c
6. The slides were washed tluee times in tap water and counterstained for 1 Omin
in Mayer's Haematoxylin Solution.
' '
7. Finally, the slides were washed in de-ionised water, air-dried and mounted in 
glycerol/gelatin
':0/I
2.20 Immunophenotypic analyses of REL-C7 cells
Further characterization of REL-C7 cells was obtained by immunophenotypic 
analyses. This was done by incubating cells with a range of specific anti-rat 
monoclonal antobodies:-
Monoclonal
Antibody
Supplier Catalogue
Number
Specificity
OX-1 Serotec MCA 43G Leucocyte common antigen (LCA) 
(CD45)
OX-4 Sera-Lab MAS 029p Immune associated (la)
OX-41 Serotec MCA 274 Macrophage and granulocytes
OX-44 Serotec MCA 371 All myeloid cells and peripheral 
lymphocytes (CD53)
OX-45 Sera-Lab MAS 260p Surface glycoprotein present on 
haematopoietic cells and 
endothelial cells (CD48)
ED-1 Serotec MCA 341 Monocytes and macrophage
The Sera-Lab antibodies (OX-4 and OX-45) were supplied as 5ml of culture 
supernatant, ready to use. The antibodies were dispensed into aliquots of 250pl and 
stored at -20^C until required.
The Serotec antibodies (OX-1, OX-41, OX-44, and ED-1) were supplied as
0.25ml of ascitic fluid. Stock solutions were prepared by adding this 0.25ml volume 
to 2.25ml of PBS / 0.5% BSA (i.e. a 1:10 dilution). The stock solutions were 
dispensed into aliquots of 200pi in Nunc cryotubes and stored at -20®C until required. 
Prior to use, an aliquot was thawed, and diluted 1:10 again, giving approximately 2ml 
of working concentration antibody.
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As outlined in the previous sections (2.19.1, 2.19.2, and 2.19.3), three lots of 
cells were analyzed:-
(a) suspension culture REL-C7 cells,
(b) adherent monolayer REL-C7 cells,
regular mixing.
iS»;'
(c) normal rat bone marrow cells.
For each cell type, cell suspensions were prepared at a concentration of 5 x lO^/ml in 
PBS.
‘i
1. To each tube (Falcon 2058, A.& J. Beveridge) was added 200pi of cell 
suspension (i.e. equivalent to 1 x lO^cells).
2. Fifty microlitres of the appropriate antibody was added, then the contents were 
thoroughly mixed and placed on ice for 3 Omin with frequent (every 5 min) 
agitation.
3. The tubes were topped up with cold FBS (-4ml) and spun for lOmin at lOOg 
in a refrigerated centrifuge at 4®C (Centra 7R, Damon/IEC).
4. The supernatants were poured off gently, the pellets were resuspended by mild 
agitation, and the tubes were topped up with PBS and washed as in step 3.
5. Again the supernatants were poured off gently, but this time the pellets were 
not resuspended.
6. To each pellet was added lOOpl of GAM-FITC (FITC-conjugated goat anti­
mouse antibodies; previously diluted 1:10 in PBS to give a working 
concentration). The contents were mixed and placed on ice for 3Omin with
.1
-
II
7. The cells were washed twice as in steps 3, 4, and 5.
8. For flow cytometric analyses, the cell pellets were gently resuspended in 1ml 
of Sheath Fluid (Becton Dickinson).
Appropriate isotype controls were set up for each antibody mouse IgG^(Serotec;
MCA 1209) and mouse IgG2(Serotec; MCA 1210).
I
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2.21 Cytogenetic analyses of REL-C7 cells
Cytogenetic analyses were kindly performed by Dr. George Breckon, MRC
Radiobiology Unit, Chilton, Didcot, Oxon 0X11 ORD, UK (presently retired).
Briefly, REL-C7 cells were maintained under standard conditions in MEM-0 ++.
1. To arrest proliferation and allow the cells to accumulate in mitosis, colcemid 
(Sigma) was added to a final concentration of 0.05qg/ml (lOjal of 50|Lig/ml 
stock colcemid into 10ml of culture). The flask was incubated for lOmin at 
37®C.
2. The contents of the flask were transferred to a sterile, 15ml centrifuge tube 
(Costar) and spun down at 200g for 1 Omin. The supernatant was carefully 
poured off and the cells resuspended in the residual supernatant by gently 
tapping the tube.
3. The cells were then subjected to hypotonic treatment. This causes the cells to 
swell and become fragile, so that when they are dropped onto slides, the cells 
burst, spreading out their chromosomes for inspection. The hypotonic agent 
was 0.075M KCl (BDH). Ten millilitres of KCl was added to the resuspended 
cells, which were then incubated for lOmin.
4. The cells were gently centrifuged at lOOg for lOmin. The supernatant was 
carefully poured off and the cells re suspended by gentle agitation in the 
residual supernatant.
5. The cells were next fixed by the addition of 10ml of freshly prepared fixative 
(absolute methanol : glacial acetic acid, 3 : 1) (AnalaR grade, BDH).
6 . The cells were spun at lOOg for lOmin and the fixative replaced with fresh 
fixative.
7. Slides were thoroughly cleaned with absolute alcohol. From about 2 -5  inches 
above the slide, 2- 3 drops of cell suspension were dropped onto the slide. The 
slides were allowed to air-dry and were G-banded by a modification of the 
method described by Gallimore and Richardson (172).
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8. The slides were transferred to a rack and placed in 2X SSC (0.3M NaCl,
0.03MNa Citrate, pH 7.2) for 21rr at 60®C.
9. The slides were then taken tlirough successive solutions of saline; distilled 
water; 50% methanol; 70% methanol; 90% methanol; and absolute methanol 
(1 min in each). The slides were then air-dried, prior to trypsinization.
10. Trypsin solution was prepared at 0.125% (Life Technologies) in saline (1 vial 
of 20ml of 2.5% trypsin, made up to 400ml with saline). The slides were
placed in the trypsin-saline solution for 20-30 secs.
11. Finally, the slides were washed in de-ionized water and stained for 2 -3  min in 
Giemsa stain (Gurr's R66) (BDH, Catalogue number 35086) (Giemsa at 10% 
in pH 6.8 buffer). The stained preparations were air-dried and mounted in 
Depex (BDH, Catalogue number 36125).
12. Photographs were taken on Kodalc Teclmical Pan 2145 film. Thirty
metaphases were analyzed under light microscopy and a further 20 metaphases 
were photographed and karyotyped.
■i
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3.1.1 Choice of FBS
Originally, a batch of FBS was used which was already available in the 
laboratories, used in another uni'elated culture activity (Flow Laboratories, Batch 
29124125).
The following batches of FBS were tested:-
Source Batch No.
Globepharm G104
Gibco/BRL 10Q2152A
Advanced Protein Products SBS70
Northumbria Biologicais 41521
Gibco/BRL 40Q
Aliquots of M E0-0+ were supplemented with one of the above sera to give multiple
of the media. As outlined in Section 2.3, cultures were maintained for one week to 
allow the cells to adapt fully to the change in FBS.
.00
iSECTION 3 RESULTS
3.1 Growth Characteristics of REL-C7 in Liquid Culture
In most cell culture procedures, serum is used to supplement the basic culture
medium. Often, the batch of serum used is of crucial importance. To ensure, as far as 
.possible, that the cells were being maintained under optimal conditions, batches of 
serum were pretested for their suitability. In addition, REL-C7 cells were cultured in 
medium containing a range of FBS concentrations to define further the optimum 
conditions. iII
1
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batches of MEM-0++.
REL-C7 cells were inoculated into 25 cm^ flasks each containing 5 ml of one
On (an arbitrary) day 0 (d.O), fresh cultures were established in each of the 
media with the starting concentration at 1.0 x lO^/ml. At daily intervals, a small 
aliquot of culture was aspirated and counted (Section 2.15). These data were plotted
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3.1.2 Effect of various FBS concentrations on REL-C7 growth
To define further the optimal conditions, media were prepared with a range 
of concentrations of FBS:- 1%, 2.5%, 5%, 10%, 15%, 20%, 30%. As before, cells
69
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as cell concentration versus time. From the logaritlunic phase of the growth curve, 
cell doubling times were calculated. A representative example is shown in Fig
3.(comparing batch G104 with batch 41251). In addition, the cells were assessed for 
viability by Trypan Blue exclusion (Section 2.4.1)
With the notable exception of batch 41521, there was no significant
difference between the batches of FBS tested (Table 1). Apart from batch 41521, the 
doubling times were consistently between 12-141ir with high viability (Table 2). 
Unless otherwise indicated, batch G104 was used for the subsequent investigations. J
were allowed to adapt to the different FBS concentrations. Daily cell counts and
viability were performed. A representative example is illustrated in Fig 4.
A clear pattern was observed in the growth characteristics. The optimal
range of FBS concentrations was between 5% and 20% with no significant difference 
in the doubling times at >5% FBS (Table 3). At high FBS concentration (30%) the
doubling time was apparently longer, though not significantly so. Below 5% FBS, the 
doubling times became progressively longer at 2.5% FBS and 1% FBS. A similar 
pattern was observed with the cell viabilities (Table 4). At FBS concentrations 
between 5% and 30% viabilities were consistently and invariably high (>96%). At 
lower concentrations, particularly 1% FBS, there was a tendency for viability to 
decrease over the time-course of the experiment so that by day 4 of culture, the 
viability was down to 82%.
A broad range of FBS concentrations (5%-30%) seemed able to maintain 
REL-C7 growth, although at 30% FBS there was some evidence to indicate that this 
concentration was slightly inliibitory as demonstrated by the extended doubling time. 
Lower concentrations (1% and 2.5%) were clearly sub-optimal, with the doubling 
times extended to 23 hi" and 28 lu' respectively, with a concommitant decrease in cell 1
Table 1
Effect of various batches of FBS on REL-C7 growth.
Data expressed as mean ± SD of three experiments.
FBS Batch Doubling Time (hr)
29124125 12.7 ±0.35
G 104 12.7± 1.1
10 Q 13.0 ±0.61
SBS 70 13.4 ± 1.0
41521 17.7 ± 1.4
40 Q 13.1 ±0.7
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Table 2
Effect of various batches of FBS on REL-C7 viability. 
Data expressed as mean ± SD of three experiments.
«■a
FBS Batch Day 0 Day 1 Day 2 Day 3 Day 4
29124125 97.0 ± 1.0 98.3+0.6 98.3 + 1.1 97.7 + 1.5 97.3 + 0.6
0104 98.0+1.0 97.7 ± 0.6 98.0 + 1.7 97.0 + 1.0 97.7 + 5.3
10 Q 97.3 + 1.1 96.7+1.5 97.7 + 2.2 97.7+1.5 97.0+1.0
SBS 70 97.0+1.7 96.9 + 1.1 98.3 + 1.1 98.7 + 0.5 98.7 + 0.6
41521 87.0 + 3.6 88.0 + 4.6 92.0 + 3.0 88.3 + 3.0 92.7 + 5.1
40 Q 97.3 + 1.2 98.3 + 1.2 98.0 + 1.0 98.3 + 0.6 97.7 + 0.6 #
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Table 3
Effect of various FBS concentrations on REL-C7 growth.
Data expressed as the mean ± SD of three experiments.
FBS Concentration (%) Doubling Time (lir)
1.0% 28.0 ±3.6
2^% 22.9 ±1.7
5.0% 13.6 ±0.7
10% 12.6 ± 0.4
15% 13.4 ±0.6
20% 12.8 ±0.5
30% 14.1 ±0.4
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Table 4
Effect of various FBS coucentrations on REL-C7 viability.
Data expressed as the mean ± SD of three experiments.
[FBS] (%) Day 0 Day 1 Day 2 Day 3 Day 4
1.0% 96.7±+ 0.6 97.0 ± 1.7 97.7 ± 0.6 91.7±1.5 82.0 ±3.0
2.5% 98.0 + 1.7 98.3 ± 1.1 97.0 ± 1.0 90.3 ± 1.5 91.7±2.1
5.0% 99.0 ±0.6 96.0 ±2.0 98.3 ±1.1 98.3 ± 0.6 99.0 ± 0
10% 98.3 ±1.7 98.7 ±0.5 98.7 ±0.6 98.7 ±0.6 97.7 ± 0.6
15% 98.3 ± 0.6 98.0 ±1.7 98.0 ± 1.2 98.3 ±0.6 97.7 ± 2.2
20% 98.0 ± 1.0 98,3 ±1.1 99.0 ± 0 99.0 ± 0 97.7 ±0.6
30% 98.0 ±1.0 98.7 ± 0.6 98.3 ± 0.6 98.7 ±0.5 98.3 ±0.6
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100 j,l1 of 4.0 X 10^/ml
10ml of 4 X lO^/ml
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viability. For routine maintenance, 10% was deemed to be the most appropriate 
concentration of FBS.
3.2 Cionogenic assay for REL-C7 cells
Liquid culture conditions allow the proliferation of a population of cells to be 
monitored by performing cell counts over a period of time. In many experiments, 
however, it can be much more informative to look at the behaviour of individual cells 
within a population. Clearly, liquid culture does not allow such single cell analyses.
The behaviour of individual cells was assessed in a cionogenic, semi-solid 
assay system (Section 2.5). In this culture system, cells were immobilised in a 
viscous medium (MEM-0++/methyl cellulose). In a given population of cells, 
normally only a proportion of the total number will proliferate and form discrete 
clones. The cloning efficiency of a particular cell line may be calculated as 
Total no.of colonies counted x 100%
Total no.of cells plated 
The cloning efficiency of REL-C7 cells was calculated in a series of experiments by 
culturing REL-C7's at various concentrations. Cells were routinely maintained in 
liquid culture (see Section 2.3) at a cell concentration between 5 x lO^/ml and 2 x 
10^/ml. Exponentially growing cells were aspirated from stock cultures and 
transferred to a 15 ml centrifuge tube. Cells were spun down at 100 g for lOmin. 
Cells were resuspended in a small (<lml) volume of fresh MEM-0++ and a sample 
was removed for counting. Appropriate dilutions were made to allow a range of final 
cell concentrations to be set up in the cionogenic assay.
Example : REL-C7 cells resuspended at 4.0 x 10^/ml.
The cell suspension was diluted 100 - fold:-
9.9 ml of MEM-0++ J
I
'
-  i  .....................
Serial 10 -fold dilutions were performed: 
100 pi of 4 X lO^/ml
900 pi of MEM-0++ 
100 pi of 4 X 1 O^/ml
900 pi of MEM-0++ 
100 pi of 4 X lO^/ml
900 pi of MEM-0++
}
}
}
1 ml of 4 X 1 O /^ml
Three tubes of 1.8 ml methylcellulose/FBS were prepared.
Tube 1 : received 600 pi of 4 x lO^/ml
Tube 2 : received 600 pi of 4 x 10^/ml
Final conentration : 1 x lO^/ml
Tube 3 : received 600 pi of 4 x lOVml
Final concentration : 1 x lOVml
Cells were plated out as described in Methods (Section 2.5.2), and colonies 
counted after 4 days incubation (Table 5). A colony characteristically appeared as a 
fairly compact, "ball" of cells (Plate 1).
Over a range of plating concentrations, REL-C7 showed a remarkable 
consistency in cloning efficiency of between 55 and 59%. Dilution effects/low cell 
numbers contributed to the imprecision of the experiments at 1 x 10^/ml and 1 x 
10 Vml. The most reproducible cell concentration to plate out in the cionogenic assay
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1 ml of 4 X lO^/ml
1 ml of 4 X IQl/ml
■i
Final concentration : 1 x 10^/ml
Table 5
Cloning efficiency of REL -C7.
No. of colonies counted
No.of
cells
plated
Exp.l Exp. 2 Exp.3 Exp.4 Exp. 5 Exp.6 Mean ± 
SD
Range
(%)
1 X 103 527 610 582 683 587 554 59 ± 7.3 53-68
1 X 102 40 68 55 71 61 49 57 ± 34.3 40-71
1 X lOl 4 6 6 5 7 5 55 + 10.0 40-70
Ï
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Plate 1
REL-C7 cells grown in methylcellulose culture. 
Cell concentration 1 x 10^/ml.
Cultured for 4 days 
Magnification 400X.
#
I F
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was 1 X  lO^/ml. This gave a mean cloning efficiency of 59%. In initial experiments, 
cells were plated at concentrations greater than 1 x lO^/ml, e.g. 5 x 10^/ml and 1 x 
lO^/ml. However, these cultures produced so many colonies that the plates could not 
be counted due to colonies overlapping.
Another aspect of this cionogenic assay was its "sensitivity", i.e. when very 
low numbers of cells (e.g. 10 cells) were plated out, the pattern of colony formation 
was remarkably similar to the ideal plating concentration (i.e. 1000 cells/ml). This 
assay, therefore, represents a very sensitive means of detecting proliferating REL-C7 
cells with cionogenic potential. This characteristic becomes important when REL-C7 
differentiation is analyzed, i.e. as cells become committed to differentiation they lose 
their proliferative ability. This may be monitored at the single cell level by a 
cionogenic assay.
3.3 in vivo assay for REL-C7 tTumourogenicity)
The malignant nature of REL-C7 cells can be demonstrated in an in vivo 
tumourogenic assay (see Section 2.6).
Series of experiments were set up to investigate how the numbers of cells 
injected per animal influenced the time taken to tumoui’ formation. In addition, low 
cell concentrations were tested to determine the minimum number of cells required to 
induce tumour formation, i.e. "sensitivity".
Long Evans babes, between 3 and 7 days old, received a subcutaneous 
injection of 0.1ml containing a range of REL-C7 numbers. To ensure that the 
physical trauma of a subcutaneous injection had no effect, control animals received an 
injection of 0.1ml of culture medium (MEM-0++) containing no cells. The animals 
were observed regularly (e.g. every two days) for the appearance of a tumour at the 
site of injection (see Table 6). On the day of detection, tumour diameter would be 
approximately 5mm and certainly no greater than 10mm. As soon as tumour 
formation was confirmed, the animals were killed. It was noted that, if animals were 
allowed to sui’vive beyond this point, the tumour cells continued to proliferate (Plate
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Plate 2
Long Evans babes showing tumour formation.
Animals each received a cell dose of 1 x 10  ^REL-C7 cells. 
Assessment shown at day 12.
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tumour. Again, because of the prolonged period of time taken for any tumour 
development, these animals were observed up to d.39, however no further tumours 
developed after d.24. As expected, no tumours were detected in the control group.
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2) until a massive dorsal growth developed.
Clearly, there is a dose response between the number of cells administered 
and the incidence of tumoui' formation. There is also a relationship between the 
number of cells administered and the time to tumour development. Tumour incidence 
was 100% in the group that received either 1 x lO^cells/babe, 1 x lO^cells/babe or 1 x 
lO^cells/bahe. In the group that received 1 x lO^cells/babe, tumour incidence was 
96% (i.e. 1 animal remained tumour free). In the group that received 1 x 
lOlcells/bahe, tumour incidence was 45% with only 10 out of 22 animals developing 
a tumour. The TD50 was calculated i.e. TD50 = tumour dose 50 i.e. the dose 
(number) of cells required to elicit tumour development in 50% of the recipient 
animals (see Figure 5). The TD5Q was 1.2 x lO^cells.
In the larger cell inocula (1 x 10^/babe, 1 x lO^/babe) tumour development 
was rapid with the first tumours being detected by d.7. Indeed in the 1x10  ^group, 
all 15 animals had been sacrificed by d.7. In the 1x10  ^group, overall tumour 
development was slower with progressively more animals developing tumoui' until 
d. 15 by which time all were positive. The same general pattern was observed in the 1 
X 10  ^ group, although tumour development was delayed until d.l3. Again, tumour 
incidence progressively increased until all animals were positive by d.23. When the 
number of cells injected was reduced to 1 x lO^/babe, no tumour was detected until 
d.l5. Animals continued to develop tumour up until d.25 by which time 23 of 24 
(96%) were positive. Due to the protracted time course of tumour development, the 
animals in this group were observed up to d.35 in case any later developing tumours 
appeared. It was felt that after this time, there was little likelihood of any further
tumours appearing. In the group of animals receiving 1 x 10  ^ cells/babe, no tumour :;p!
was detected until d.l9. Subsequently, a total of 10 of 22 (45%) animals developed
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Clearly, the time course of tumour development is a "numbers game", i.e. (up 
to a point) the more cells you add, the quicker the tumour develops. The end-point of 
this assay is rather crude and subjective - namely, on 'what day did the observer detect 
a tumour. By necessity, this measurement is somewhat imprecise. Nevertheless, it 
would be anticipated that an inoculum of 1 x 10  ^cells would form the critical mass of 
cells that is detectable as tumour more quickly than, say, 1 x 10  ^ cells. If tumour 
formation simply reflected the number of cells injected, then one might expect that, in 
a particular group, tumour would appear on all the animals on, more of less, the same 
day. Clearly, this is not the case. For example, in the group that received 1 x 10  ^
cells/babe, although no tumour was detected until d.l3, animals continued to develop 
tumour over the ensuing 10 days. Similarly, in the group that received 1 x 10% 
cells/babe, tumour was detected from d.l5 through to d.25. This imprecision in the 
time taken for tumour formation within a particular group can be explained, at least in 
part, by natural variation between animals. These data were accumulated from 20 
litters of L.E.babes. One would expect differences, certainly, between litters and 
probably some variation within a litter as well. Taking into account this population 
heterogeneity, one would expect considerable variation in the ease with which 
injected cells could produce a tumour.
There is also an inlierent inaccuracy in the number of cells administered per 
animal. First of all, every time the cells are diluted another inaccuracy is introduced. 
For the animals who received 1 x 10  ^ cells, the cell concentration was "1 x 10^/ml". 
This can only be regarded as a nominal value. Careful laboratory teclmique can 
minimise this effect, but cannot overcome it. Similarly the cell inoculum was a 
volume of 0.1 ml using a 1 ml syringe. Although great care was taken to administer 
0.1ml, there was bound to be significant aliquot to aliquot variation. Another source 
of inaccuracy was occasionally observed with the actual injection procedure. After 
injection of the cells, as the needle was withdrawn, it was not uncommon for a small 
drop of the cell suspension to leak out of the puncture hole. Obviously, such animals 
did not receive the planned dose of cells.
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Notwithstanding these limitations, the tumourogenic assay still represents a 
convenient and sensitive means of measuring a fundamental property of the REL-C7 
cell line, namely, its malignancy. In later sections, data will be presented showing
Experiments were set up to establish the optimum conditions for erytlnoid
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how the growth characteristics of these cells can be modulated and how these 
alterations affect the malignant nature of the cells.
3.4 Chemically - induced erythroid differentiation of REL-C7
It has been laiown for some years that cell lines established from 7,12- 
DMBA induced leukaemia can be stimulated to differentiate along an erytlrroid 
pathway (143). On exposure to, for example, DMSO or HMBA, cells can be induced 
to differentiate and to synthesize adult rat haemoglobin. Although the original 
leukaemia and subsequent leukaemic cell lines appear morphologically relatively 
undifferentiated, the cells are generally regarded as erytlrrol eukaemic (REL-cells: Rat 
Erytliroleukaemic).
3.4.1 DMSO - induced differentiation
differentiation of REL-C7 by DMSO. Cultures of REL-C7 cells were exposed to a 
range of concentrations of DMSO and the extent of differentiation was assessed daily 
by the benzidine stain for the detection of haemoglobin (see Section 2.7 Materials and 
Methods). In addition, morphological assessment was also carried out. Plate 3 shows 
a typical benzidine stain. Those cells that have accumulated haemoglobin, stain with
, .Æ îa strong blue colouration. Those cells which have not differentiated, do not produce 
haemoglobin and appear yellow.
Morphological analyses also demonstrated the fundamental changes that take 
place in cells exposed to DMSO. REL-C7 cells maintained in MEM-0++ under 
standard culture conditions, had a primitive appearance (Plate 4A) with Wright's stain. 
The nucleus usually had a finely reticular appearance and nucleoli could be discerned. 
The cytoplasm was basophilic (deep blue in colour). They could probably be classed 
as (pro?)erythroblasts.
I
Plate 3
Benzidine staining of REL-C7 cells exposed to 1.5% DMSO for 4 days.
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Plate 4
Morphology of REL-C7 cells by Wright stain.
Magnification 400X.
A. REL-C7 cells culture in MEM-0++ under standard conditions.
B. REL-C7 cells cultured in MEM-0++, incubated with 1.5% DMSO for 4 
days
Following exposure to DMSO, it could be readily seen that these cells had 
matured to a clearly recognizable erytliroid morphology (Plate 4B). As the cells 
differentiated, there was a marked reduction in cell volume and the nucleus : 
cytoplasm ratio decreased. The nucleus was often eccentric, with clumped cliromatin. 
Haemoglobin production was indicated by the pink perinuclear colouration in the 
cytoplasm. In some cases, cells matured even further and a condensed, pyknotic 
nucleus could be observed in a rather featureless, pink cytoplasm. These cells 
resembled erythroid cells at the late normoblast stage of development. In the 
occasional cell, the nucleus seemed to be in the process of extrusion, i.e. oneof the 
final stages in mature red blood cell production.
Data from 4 experiments are summarised in Table 7.
Several conclusions can be drawn:-
a) Irrespective of the concentration of DMSO used, significant 
haemoglobinization is not detectable until 72 In of culture. Certainly, up to a DMSO 
concentration of 0.5% there was no haemoglobinization at all over the first 48 hr. 
DMSO concentrations between 0.75% and 2.0% did produce some benzidine positive 
cells after 48 hr culture, but these numbers were very low, never constituting more 
than 2% in any one experiment. It was only after 72 In incubation that high levels of 
benzidine positive cells could be detected reproducibly. At the higher concentrations 
of DMSO (1.0% - 2.0%) a dramatic increase in benzidine positive cells was 
demonstrated between 48 and 72 In of culture, and this increase continued, although 
less markedly, up to 96 hr of culture.
There is a low level of spontaneous haemoglobinization which occurs in the 
absence of DMSO. Wlien REL-C7 cells are cultur ed in MEM-0 ++ under standard 
conditions, occasional benzidine positive cells may be observed. In any one flask 
these spontaneously occurring benzidine positive cells rarely exceeded 1%. A typical 
result would be that, if 400 cells were counted, 1 or 2 might be benzidine positive, i.e. 
< 1%. Additional data are reported in Section 3.5.1.
'ï l■-■il:;'
Table 7
Effect of various concentrations of DMSO on erythroid differentiation of 
REL-C7.
Percentage of cells staining positive for the benzidine reaction.
Cells were cultured for 96hr in MEM-0++ supplemented with the appropriate volume 
of DMSO.
Data are expressed as the mean ± SD of four experiments.
Concentration 
of DMSO 
(v/v)
Oln 24 In 48 hr 72 In 96 hi* 120 hi’
0 <1 <1 <1 <1 <1 <1
0 .10% <1 <1 <1 1 1 <1
0.25% <1 <1 <1 3.25 ±1.3 5.25 ±1.7 2.25 ±1.3
0.50% <1 <1 <1 3.75 ±2.4 7.50 ± 1.7 3.50 ±2.6
0.75% <1 <1 1 8.25 ± 1.3 12.3 ±2.5 9.0 ±1.8
1.0% <1 <1 1 16.5 ±3.9 20.5 ± 5.0 17.8 ±3.9
1.25% <1 <1 1 27.0 ±6.3 45.8 ±6.2 31.3±11
1.50% <1 <1 1.5 ±0.6 45.8 ±6.2 64.0 ±5.0 ND
1.75% <1 <1 1.5 ±0.6 30.5 ±4.7 54.5 ± 6.6 ND
2 .0% <1 <1 1.25 ±0.5 21.0 ±3.7 31.0 ± 8.6 ND
i
1
ND = Not Done (cells unevaluable).
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marked deterioration in the appearance of the cells was observed, e.g. pie omorphic 
cells debris. Trypan blue assessment of these cultures revealed considerable cell 
damage (Table 8). Reliable analyses could not be performed. The other DMSO 
concentrations between these two extremes (i.e. say, 1.0% - 1.5%) also showed some
90
:
b) The lowest concentration of DMSO that produced appreciable
haemoglobinization was 0.25%. At this concentration only a moderate level of 
.erytliroid differentiation was obtained with a peak value of 5.25% on day 4, which 
.subsequently declined to 2.25% following a further 24 lir of incubation. A similar 
pattern was observed when DMSO was present at 0.5%.
c) The concentration of DMSO that produced the greatest degree of
haemoglobinization was 1.5%. The first increase in benzidine positive cells was
detected after 48hr incubation, but only at a modest level of 1.5%. Over the next 24 hr
the numbers rose rapidly from 1.5% to 45.8% and increased further, though not to the
same degree, over the next 24 In to 64.0%. The general trend was that as the DMSO
concentration increased, then so too did the percentage of benzidine positive cells.
This relationship was observed up to the optimum DMSO concentration of 1.5%.
DMSO concentrations in excess of this (i.e. 1.75%, and 2.0%), showed decreased 
.benzidine positivity.
.d) For each individual DMSO concentration studied, the maximum number
3
of benzidine positive cells was obtained after 96 In culture. Beyond this time point, 
there was a reduction in the number of erythroid differentiated cells when the DMSO 
concentration was sub-optimal. At the lower DMSO concentrations, e.g. DMSO 
0.25% and 0.50%, only a relatively small proportion of cells had been induced to 
differentiate, as demonstrated by the low percentage benzidine positive results. It 
appeared, therefore that those cells that had not been committed to differentiate, 
continued to proliferate. By 120 hr of culture, these proliferating cells had 
proliferated sufficiently to reduce the relative number of benzidine positive cells. A 
different phenomenon was observed at higher DMSO concentrations. After 120 h of 
culture, with DMSO at either 1.75% or 2.0%, the cells were difficult to evaluate. A
Ï
Table 8
Trypan Blue viability assessment of REL-C7 cells exposed to various DMSO 
concentrations.
% DMSO 
concentration
Ohr 72 hr 96 hr 120 Irr
1.0 % 99 99 97 98
1.25% 99 98 97 95
1.50% 99 97 98 96
1.75% 99 96 93 90
2.0 % 99 98 85 83
3.4.2 Effect of various compounds on REL-C7 differentiation
Although DMSO is the compound most widely used to induce differentiation 
in REL cells, other chemicals have been identified which can induce differentiation in 
similar cell lines (e.g. murine Friend erytliroleukaemic cells). Experiments were set 
up to investigate these compounds to see if they were effective in inducing 
differentiation in REL-C7.
3.4.2.1. HMBA fhexamethylenebisacetamidet
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deterioration in the quality of the cells. But, at the same time, a significant proportion 
of undifferentiated cells continued to proliferate.
The optimum concentration of DMSO to produce the maximum number of 
benzidine positive cells was deemed to be 1.5%. Below this concentration 
differentiation was sub-optimal. Above this concentration excessive cell death 
occurred.
I
..I
Stock FIMBA was prepared as outlined in Section 2.7.2 at a concentration of 
50 mM. Cultures of REL-C7 cells were exposed to a range of concentrations of 
HMBA and the extent of differentiation was assessed, as before, by the benzidine 
reaction. As with all investigations of putative inducers, flasks of medium were pre­
equilibrated, had the appropriate volume of stock chemical added, and only then were 
cells inoculated into the flasks. Data from 4 experiments are summarised in Table 9.
The results show some similarities to DMSO-induced differentiation. As 
with DMSO, significant levels of haemoglobinized cells were first detected after 72 lir 
of culture, regardless of the HMBA concentration. At any one concentration of 
HMBA, maximal haemoglobinization was always obtained after 96 hr of culture, the : A
levels thereafter declining. The concentration of HMBA that was most effective in 
inducing differentiation was in the range 2mM - 3mM. HMBA at 3 mM seemed 
slightly superior, but not significantly so (Students t-test, p>0.5 ). Although HMBA 
could reproducibly induce REL-C7 cells to differentiate, it was less effective than
I
Table 9
Effect of various concentrations of HMBA on erythroid differentiation of 
REL-C7.
Percentage cells staining positive for the benzidine reaction.
Data are expressed as the mean ± SD of foui* experiments.
[HMBA]
mM
Oln- 24 hr 48 In* 72 hi- 96 hi* 120 hr
0 <1 <1 <1 <1 <1 <1
1.0 mM <1 <1 1.0 4.3 ±3.1 6.3 ± 5.0 1.0
2.0mM <1 <1 1.0 10.5 ±5.9 24.0 ± 13 10.0 ± 1.6
3.0 mM <1 <1 1.0 13.0 ± 6.6 27.8 ±11 25.5 ±3.6
4.0 mM <1 <1 1.5 ± 0.6 3.3 ±4.8 9.5 ± 9.6 NE
NE = Not Evaluable
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DMSO. The highest mean level of haemoglobinization was 27.8% when cells were 
cultured for 96 h in the presence of 3mM HMBA. In one of the four experiments, at 
this concentration, 40% benzidine positivity was obtained. This was the highest result 
recorded using HMBA.
In summary, HMBA can induce REL-C7 cells to differentiate in similar 
fashion to DMSO. However, HMBA is inferior to DMSO as an inducer of erythroid 
differentiation.
3.4.2.2 ATRA fall trans Retinoic Add)
Stock ATRA was prepared as outlined in section 2.7.3. at a concentration of 
100 mM. Since ATRA requires to be dissolved in ethanol, a preliminary experiment 
was set up to assess the effect of ethanol alone on REL-C7 cells (Table 10). Ethanol 
had surprisingly little effect on the growth and viability of REL-C7 cells, even at 
concentrations as high as 0.5% (v/v) (i.e. 25 pi ethanol per 5 ml culture). Over the 
range of ethanol concentrations studied, there was no appreciable difference in cell 
numbers or viability.
A range of concentrations of ATRA was prepared. To minimise any 
potential effects of the ethanol, ATRA was added in a volume of 5 pi per 5 ml of 
culture, i.e. 1:1000. Consequently, all the ATRA concentrations had to be prepared at 
1000 “ fold the desired final concentration; e.g. to obtain a final ATRA concentration 
of 10“  ^M, 5 pi of ATRA at lO'^M were added to 5 ml medium. As usual, the 
appropriate volume of cells was added last. Data from 2 experiments are summarised 
in Table 11.
From the data it can be seen that ATRA can indeed induce erythroid 
differentiation in REL-C7 cells. In comparison to cells induced by DMSO (or 
HMBA), with ATRA the appearance of haemoglobinized cells was somewhat delayed 
until 72 h of culture (cf. 48 hr for DMSO). The concentration of ATRA that produced 
the highest percentage of benzidine positive cells was 1 x 10"^M. This concentration 
gave a rather modest 18.5% after 96 li culture. A concentration of 1 x 10"^M seemed
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Table 10
Effect of various ethanol concentrations on growth of REL-C7.
In all cases, the viability was > 96%.
Data are cell numbers xlO^/ml.
[Ethanol] (%) 0 lir 24 In- 48 hr
0 0.10 0.29 0.89
0.001 0.10 0.28 0.79
0.005 0.10 0.25 0.63
0.010 0.10 0.22 0.76
0.050 0.10 0.26 0.88
0.10 0.10 0.23 0.79
0.50 0.10 0.27 0.71
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Table 11
Effect of various ATRA concentrations on erythroid differentiation of REL-C7.
Percentage of cells staining positive for the benzidine reaction.
[ATRA](M) 0 lir 24 hr 48 hr 72 hr 96 lir
0 <1 <1 <1 <1 <1
10-8 <1 <1 <1 2.0 2.5
10-7 < 1 <1 <1 5.0 6.0
10-6 <1 <1 <1 6.0 16.5
10-5 <1 <1 <1 10.5 18.5
10-4 <1 <1 <1 4.5 4.5
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only marginally inferior (16.5% benzidine positive). At an ATRA concentration of 1 
X  10"4m, the number of haemoglobinized cells declined to 4.5%. A remarkable 
finding was the range over which ATRA could induce differentiation, albeit some of it 
low. The data presented indicate that ATRA is effective over, at least, a 4 - log range 
of concentrations from 1 x lO"  ^M to 1 x 10"^M.
3.4.2.3 Sodium Butyrate (Na Bu)
A stock solution of Na Bu was prepared at 20 mM as described in section 
2.7.4. REL-C7 cells were exposed to Na Bu over a range of concentrations from 0.05 
mM to 5 mM. Data from 2 experiments are presented in Table 12.
Na Bu induced, at best, only a modest percentage of benzidine positive cells. 
The maximum obtained was 4% with Na Bu at a concentration of 1 mM. In effect,
Na Bu does not appear to be a particularly useful inducer of erytln-oid differentiation 
in REL-C7 cells.
3.4.2.4 N-methylformamide fNMFl and Cytosine arabinoside (ara-C)
Two further compounds were investigated for their ability to induce REL-C7 
cells to differentiate, viz, NMF (N-methylformamide) and ara-C (cytosine 
arabinoside).
Cells were exposed to NMF over the range I x lO '^ M to lx  10"^M. There
.was no significant induction of benzidine positive cells, i.e. no NMF concentration 
induced >1% benzidine positive cells i.e. same as background. The cells were still 
functional when incubated with NMF as demonstrated by the fact that they retained 
high viability by trypan blue exclusion (data not shown). In addition, the cells 
continued to proliferate, albeit slightly suboptimally as compared to control cultures 
(control culture doubling time; 13.0 Irr; IG'^M NMF culture doubling time: 13.9 hr). 
Clearly, therefore, the absence of 
non-specific toxic effect of NMF.
i
induction of differentiation was not due to some
;
97 I
Table 12
Effect of varions concentrations of Na Bu on crythroid differentiation of 
REL-C7.
Percentage of cells staining positive for the benzidine reaction.
[NaBu]
(mM)
0 hr 24 hr 48 hi' 72 hr 96 hr
0 <1 <1 <1 <1 <1
0.05 <1 <1 1 2 <1
0.10 <1 <1 1 3 <1
0.50 <1 <1 1 2 <1
1.0 <1 <1 2 4 <1
5.0 <1 <1 1.5 1 <1
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:Initially, ara-C cultures were set up over a range of concentration from 1 x 
10"4m  to 1 X 10"^M. However, at concentrations of 1 x 10"4m  and 1 x 10“^ M., 
excessive cell death occurred. At concentrations of 1 x 10“^ M and lower, cell
I
i
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viability was unaffected. As with NMF, ara-C was unable to induce erythroid 
differentiation i.e. no ara-C concentration induced >1% benzidine positive cells. Only 
at ara-C 1 xlO"^M was proliferation slightly suboptimal.
In conclusion, DMSG was shown to be an effective inducer of erythroid 
differentiation in REL-C7 cells. HMBA and ATRA could also induce differentiation.
though not to the same extent as DMSG. Other compounds studied were less
effective. Na Bu produced only minimal levels of haemoglobinized cells, while NMF ii
and ara-C were completely ineffective.
A3.4.3 Effect of DMSO - induced differentiation on proliferation of REL-C7 cells
Generally speaking, leukaemic cell lines, like REL-C7, appear to have 
undergone some sort of maturation arrest by which the normal process of
■•Vdifferentiation has been blocked. For example, morphologically, REL-C7 cells seem
1|
to be arrested at an early, proerytlmoblast(?) stage. In normal haematopoiesis there is 
an inter-relationship between proliferation and differentiation, in that immature, 
undifferentiated cells have extensive proliferative potential. As cells differentiate 
towards more mature forms, they progressively lose this proliferative capacity until, 
as end-stage cells, they are incapable of further cell division.
In the previous section, it was demonstrated that REL-C7 cells could be 
induced to differentiate and proceed to a more mature erythroid morphology. To 
assess the effects of DMSG on cell proliferation, REL-C7 cell numbers were 7|
measured over the induction period and compared to control cells. Cell counts were 
done using a haemocytometer (Section 2.15). A typical experiment is shown in "
Figure 6 .
■ A:The growth curve for proliferating REL-C7 cells comprised a period of 
exponential growth (log phase) followed by a plateau when no further proliferation :
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occurred (stationary phase). From Figure 6 it can be seen that when the cell density 
reached approximately 1.5 x 10^/ml the rate of increase in cell numbers began to 
decrease rapidly, reaching a maximum of about 2.8 x 10^/ml. After this point, if the 
cultures were not fed, the cells began to die. The doubling time in the log phase was 
calculated (Section 2.15). Over a 60 Irr incubation period, the cell numbers doubled 
five times
Time 0
Time 60
Count 0.05 X 10^/ml 
0.10 
0.20 
0.40 
0.80
1.60x 106/ml
Doubling # 1 
Doubling #2 
Doubling #3 
Doubling #4 
Doubling #5
This gives an average cell doubling time of 12hi\
When cells were exposed to 1.5% DMSO, a clear difference in the growth 
kinetics could be seen. Again, a bi-phasic growth pattern was obtained. Over the first 
48 hr of culture, the cells continued to grown exponentially, albeit with a longer 
doubling time than control cells grown in DMSO - &ee medium. In the presence of 
DMSO, the doubling time was extended to 16 hr. Over the next 12 hours, the rate of 
cell division decreased and a second phase of linear growth appeared. In this second 
phase, only a modest, but nevertheless measurable, increase in cell numbers was 
obtained. The final cell density of 0.76 x 10^/ml was much less than control cultures. 
Clearly, DMSO had a profound effect on both the rate and extent of proliferation of
101
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REL-C7 cells. It has previously been shown (Section 3.4.1) that, following exposure 
to DMSO, REL-C7 cells can differentiate to more mature cells, committed to the 
erytloroid lineage. Data are presented which show that as these cells are induced to 
differentiate, their proliferative ability declines. This can be seen most clearly after 
721n' and 96 hr of incubation in the presence of DMSO. At these time points, high
I
haemoglobin is a relatively late event, and, in fact, DMSO exerts profound effects on 
REL-C7 cells from a very early stage.
To investigate further the mechanism of induction, REL-C7 cells were 
exposed to DMSO and assessed for their clonogenicity (Section 3.2) and their
transferred to a 15 ml centrifuge tube and the cells spun down (lOOg for lOmin). The 
cell pellet was resuspended in a small volume (-1ml) of MEM-0++ and the final 
volume adjusted to 10ml, again with MEM-0++. The cells were spun down (lOOg for
102
*
1
levels of benzidine positive cells were present (e.g. 64% benzidine positive at DMSO 
1.5% / Time 96hr). At these same time points, cell proliferation was greatly reduced. 
For example over a 36hr period (Time 601ir Time 961ir) the cell numbers increased 
only modestly from 0.52 x lO^/ml to 0.70 x lO^/ml.
It is interesting to note that, although significant numbers of benzidine 
positive cells did not appear until 72 hr of incubation, DMSO exerted its inliibitory 
effects on REL-C7 proliferation from a much earlier time point. From Figure 8, the 
first time point of the growth curve was after 18 lir of culture. Already, proliferation
in the presence of DMSO had been reduced compared to the control culture. This 
effect continued and became more obvious. It would appear that the production of
tumourogenicity (Section 3.3).
3.4.4 Effect of DMSO on dongenicity of REL-C7
To look at the effect of DMSO on the proliferative ability of REL cells, 
clonogenic assays were set up. Multiple cultures were established at a cell 
concentration of 5 x lO^/ml in MEM-0++/1.5% DMSO (see section 2.7.1), total
.volume 5 ml. After the appropriate exposure time, the contents of one flask were
a
lOmin). This washing procedure was repeated once more, and the final cell pellet 
resuspended in -1ml MEM-0++. For the clonogenic assay, cells were routinely 
suspended in methyl cellulose/FBS at a concentration of 1 x lO^/ml. Aliquots of 1 ml 
were dispensed into 35 mm suspension culture dishes and incubated under the usual 
conditions. After a 96 hi' incubation, the plates were scored for the number of 
colonies (colony >50 cells). The data from 5 experiments are summarised in Table 
13.
Clearly, DMSO has a profound effect on the dongenicity of REL-C7 cells. 
After as little as 2 Irr exposure to DMSO, a small but detectable, decrease in the 
cloning efficiency was observed (49.5% clonogenicity cf. 54% in controls). The 
DMSO-41rr sample showed a further reduction in cloning efficiency (down to 47.2%). 
After 61rr exposure to DMSO, a ftirther, this time significant, reduction in cloning 
efficiency was measured (Student's t-test; p<0.05). Figure 7 shows that this trend 
continued with a linear reduction in cloning efficiency up until 24 hr of DMSO 
exposure (clonogenicity 5%). The DMSO-48 hr sample showed only minimal 
cloning efficiency, 0.325%.
These results demonstrate that as REL-C7 cells were increasingly induced to 
differentiate, proliferation was concomitantly down - regulated. Analysis of single 
cells by the clonogenic assay revealed that 24 hr exposure to DMSO prevented 95% 
of REL cells from proliferating normally, and by 48 hr exposure >99% were non­
proliferative. From Figure 7, the linear reduction in cloning efficiency indicates that 
DMSO exerts its influence on REL cells immediately (i.e. no detectable lag time). 
Indeed, a statistically significant reduction in cloning efficiency was observed after 
only 6hr exposure to DMSO. Thus, although DMSO-committed REL cells may 
require some days to accumulate detectable haemoglobin, early events take place 
within the first few hours that have a profound effect on proliferation and the 
expression of the differentiated phenotype.
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Table 13
Effect of various exposure times of DMSO on REL-C7 clonogenicity.
Data are expressed as the mean ± SEM of five experiments.
Exposure Time 
to DMSO (In)
% Clonogenicity
0 54 ±3.34
2 . 49.5 ± 2.40
4 47.2 ± 2.06
6 43.3 ±3.20
8 39.5 ±0.50
18 13.3 ±2.67
24 5.0± 1.15
48 0.325 ±0.125
1
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3.4.5 Effect of DMSO on tumourogenicity of REL-C7
One of the key properties of REL-C7 cells is their malignancy. As 
previously shown (Section 3.3) REL cells can readily proliferate in vivo, producing 
tumours when injected into Long Evans babes.
The preceding experiments have demonstrated that, in in vitro assays, REL-
C7 cell proliferation can, to all intents and purposes, be switched off. Experiments 
were set up to investigate if REL-C7 cells exposed to DMSO similarly lost their 
malignant potential, i.e. their ability to produce tumours.
In the first series of experiments, REL-C7 cells were exposed to 1.5 % It
DMSO for 961ir to achieve maximum levels of differentiated, haemoglobinized cells.
At the end of this incubation period, cells were washed twice as before and finally 
re suspended in a small volume (~lml) of MEM-0++. Appropriate cell dilutions were 
made to enable a range of cell doses to be administered to recipient babes (see Section 
2.6). Prior to injection, an aliquot of these cells was always stained with the benzidine 
reagent to ensm'e that they had indeed differentiated. Invariably, between 60% and 
70% of the cells stained benzidine positive. At the same time, control babes received a 
range of REL-C7 cells that had not been exposed to DMSO. Recipient animals were 
monitored regularly for the appearance of tumour (Table 14).
Overall, there was a striking reduction in the tumourogenic potential of REL- 
C7 cells. A group of 13 animals each received 1 x 10^ control REL cells. In 
accordance with previous experiments (Section 3.3), 100% of animals developed 
tumour within 17 days of injection (cf. previous data: 100% tumour incidence by day 
15). In contrast, of the animals which received 1 x 10^ DMSO- treated cells, only 
43% (3/7) developed tumour. Furthermore, in those animals, there was a profound 
delay before tumour first appeared. In the control group, tumoui" was first detected on 
d.7 and all animals had succumbed by dl7. In the DMSO group, the first tumour did 
not appear until d.l9 and no further animals developed tumour after d.29.
A group of 12 animals each received 1x10^ control REL cells. The results 
were in general agreement with previous studies. As before, there was 100%
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incidence of tumour formation. Tumours first appeared on d.9 (cf d.l3 in Section 
3.3), and by d.l7 all animals had succumbed (cf. d.23 in Section 3.3). In contrast, in 
the DMSO group of 8 animals, no tumours developed.
A group of 15 animals each received 1x10^ control REL cells. The 
incidence of tumour was 93% (14/15) (cf. 96% (23/24) in Section 3.3). The first 
tumour appeared on dl 1 (cf. d 15 in Section 3.3) and tumours continued to develop 
until d.23 (cf. d.25 in Section 3.3). Again, in the DMSO group, no tumour was 
detected in any of 8 animals.
The last group comprised 17 animals and each received 1x10^ control REL 
cells. The tumour incidence was 53% (9/17) (cf. 45% (10/22) in Section 3.3).The first 
tumour appeared on d.l5 (cf. d. 19 in Section 3.3) and no further tumour was detected 
beyond d.25 (cf. d.25 in Section 3.3). There was no incidenee of tumour in any of the
9 animals that received 1 x 10  ^ DMSO-treated cells.
From a validation point of view, all the control groups corroborated the 
results of the larger study in Section 3.3, both in the time course of tumour detection 
and in the overall incidence of tumour in the various groups. Across the groups of 
animals that received DMSO-treated cells, there was a remarkable reduction in 
tumourogenicity. The number of animals in each group was small, making accurate 
analysis difficult. However, some general observations can be made. In Section 3.3 
the TD50 was calculated to be 12 cells/babe. In the present series of experiments the 
TD50 was 9 cells (Figure 8). Indeed, if the two sets of data are combined, a TD50 of
10 cells is obtained. Using DMSO-treated cells, it was only in the group of animals 
that each received 1x10'^ cells that any tumour developed (45% incidence). Control 
experiments demonstrated that, in animals receiving 10 undifferentiated REL-C7 
cells, a tumour incidence of 50% could be expected. In those animals that received 1 
X  104 DMSO-treated REL-C7 cells, the incidence of tumour was not dissimilar to 
those control animals i.e. 43% cf 50%. These data indicate that only a small 
proportion of the DMSO-treated REL-C7's have retained their tumourogenic 
potential. To extrapolate from the control experiments, an inoculum of 1 x 10^
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DMSO-treated cells may contain approximately 10 cells which still retain sufficient 
proliferative potential to give rise to tumour, i.e. only 1 in 1,000. This represents a 
remarkable reduction in the number of clonogenic malignant cells.
Clearly, DMSO had a profound effect on the proliferation of REL-C7 cells. 
Cell proliferation was rapidly and effectively down-regulated as demonstrated by in 
vitro cell culture. In particular, single cell analyses (clonogenic assay) indicated that 
when REL-C7 cells were exposed to DMSO for 48 h, only 0.325% (i.e. 3 in 1,000) 
retained any proliferative ability. Similarly, DMSO exposure markedly reduced the 
ability of REL-C7 cells to form tumour s in recipient animals.
Taken together, these data indicate that as DMSO induces REL-C7 cells to 
differentiate, there is a reciprocal loss of proliferative potential. After 4 days of 
culture, the majority of cells are phenotypically mature erythroid with few retaining 
any proliferative ability.
3.5 Commitment to erythroid differentiation
Data have been presented demonstrating that DMSO can induce REL-C7 
cells to differentiate and synthesize haemoglobin in cultme. On the whole, the end­
point of these experiments was to assess the cells for haemoglobin production after 4 
days of exposure to DMSO. However, it was clear that, although some 96 hours may 
be required for maximum production of haemoglobin, a significant down-regulation 
in cell division and proliferation could be detected after only a few hours exposure to 
DMSO. Experiments were set up to investigate this induction process by analysing 
the kinetics of commitment to differentiation.
Commitment is defined as the ability to continue differentiation in the 
absence of inducing agent.
REL-C7 cells were exposed to DMSO for various defined periods of time, 
then the DMSO was removed and the cells were monitored to see if they continued to 
differentiate or if they reverted to the undifferentiated phenotype. The fate of these 
cells was followed by several different assessments: -
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1. Single cell analysis,
2. ^H-thymidine incorporation,
3. Cell cycle analysis,
4. Cell size,
5. Scanning electron microscopy
3.5.1 Single Celt Analyses
To investigate the kinetics of commitment to differentiation, single cell 
analyses were performed. These experiments were based on the limiting dilution 
studies set up for cloning REL cells (Section 2.3.1).
Experiments were set up to establish the most convenient cell concentration 
to use. With the cell concentration at, nominally, 10 cells/ml, aliquots of 100 pi were 
dispensed into the wells of a 96-well tissue culture plate, i.e. "1 cell/well". Data from 
2 experiments are shown in Figure 9.
A total of 120 wells each received 100 pi of REL-C7 at 10 cells/ml, i.e. a 
total of 120 cells were dispensed. After 4 days of culture, the wells were examined 
for colony formation. Any cells which had proliferated to form a clone were easily 
detected. Furthermore, some wells, which were positive for growth, contained more 
than one clone. These multiple clones/well could be readily identified, thus 
minimising any counting inaccuracy.
From Figure 9, it can be seen that from, theoretically, 120 cells, 63 clones 
were obtained, i.e. 52.5% clonogenicity. This value is remarkably close to the 
previous cloning efficiency value of 55-59% (Section 3.2). Fifty-nine per cent of the 
wells (71 out of 120) eontained no clones. Thirty-two percent of the wells (38 out of 
120) contained a single clone and nine percent of the wells (11 out of 120) contained 
multiple clones (8 wells contained 2 clones; 3 wells contained 3 clones). The 
incidence of multiple clone wells (9%) was deemed to be unacceptably high and so 
fuither experiments were set up at a reduced concentration of 0.5 cell/well. Data from 
4 experiments are shown in Figure 10.
I l l
Figure 9
Limiting dilution cultures of REL-C7 cells with 1 cell / well.
Number of clones per well.
Plate 1
0 0 0 0 0 0 0 0 0 0
1 1 0 2 0 1 0 1 0 3
1 0 0 1 1 1 0 0 0 1
0 0 3 0 0 2 0 1 1 1
1 1 0 1 2 1 0 1 0 0
0 0 0 1 1 0 0 1 0 1
Plate 2
0 0 1 2 2 3 0 0 0 0
1 0 1 2 0 0 0 0 0 1
1 0 0 0 0 0 0 0 0 1
0 0 0 0 2 0 1 0 1 0
0 0 0 1 1 2 1 0 1 1
0 0 1 1 0 0 1 0 1 0
Range (clones per well) : 0 - 3.
Total number of clones : 63
Total number of cells plated ; 120
Overall clonogenicity : 52.5% (63/120)
Frequency : 0 clones per well
: 1 clone per well 
: 2 clones per well 
: 3 clones per wei
: 71 (59% of wells)
: 38 (32% of wells)
: 8 (6.7% of wells) 
: 3 (2.5% of wells)
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Figure 10
Limiting dilution culture of REL-C7 cells with cells at 0.5 cell / well.
Number of clones per well.
Plate 1
0 1 0 0 0 0 0 0 0 0
0 0 0 1 0 0 0 0 1 0
0 1 0 0 1 0 1 0 0 0
0 0 0 0 0 1 1 0 0 0
0 0 1 0 0 0 0 0 0 0
1 0 1 1 0 0 0 0 0 2
Plate 2
0 0 0 1 1 1 1 0 1 0
1 1 0 1 1 0 0 1 0 1
0 0 0 0 1 0 0 0 0 0
1 1 0 0 0 0 0 0 0 0
1 0 1 0 0 0 0 0 1 1
1 0 0 2 0 0 1 0 0 0
Plate 3
0 1 0 0 0 0 0 1 1 0
1 2 0 2 1 1 0 0 1 1
0 1 1 0 0 0 0 0 0 0
0 1 0 0 0 0 1 0 0 0
1 0 0 0 1 0 0 0 0 0
0 1 0 0 1 1 0 1 0 0
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Plate 4
0 0 0 0 0 1 0 1 0 1
0 1 0 0 0 0 1 0 0 0
1 0 0 0 0 0 0 1 1 0
0 0 0 2 2 0 0 0 0 0
1 0 0 0 0 0 0 1 0 1
0 0 0 0 1 0 0 0 0 0
Range (clones per well) : 0 - 2
Total number of clones : 74
Total number of cells plated : 120
Overall clonogenicity : 61.7% (74/120)
Total number of wells 
Frequency
240
0 clones per well
1 clone per well
2 clones per well
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: 172 (72% of wells) 
: 62 (26% of wells) 
: 6 (2.5% of wells)
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The overall cloning efficiency was 61.7% (75 clones from 120 cells). Again, 
this compared most favourably with the previously established value of 55-59% 
(Section 3.2). Using this reduced cell concentration, 72% of the wells (172 out of 
240) contained no clones; 26% of the wells (62 out of 240) contained a single clone; 
only 2.5% of the wells (6 out of 240) contained 2 clones. No wells contained greater 
than 2 clones. Due to the low incidence of multiple clone wells, a cell plating 
concentration of 0.5 cell/well was chosen as the most convenient for subsequent 
analyses.
3.5.2 Spontaneous erythroid differentiation
As previously reported (Section 3.4.1), REL-C7 cells demonstrate a low 
background level of spontaneous differentiation i.e. differentiation in the absence of 
any inducer. In DMSO-free culture, the number of benzidine positive cells rarely 
exceeded 1%.
In an effort to investigate the origin of these differentiating cells, limiting 
dilution cultures were set up at 0.5 cell/well. Multiple 96-well plates were set up and 
the contents of the wells were analysed after 24 lir, 48hr, 72hr, 96hr, 120 lir and 144 
hr of incubation. At the appropriate time point, individual well cultures were 
terminated by the addition of the benzidine reagent (see Section 2.9). Providing that 
the benzidine was added slowly and carefully, the cells in the well were not 
significantly disturbed. For each well, the total number of cells was counted and the 
number of benzidine positive cells was counted. Data are presented in Tables 15A- 
15F, and summarised in an additional table.
After 24hr, 48hr, 72hr and 96 hr of culture (Tables 15 A, B, C, D) it was 
possible to count the number of cells in each individual colony. Because the cells 
were cultured in liquid medium, colonies tended to be disperse in appearance as 
opposed to the 3-dimensional ball of cells seen when cells were cultured in methyl 
cellulose. This dispersed morphology facilitated counting, Obviously with the bigger 
colonies obtained after 120 hr and 144 hr of culture, counting of numbers of cells per
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Table 15
Benzidine staining of individual REL-C7 clones cultured in the absence of 
inducer.
Assessment at various time points.
15 A. 24 hr of culture
Clone # Total no. of cells No. of B+ve cells
1 4 0
2 4 0
3 2 0
4 8 0
5 4 0
6 4 0
7 4 0
8 3 0
9 4 0
10 4 0
Total no. of cells 41 0
.'. Overall incidence of B+ve cells :
Incidence of colonies containing B+ve cells ; 
Mean no.of cells per colony (mean ± SD) : 
Median " " ” :
Clonogenicity (60 wells = 30 cells) :
0%
0%
4.1 ± 1.5 
4
33% (10/30)
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Table 15 B. 48 hr of eulture
Clone # Total no. of cells No. of B+ve cells
1 4 0
2 8 0
3 6 0
4 9 0
5 20 0
6 4 0
7 6 0
8 10 0
9 12 0
10 16 0
11 6 0
12 8 0
13 9 0
14 12 0
15 8 0
16 8 0
Total no. of cells 146 0
Overall incidence of B+ve ceils :
Incidence of colonies containing B+ve cells : 
Mean no.of cells per colony (mean ± SD) : 
Median " " " :
Clonogenicity (60 wells = 30 cells) :
0%
0%
9.1 +4.2 
8
53% (16/30)
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Table 15C. 72 hr of culture
Clone # Total no. of cells No. of B+ve cells
1 32 0
2 30 0
3 34 0
4 22 0
5 60 4 (= 6.7%)
6 22 0
7 8 0
8 48 0
9 30 0
10 26 0
11 60 0
12 36 0
13 38 3 (=8%)
14 28 0
Total no. of cells 474 7
■I
Overall incidence of B+ve cells :
Incidence of colonies containing B+ve cells : 
Mean no.of cells per colony (mean + SD) : 
Median " " " :
Clonogenicity (60 wells = 30 cells) :
1.5% (7/474) 
14% (2 / 14) 
34± 14 
31
47% (14/30)
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Table 15 D. 96 hr of culture
Clone # Total no. of cells No. of B+ve cells
1 60 0
2 25 0
3 -200 0
4 120 0
5 30 0
6 150 8 (=5%)
7 80 0
8 -200 0
9 -200 0
10 100 0
11 50 0
12 60 0
13 50 6 (=12%)
14 150 0
15 40 0
16 40 0
17 -260 10 (=3.8%)
18 80 0
19 100 0
20 150 0
21 46 0
22 36 0
23 -200 6 (=3%)
24 60 0
Total no. of cells -2,500 30
119
Overall incidence of B+ve cells : 1.2% (30 / 2,500)
Incidence of colonies containing B+ve cells : 17% (4 / 24)
120
I
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Mean no.of cells per colony (mean + SD) : 104 ±69
Median " " : 80
Clonogenicity (90 wells = 45 cells) : 53% (24 / 45) I'
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Table 15 E. 120 hr of culture
Clone # Total no. of cells No. of B+ve cells
1 -200 0
2 -200 0
3 -200 0
4 -200 0
5 -250 0
6 -500 0
7 25 0
8 - 1,000 0
9 -300 30 (=10%)
10 - 1,000 0
11 150 0
12 150 0
13 150 8 (=5%)
14 -200 0
15 100 5 (=5%)
16 50 25 (=50%)
17 - 1,000 0
18 -200 0
19 - 1,000 0
20 -500 0
21 150 0
22 - 1,000 25 (=2.5%)
Total no. of cells - 10,000 93
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.% Overall incidence of B+ve cells :
Incidence of colonies containing B+ve cells : 
Mean no.of cells per colony (mean ± SD) ; 
Median " " " :
Clonogenicity (90 wells = 45 cells) :
0.93% (93/ 10,000) 
23% (5 / 22)
454 ± 356 
225
49% (22 / 45)
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Table 15 F. 144 hr of culture
Clone # Total no. of cells No. of B+ve cells
1 - 1,000 0
2 -200 0
3 - 2,000 0
4 -200 14 (=7%)
5 -2,000 36 (=1.8%)
6 60 0
7 - 1,000 20 (=2%)
8 - 2,000 8 (=0.4%)
9 -3,000 0
10 - 1,000 0
11 60 56 (=90%)
12 - 2,000 0
13 - 1,000 0
14 - 2,000 10 (=0.5%)
15 - 1,000 0
16 -1,500 0
17 - 2,000 53 (=2.7%)
18 -200 10 (=5%)
Total no. of cells -22,000 207
%
%
■ ; s
#
i
I
Î.'. Overall incidence of B+ve cells ; 0.94% (207 / 22,000) 1
Incidence of colonies containing B+ve cells : 49% (8/18)
Mean no.of cells per colony (mean + SD) : 1222 ± 873 :
Median " " " : 1,000 .e
: iClonogenicity (60 wells = 30 cells) : 60% (18/30) 4%:
'
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Table 15 Summary
124
Duration of 
Culture(lir)
Total no. 
of cells
No. of 
B+ve cells
% B+ve Incidence 
of cols 
containing 
B+ve cells 
(%)
Median 
no. of 
cells per 
colony
Cloning
efficiency
(%)
24 41 0 0 0 4 33
48 146 0 0 0 9 53
72 474 7 1.5 14 31 47
96 -2,500 30 1.2 17 80 53
120 - 10,000 93 0.93 23 225 49
144 - 20,000 207 0.94 44 1,000 60
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colony became less accurate. As an aid to counting, similar sized colonies were often 
pooled, spun down to a smaller volume and a manual cell count (haemocytometer) 
performed. The total number of cells was then divided by the number of input 
colonies to give an average number of cells per colony. This proved useful in 
estimating the approximate number of cells in colonies > 250 cells.
From Tables 15A-F, it could be seen that the overall cloning efficiency was 
similar to previous experiments: - 24 hr culture, 33% (10/30); 48 hr culture, 64% 
(16/30); 72 lir culture, 57% (14/30); 96 lir culture, 53% (24/45); 120 lir culture, 49% 
(22/45); 144 hr culture, 60% (18/30).
Likewise, cell proliferation, as assessed by the doubling times, was similar to 
earlier experiments. For each of the six time-points, the mean number of cells per 
colony was calculated, e.g. for the 72 hr culture, a total of 474 cells were counted 
from 14 colonies giving a mean of 34 cells per colony (474/14). Between the 24 hr 
culture and the 48 hi* culture, the doubling time was 21 hi*. Between the 48 lir culture 
and the 721ir culture, the doubling time was 12.7 hi*. Between the 72 hr culture and the 
96 hr culture, the doubling time was 15.7 hi*. Between the 96 hr culture and the 120 hi* 
culture, the doubling time was 11.5 hi*. Between the 120 lir culture and the 144 hr 
culture, the doubling time was 17.8 hi*.
When compared to the previously established doubling time of 12-14 lir, the 
doubling time of 21 lir between the first two experiments is appreciably longer. This 
may be due to some sort of lag phase as the cells adapt to fresh culture conditions. In 
addition, the accuracy of this figure will be compromised by the relatively few cells 
that were analysed. The doubling times of 12.7 hr, 15.7 In* and 11.5 hi* are all similar 
to the established value of 12-14 In*. The value 15.7 lir is slightly high, while the 
value 11.5 In* is slightly low. This may reflect the inherent counting inaccuracy and 
the fact that relatively few cells were analysed. The final doubling time of 17.8 lir 
was significantly longer than the normal 12-14 hr. In addition to the inaccuracies 
outlined above, it is likely that necessary nutrients in the culture medium were
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becoming increasingly depleted after 6 days of culture. This would account for the 
rate of proliferation slowing down.
The overall incidence of benzidine positive (B+ve) cells was calculated by 
counting the number of B+ve cells within colonies and dividing this figure by the total 
number of cells in all the wells of each experiment. As expected, a small but 
detectable proportion of cells gave rise to some B+ve cells. The overall incidences of 
B+ve cells were:-
5-
24 hr culture : 0% (0/41)
48 hr culture : 0% (0/146)
72 hr culture : 1.5% (7/474)
96 lir cultuie : T2% (30/2,500)
120 lir culture : 0.93% (93/10,000)
144 lir culture : 0.94% (207/22,000)
Interestingly, no B+ve cells were detected in either the 24 hr or 48 hr culture. 
As discussed earlier, this may reflect the low numbers of cells analysed. The first 
B+ve cells were detected in the 72 lir culture and the numbers continued to rise in the 
subsequent culture. The proportion of B+ve cells declined over time. This is to be 
expected since any cells that differentiate will lose their proliferative ability, unlike 
the majority of cells which do not differentiate and continue to divide, thus increasing 
the proportion of B-ve cells. Wlien the incidence of colonies containing B+ve cells 
was examined, a pattern emerged, whereby as the culture period increased then, the 
proportion of colonies containing B+ve cells correspondingly increased:- 
24 lir culture : 0% (0/10)
48 lir culture : 0% (0/16)
72 111’culture : 14% (2/14)
96 lir culture ; 17% (4/24)
120 hr culture : 23% (5/22)
144 hr culture : 44% (8/18)
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:If, as it seems, this spontaneous differentiation is a chance event, then this
1trend is to be expected. The longer the cells are cultured, the more cells will be f
produced, increasing the probability that a cell will, by chance, spontaneously |
differentiate.
IIn those colonies that did contain B+ve cells, the actual proportion of B+ve :
cells ranged from <1% of the total cells in a colony up to ~ 90% of the cells. The
3.5.3 DMSO - induced erythroid differentiation
In the previous section, the spontaneous differentiation of REL-C7 cells was 
investigated by examining single cells cultured in the absence of inducer in 96-well 
tissue culture plates. As a follow-on from this, similar experiments were set up 
whereby REL-C7 cells were exposed to DMSO (1.5%) for defined periods of time 
before being plated out at limiting dilution (see Section 2.9).
Ireciprocal relationship between proliferation and differentiation can be amply demonstrated if all the colonies that contained B+ve cells are arranged in order of %
B+ve (Table 16). The general trend is that as the proportion of B+ve cells per colony 
increases then the total number of cells per colony correspondingly decreases. Thus 
in any given colony, an increase in the number of differentiating cells is accompanied i
by a decrease in the number of proliferating cells. IiThus, spontaneous differentiation occurs in a minority of cells and appears to be a 
chance event.
ftMultiple cultures of REL-C7 cells in DM SO-containing medium were
.«■s
established. Cells were exposed to DMSO for the following times:- 4 lir, 8 lir, 16 hi’,
24 hr, 32 hr and 48 ln’. After the appropriate period of time had elapsed, DMSO 
exposure was terminated by washing the cells free from DMSO and resuspending 
them in MEM-0 ++ alone (i.e. no DMSO). The cell concentration was adjusted to "5 
cells/ml" and aliquots of 100 pi were dispensed into the wells of a 96-well tissue ; ||
culture plate (i.e. 0.5 cell/well). These cultures were maintained for 5 days, when the
f t127
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Table 16
Relationship between the proportion of B+ve cells per colony and the total 
number of cells per colony.
% B+ve cells per colony Total no. of cells per colony
0.4 - 2,000
0.5 - 2,000
2 - 2,000
2 - 1,000
2.5 -1,000
3 - 2,000
3 -200
3.3 -260
5 -200
5 150
5 100
5 150
6.7 60
7 -200
10 -300
12 50
50 50
90 60
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Generally speaking, the overall cloning efficiency was similar to previous 
experiments:- 0 lu' exposure, 47%; 4 hr exposure, 60%; 8 lir exposure, 60%; 16 Irr 
exposure, 63%; 24 hr exposure, 60 %; 32 lir exposure, 77%; 48 In- exposure 30%.
between 24 and 32 lir of DMSO exposure (i.e. from 50 cells/colony 4 
cells/colony). In the 32 hr and 48 lii' exposure experiments, the median number of 
cells/colony was low (4 and 2 respectively). Nevertheless, for the pui'poses of these 
analyses, they were regarded as clones.
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wells were examined for cell growth. The number of cells per well was counted 
/estimated and the benzidine reagent was added to detect those cells that had 
differentiated (Tables 17A-G, summary).
■ft’
Again, there will be some inaccuracy in these figures, reflecting the relatively small 
numbers of cells analysed. In the plate with cells exposed to DMSO for 48 hr, there 
may be an additional inaccuracy. From Table 17G it can be seen that there was very
little cell proliferation and that in these wells identified as positive for growth, 6/9 
contained only 2 cells. Clearly, when so few cells are present, it becomes difficult to 
detect them. Although great care was taken to scan the entire contents of each well, it 
is conceivable that the occasional single cell or cell doublet may have evaded 
detection.
As an indicator of proliferation, the median number of cells per colony was
calculated for each exposure time point (see Table 17 Summary). A clear pattern 
emerged whereby the number of cells per colony declined with increasing exposure to 
DMSO, i.e. DMSO exposure down-regulated proliferation. There was no significant 
difference between the control cells ( no exposure to DMSO) and the cells exposed to 
DMSO for 4 In'. However, a significant reduction in proliferation was seen in the 
cells exposed to DMSO for 8 hr (625 cells/colony cf-1,000 cells per colony in control
'cells) (P<0.02, Students' t-test). This reduction in number of cells per colony 
continued with increasing DMSO exposure times:- 16 hr exposure, 156 cells/colony;
24 In exposure, 50 cells/colony; 32 hr exposure, 4 cells colony; 48 hr exposure, 2 
cells/colony. The proliferative down- regulation appeared to be particularly profound
t-
I
Table 17
Benzidine staining of individual clones from cells exposed to DMSO for various 
periods of time then cultured in DMSO-free medium.
17A. 0 hr exposure
Clone # Total no. of cells No. of B+ve cells
1 - 1,000 0
2 - 1,000 0
3 - 1,000 0
4 - 1,000 43 (=4.3%)
5 -500 16 (=3.2%)
6 - 1,000 0
7 - 1,000 0
8 - 1,000 0
9 - 1,000 0
10 - 1,000 0
11 - 1,000 51 (=5.1%)
12 - 1,000 0
13 150 0
14 - 1,000 0
Total no. of cells -12,650 110
Incidence of B+ve cells :
Incidence of colonies containing B+ve cells : 
Mean no.of cells per colony (mean + SD) ; 
Median " " " :
Clonogenicity (60 wells = 30 cells) :
0.87% (110/ 12,650) 
21% (3/14)
903 ± 255 
- 1,000 
47% (14/30)
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Table 17B. 4 hr exposure
Clone # Total no.of cells No. of B+ve cells
1 - 1,000 0
2 - 1,000 0
3 - 1,000 0
4 - 1,000 0
5 - 1,000 0
6 - 1,000 0
7 - 1,000 8 (=0.8%)
8 - 1,000 0
9 -200 77 (=39%)
10 - 1,000 0
11 - 1,000 0
12 - 1,000 0
13 - 1,000 0
14 50 6 (=12%)
15 - 1,000 0
16 - 1,000 0
17 -200 23 (=11.5%)
18 - 1,000 0
Total no. of cells -16,000 114
Overall incidence of B+ve cells ;
Incidence of colonies containing B+ve cells : 
Mean no.of cells per colony (mean + SD) ; 
Median " " " :
Clonogenicity (60 wells = 30 cells) :
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0.71% (114/ 16,000) 
22% (4/18)
900 + 330 
- 1,000 
60% (18/30)
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Table 17C. 8 hr exposure
Clone # Total no. of cells No. of B+ve cells
1 -200 0
2 -200 0
3 -200 0
4 -200 8 (=4%)
5 -1,000 0
6 150 27 (=18%)
7 -1,000 0
8 112 27 (=24%)
9 -250 18 (=7.2%)
10 -1,000 51 (=5.1%)
11 -1,000 24 (=2.4%)
12 56 15 (=27%)
13 -1,000 26 (=2.6%)
14 -1,000 0
15 32 0
16 -1,000 9 (=0.9%)
17 -1,000 5 (=0.5%)
18 -1,000 0
Total no. of cells - 10,000 210
/. Overall incidence of B+ve cells :
Incidence of colonies containing B+ve cells : 
Mean no.of cells per colony (mean ± SD) : 
Median " " " :
Clonogenicity (60 wells = 30 cells) :
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2 .1% (210 7 10,000) 
56% (10/18)
555 ±438 
625
60% (18/30)
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Table 17D. 16 hr exposure
Clone # Total no. of cells No. of B+ve cells
1 -300 20 (=7%)
2 62 6 (=10%)
3 -500 0
4 -200 0
5 -500 12 (=2.4%)
6 -200 11 (=5.5%)
7 64 0
8 -400 0
9 117 0
10 16 16 (=100%)
11 10 10 (=100%)
12 - 1,000 30 (=3%)
13 -500 21 (=4%)
14 10 5 (=50%)
15 40 0
16 156 37 (=24%)
17 -300 16 (=5.3%)
18 142 6 (=4.2%)
19 34 7 (=21%)
Total no. of cells -4,500 197
Overall incidence of B+ve cells :
Incidence of colonies containing B+ve cells : 
Mean no.of cells per colony (mean ± SD) ; 
Median " " " :
Clonogenicity (60 wells = 30 cells) :
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4.4% (197/4,500) i
68% (13/19)
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240 ± 253 ,
156
63% (19/30) f t
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Table 17E. 24 hr exposure
Clone # Total no. of cells No. of B+ve cells
1 -500 0
2 8 8 (=100%)
3 -600 19 (=3%)
4 104 53 (=51%)
5 10 8 (=80%)
6 42 17 (=40%)
7 3 3 (=100%)
8 154 0
9 10 8 (=80%)
10 144 0
11 50 6 (=12%)
12 -200 21 (=10.5%)
13 - 1,000 10 (=1%)
14 5 5 (=100%)
15 150 0
16 8 8 (=100%)
17 3 3 (=100%)
18 3 3 (=100%)
Total no. of cells -3,000 172
Overall incidence of B+ve cells :
Incidence of colonies containing B+ve cells ; 
Mean no.of cells per colony (mean ± SD) : 
Median " " " :
Clonogenicity (60 wells = 30 cells) :
5.7% (172 7 3,000) 
78% (14/ 18)
170 ±269 
50
60% (18/30)
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Table 17F. 32 hr exposure
Clone # Total no. of cells No. of B+ve cells
1 30 1 (=3%)
2 2 2 (=100%)
3 6 6 (=100%)
4 3 1 (=33%)
5 2 2 (=100%)
6 1 1 (=100%)
7 3 3 (=100%)
8 2 2 (=100%)
9 8 8 (=100%)
10 4 4 (=100%)
11 5 5 (=100%)
12 63 0
13 2 1 (=50%)
14 14 14 (=100%)
15 4 4 (=100%)
16 -300 62 (=21%)
17 2 2 (=100%)
18 18 14 (=78%)
19 3 3 (=100%)
20 4 4 (=100%)
21 2 2 (=100%)
22 8 8 (=100%)
23 2 2 (=100%)
Total no. of cells 488 151
I
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/. Overall incidence of B+ve cells : 31% (151 / 488)
Incidence of colonies containing B+ve cells : 96% (22 / 23)
Mean no.of cells per colony (meani SD) : 21+62
Median " : 4
Clonogenicity (60 wells = 30 cells) : 77% (23 / 30)
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Table 17G. 48 hr exposure
Clone # Total no. of cells No. of B+ve cells
1 2 2 (=100%)
2 6 6 "
3 2 2 "
4 2 2 "
5 4 4 "
6 2 2 "
7 2 2 "
8 2 2 "
9 3 3 "
Total no. of cells 25 25
Overall incidence of B+ve cells :
Incidence of colonies containing B+ve cells : 
Mean no.of cells per colony (mean ± SD) : 
Median " " " :
Clonogenicity (60 wells = 30 cells) :
100% (25/25) 
100% (9 / 9) 
2.8+ 1.4 
2
30% (9/30)
I
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Table 17 Summary
Exposure 
Time (hr)
Total no. 
of cells
No. of 
B+ve cells
% B+ve Incidence 
of cols 
containing 
B+ve cells 
(%)
Median 
no.of cells 
per colony
Cloning
Efficiency
(%)
0 12,650 110 0.87 21 - 1,000 47
4 16,000 114 0.71 22 - 1,000 60
8 10,000 210 2.1 56 -625 60
16 4,500 257 4.4 68 156 63
24 3,000 172 5.7 78 50 60
32 488 151 31 96 4 77
48 25 25 100 100 2 30
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The overall incidence of B+ve cells was calculated as before. The data
tl
clearly demonstrate that REL-C7 cells can indeed become committed to differentiate 
(Table 17 Summary). Exposure to DMSO for 4 Irr did not induce significant 
differentiation when compared to control cells. The overall proportion of B+ve cells 
after 4 hr DMSO exposure was 0.71%, compared to 0.89% in control cultures. 
However a marked increase in the percentage of B+ve cells was observed in those 
cells exposed to DMSO for 8 Irr: 2.1% B+ve cf 0.89% in control cells. The proportion 
of cells that stained B+ve continued to rise with increasing exposure to DMSO:- 16 hi’ 
exposure, 4.4 % B+ve; 24 hi' exposure, 5.7% B+ve; 32 Irr exposure, 31% B+ve; and 
48 lir exposure, 100% B+ve.
Thus, data aie presented which demonstrate that DMSO is not required to be 
present continually to induce differentiation in REL-C7 cells. Furthermore, although 
it may take cells some 96 In.' in conventional suspension cultures to achieve extensive
I
accumulation of haemoglobin, a proportion of REL-C7 cells can be committed to
■■■differentiate after as little as 8 hr exposure to DMSO. With increasing exposure 
times, the proportion of cells that become committed correspondingly increases.
■3.5.4 Phenotypic analyses of REL-C7 colonies following incubation with 
DMSO
When examining colonies for the presence of B+ve cells, three types of 
colony could be defined:-
a) undifferentiated colonies, i.e. containing no B+ve cells,
b) mixed colonies, i.e. containing both B+ve and B-cells,
c) differentiated colonies, i.e. exclusively B+ve.
These data ai’e summarised in Table 18.
Control cultures (i.e. no exposure to DMSO) and cells exposed to DMSO for 
4 hr produced very similar results. From these cultures, the majority of colonies 
obtained were undifferentiated and exclusively B-ve. At the time of assessment (120
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Table 18
Heterogeneity of clones from REL-C7 cells exposed to 1.5% DMSO for various 
periods of time.
Exposure Time (hr) U ndifferentiated 
Colonies (%)
Mixed
Colonies
(%)
Uniformly 
B+ve Colonies (%)
0 79 21 0
4 78 22 0
8 44 56 0
16 32 58 11
24 22 44 33
32 4 22 74
48 0 0 100
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Ill” of culture), these colonies contained of the order of 1,000 cells. The rest of the 
colonies (0 exposure, 21%, 4 hr exposure 22%) were of the mixed phenotype. These 
mixed colonies were generally of comparable size with the undifferentiated colonies 
although a small proportion contained only 50-500 cells. With the exception of clone 
#9 from cells exposed to DMSO for 4 lir, these mixed colonies contained 0.8 - 12% 
differentiated cells. These differentiated cells tended to be present in small local foci 
within the colony. No uniformly B+ve colonies were detected.
After 8 Irr exposure to DMSO, a marked alteration had taken place in the 
proportions of the various colony types. Less than half (44%) of the colonies were 
now of the undifferentiated type. Although some colonies still contained -1,000 cells, 
50% of the colonies were smaller, containing 32- approximately 250 cells. The 
majority (56%) of colonies were mixed. The proportion of differentiated cells within 
any one colony ranged from 0.5 - 27%. The colony size was fairly heterogeneous, 
varying from 32 cells up to -1,000 cells.
After 16 hr exposure to DMSO, a further shift was observed. The proportion 
of undifferentiated colonies had decreased further to 32%. Again, there was a general 
reduction in colony size with only 1 out of 19 colonies containing -1,000 cells. The 
majority (58%) of colonies wo-s mixed with the proportion of differentiated cells in 
the range 2-50% of any one colony. Interestingly, with this exposure time, a small (2 
out of 19) but significant proportion of colonies were exclusively B+ve. These 
colonies were small and eompact and contained 16 and 10 cells respectively.
A further change was observed with those cells exposed to DMSO for 24 hr. 
The proportion of undifferentiated colonies showed a further decrease from 32% (16 
hi” exposure) to 22%. In addition, the proportion of mixed colonies also decreased 
from 58% (16hr exposur e) to 44%. This fall could be accounted for by the marked 
increase (3-fold) in the proportion of colonies that were uniformly B+ve from 11%
(16 hr exposure) to 33%. These colonies were small, containing 3-8 cells per colony.
This trend continued with 32 hr DMSO exposure. As the proportion of 
undifferentiated colonies and mixed colonies decreased (22 4% and 44 -^22%
141
respectively), the proportion of fully differentiated colonies continued to increase. In 
fact, of all the colonies obtained, 75% were uniformly B+ve. These colonies rarely 
contained more than 8 cells per colony (the exception was colony #14 which 
contained 14 cells).
By 48 Irr of DMSO exposure, all the colonies that were detected were 
imiformly B+ve. These "colonies" were small, containing between 2 and 6 cells per 
colony. Only 9 out of 30 wells were positive for cell growth. Clearly, this number is 
small. If more cloned cells had been analysed, it is likely that some mixed colonies 
would have been observed i.e. some cells that had not fully differentiated.
This analysis of colony phenotype clearly demonstrates the effects of DMSO 
on individual cells. In control cells (and even 4 hi’ DMSO exposure cells) it can be 
seen that most cells produce progeny that are undifferentiated. A minority of these 
control cells produce progeny that contain a small proportion of differentiated cells. 
With increasing exposure to DMSO, a pattern emerged whereby more and more 
individual cells started to produce progeny with an increasing proportion of 
differentiated cells. This continued until the vast majority of progeny cells were 
differentiated, illustrating the process of commitment of differentiation.
3.5.5. Thymidine incorportion.
It has been amply demonstrated that exposure to DMSO induces REL-C7 
cells to differentiate and down-regulates proliferation as assessed by cell division. 
Clearly, cell division is the culmination of many diverse cellular acitivities working in 
concert. Rather than look at this complex process, experiments were set up to look at 
one aspect of cell division, namely DNA synthesis.
Multiple cultures of REL-C7 cells were exposed to 1.5 % DMSO for varying 
periods of time. Proliferation was then assessed by adding to the cultures, a pulse of 
radioactive label (^H-thymidine) (see Section 2.10). Thus, those cells that are 
proliferating rapidly will incorporate relatively lai’ge amounts of ^ H-thymidine, while 
those cells in which proliferation has been down-regulated will incorporate
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Thus, for each DMSO time point, the same number of cells was assessed in the 
thymidine incorporation assay. This allowed direct comparison between the cultures 
from various time points. Data from three experiments are summarised in Table 19.
*
correspondingly low levels of the label. This represents a very sensitive technique for 
detecting subtle changes in the proliferative status of cells.
In initial experiments, REL-C7 cells were exposed to DMSO for 24 In, 48 In, 
72 In and 961n. At the various time points when cells were set up in DMSO- 
containing cultures, control cultures were also established i.e. DMSO free cultrnes. 
Eighteen hours before the end of the experiment, the cells from each flask culture 
were spun down and resuspended at 0.05 x 10^/ml. Aliquots of 200 pi were
dispensed into the wells of a tissue culture plate, and the ^H-thymidine was added.
In all tlnee experiments, exposure to DMSO resulted in a progressive 
reduction in cell proliferation. In two of the experiments (Experiments # 1 and #2), a 
significant reduction in proliferation was obtained after 24 hr exposure to DMSO as 
compared to control cultures which were not exposed to DMSO at all (in both cases, 
p<0.02; student's t-test). This proliferative down-regulation became more pronounced 
with increasing exposure time to DMSO, and in subsequent cultures (i.e. 48 hr, 72 hr, 
and 96 lir exposure) this down-regulation became highly significant (p<0.001).
Experiment #3 showed the same general effects as #1 and #2. As above, 
after 24 hr exposure to DMSO, there was a reduction in cell proliferation, but on this 
occasion it was not significant (0.05<p<0.1). However, after 48hr exposure there was 
a significant reduction in proliferation (p<0 .01) and this reduction became highly 
significant after 72 lir and 96 hr exposure (p<0.001). To ensure that any reduction in 
proliferation was due to DMSO and not due to any limitation in the culture conditions 
(e.g exhaustion of nutrients, accumulation of cellular waste products), control cultures 
containing no DMSO were set up in parallel. These cells were manipulated in the 
exact same fashion as the DMSO cultures, i.e. at the appropriate time, the flask 
cultures were poured into a centrifuge tube, spun down, resuspended, the cell count 
was adjusted and aliquots of 200pl were dispensed into the wells of a 96-well tissue
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Table 19
Effect of DMSO exposure on the uptake of ^ H-thymidine into REL-C7 cells. 
Experiment 1
DMSO Exposure (hr) n mean ± SD P-value
0 9 23977 ± 2583
24 9 19298 ±3334 P < 0.02
48 10 12772 ±858 F <0.001
72 10 9211± 1046 P <  0.001
96 10 5507± 1315 P <  0.001
Values are counts per minute (cpm). 
Experiment 2
Experiment 3
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DMSO Exposure (hr) n mean ± SD P-value
0 8 35258 ±2661 -
24 10 31157±1907 P < 0.02
48 10 22919 ±2006 P <  0.001
72 9 13574 ±3885 P < 0.001
96 10 9293 ± 964 P <  0.001
DMSO Exposure (hr) n mean ± SD P-value
0 10 22552 ±4406 —
24 10 18421 ±2808 0.05 <P <0.1
48 10 16002± 1655 P<0.01
72 10 5866 ±566 P <  0.001
96 10 5094 ± 453 P <  0.001
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culture plate. Data are presented in Table 20 which indicate that all these cultures 
retained similar levels of proliferation. There were no significant differences between 
any of these control cultures. Thus, any reduction in proliferation is unlikely to be 
due to non-specific culture effects, but is most likely to be due to a proliferative down- 
regulation induced by DMSO.
Although each of these experiments showed the same down-regulatory effect 
of DMSO, there was wide variation in the raw data generated (i.e. cpm) between 
experiments. For example, in experiments # 1 and #3, the greatest uptake of ^ H- 
thymidine was seen, as expected, in the cells that were cultured in the absence of 
DMSO; 23, 977 cpm and 22,552 cpm respectively. However, in experiment #2, the 
corresponding DMSO-free culture generated 35,258 cpm, about half as much again 
compared to experiments #1 and #3. Indeed, in experiment #2, cells exposed to 
DMSO for 48 hr showed a highly significant (p<0.001) reduction in proliferation as 
compared to control cultures. Yet these cells exposed to DMSO for 48 Irr generated 
22,919 cpm - very similar to the control cultures in experiments #1 and #3. To 
combine the results of the experiments, it was felt necessary to "normalise" the data 
within each experiment, i.e. in a given experiment the cpm from the control (no 
DMSO) culture was deemed to be 100%, and the subsequent cpm's from the DMSO- 
treated cultures were expressed as a percentage of the control (Table 21). Thus, 
although between experiments there is some variability in the data, within each 
experiment the data is very reproducible (note the "tight" value for the SEM's).
The data from Table 21 may be represented diagramatically (Figure 11). A 
linear relationship exists between length of exposure to DMSO and percentage 
decrease in ^H-thymidine uptake (proliferation).
Clearly, then, over a period of time, DMSO can exert a powerful anti­
proliferative influence on REL-C7 cells. The linear relationship demonstrated in 
Figure 11 implies an early onset of this down-regulatory effect. In an effort to see just 
how rapidly DMSO can induce this proliferative switch-off, further experiments were 
set up in which REL-C7 cells were exposed to DMSO for shorter periods of time, viz,
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Table 20
Uptake of ^ H-thymidine into REL-C7 cells. Control cnltures for REL-C7 cells 
exposed to DMSO for various periods of time.
Duration of culture (hr) n mean ± SD P-value
24 10 35258 ±2661 -
48 10 34969 ±1603 0.5 <P NS
72 10 38092 ±5548 0.1 < P < 0.5 NS
96 10 32071 ±3864 0 . K P < 0 . 5 NS
a
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Table 21
Effect of DMSO on ^H-thymidlne uptake by REL-C7 cells. Data expressed as 
percentage of control cultures.
Î
' ,;0
i/i;
s
DMSO Exposure (hr) cpm (% of control) mean ± SEM
0 100
24: #1 80
#2 88 83 ± 2.4
#3 82
48 : #1 53
#2 65 63 ±5.3
#3 71
72 : #l 38
#2 38 34 ±4.0
#3 26
96: #1 23
#2 26 24 ±1.0
#3 23
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2 lir, 4 hi’, 6 hr and 8 hi\ The methodological details are laid out in Section 2.10. Data
from thi'ee experiments are summarised in Table 22.
These data corroborate the previous studies, in that increasing exposure to
DMSO progressively reduces cell proliferation as measured by ^H-thymidine uptake.
In all three experiments there was a detectable reduction in proliferation after as little
as 2 In' exposure to DMSO. However, there was wide variation in the statistical
significance of these changes. The difference was significant at the level of p<0.05 in
experiment #1 and significant at the level of p<0.01 in experiment #2. However, in
experiment #3, the small reduction after 2 In exposure to DMSO was not significant
(p>0.5). After 4 In exposure, the proliferative down-regulation was highly significant 
.(p<0.001) in experiments #1 and #3. In experiment 2 the results were less clear cut.
The cpm value after 4 In exposure was actually slightly higher than the figure for 2 hr 
exposure, though not significantly so (p>0.5). Compared to the control value, the 4 hr 
exposure value was still statistically significantly different (p<0.05; cf 2 In exposure,
p < 0 . 0 1 ) .
These minor discrepancies probably reflect the limits of the sensitivity of the 
^H-thymidine uptake assay. Wlien there are only small, subtle differences between 
test samples, it becomes difficult to demonstrate any reproducible, statistically 
significant changes.
In any event, all tlnee experiments demonstrate a highly significant 
(p<0.001) reduction in proliferation after 6 In exposure to DMSO as compared to
icontrol cultures, and at least a significant (p<0.05) reduction after 4 hr exposure.
These data clearly demonstrate that DMSO can rapidly modulate the 
proliferative status of REL-C7 cells. This effect can be first detected after 2-4 hr
.exposure to DMSO. Previously, (Section 3.5.3,, DMSO-induced erythroid 
differentiation) it was shown that REL-C7 could become committed to differentiate 
after 8 In exposure to DMSO. It is likely that this reduction in the rate of proliferation 
is a necessary early event in the process of commitment to differentiation.
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Table 22
Effect of DMSO Exposure on the uptake of ^ H-thymidine into REL-C7 ceils.
Experiment 1
DMSO Exposure (hr) n mean ± SD P-value
0 10 8816 ±747 -
2 10 7667 ± 1479 P < 0.05
4 10 6218± 1247 P <  0.001
6 10 5614+ 1252 P <  0.001
8 10 5531 + 1319 P <  0.001
Values are cpm. 
Experiment 2
DMSO Exposure (hr) n mean ± SD P-value
0 10 2913 + 103
2 10 2431 +30.2 P<0.01
4 9 2486 + 64.4 P < 0.05
6 10 1836 + 52.2 P <  0.001
8 10 1638 + 100 P <  0.001
Experiment 3
DMSO Exposure (hr) n mean + SD P-value
0 6 4346 + 799
2 6 4072 + 710 P > 0.5 NS
4 6 3394 + 178 P <  0.001
6 6 3158 + 191 P <  0.001
8 6 2250 + 387 P <  0.001
NS = not significant.
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%3.5.6. Cell Cvde Analyses
1
ÎIn the previous two sections, data were presented showing that as REL-C7 
ceils became coimnitted to erythroid differentiation, their proliferative ability 
correspondingly declined. This proliferative down-regulation was measured by
colony formation {in vitro clonogenic assay) and ^H-thymidine incorporation. In 
this section, experiments were set up to analyse further the way in which DMSO
effected these profound proliferative changes. Cell cycle analyses were performed on 
REL cells that had been exposed to DMSO for various periods of time.
In eukaryotic cells, DNA synthesis does not occur tliroughout the cell cycle,
'but is restricted to a special phase of it, occurring before mitosis (cell division). This 
phase is called S-phase (S for synthetic). A gap of time occurs after DNA synthesis
and before cell division. Another time gap occurs after division and before the next S- 
phase The cell cycle, thus consists of the M (mitotic) - phase, a G i-phase (the first 
gap), the S-phase, a G2 phase (the second gap), and back to M. Some non dividing 
cells can suspend the cell cycle after mitosis and just prior to DNA synthesis. Such 
"resting" cells, which have exited from the cell cycle before the S-phase, are said to be 
in the Gq state.
The cell cycle status of the various cell suspensions was assessed by 
measuring the uptake and incorporation into DNA of a thymidine analogue, 
bromodeoxyuridine (BrdU) (Section 2.11), Thus, when cells were pulse labelled with 
BrdU, only those cells which were actively synthesising DNA (i.e. in the S-phase of
■the cell cycle) could incorporate BrdU into their DNA. A monoclonal antibody, anti-
BrdU, was then used to identify those cells undergoing DNA synthesis at the time of
,the pulse. The proportion of cells in S-phase of the cell cycle was then determined by 
flow cytometry. In addition, the cell suspensions were incubated with propidium 
iodide (PI) which stains DNA. Thus, the total DNA content of cells could be assessed
by measuring PI uptake. In this manner, it was possible to identify three populations
.......................................of cells depending on their position in the cell cycle. Gates were then drawn round
each of these subpopulations and by counting the number of events within each
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defined area, the percentage of cells in each phase of the cell cycle could be 
determined. A specimen contour plot from the Becton Dickinson Source Book is 
shown in Figure 12.
Those cells which aie quiescent (i.e. Gq) or have just completed mitosis (i.e. 
in G%) will not be synthesising DNA, will therefore not have incorporated significant 
amounts of BrdU into their DNA and therefore will show no positive reaction with the 
FITC-labelled anti-BrdU. They will each contain "n" amount of DNA, where n is an 
indeterminate unit value-.
Those cells which have entered S-phase will be actively synthesising DNA, 
will therefore have incorporated BrdU into their DNA and will show a positive 
reaction with anti-BrdU-FITC. There will be some variation in the amount of BrdU 
incorporated by the cells in this subpopulation. This reflects the level of activity of 
DNA synthesis in individual cells over the time period when BrdU was available to be 
incorporated. Thus, those cells that were already in S-phase when the 30 minute 
incubation with BrdU was started, would be able to incorporate BrdU over the entire 
30 minutes exposure (presuming S-phase extends for more than 30 minutes) and 
would tend to accumulate relatively large amounts. Conversely, those cells that 
perhaps entered S-phase at some point during the BrdU incubation would be able to 
incorporate BrdU for only a corresponding proportion of that 30 minute period. They 
would, therefore, accumulate less BrdU.
Lastly, those cells that had completed S-phase would now be in G2 or 
undergoing mitosis (M). As in the first subpopulation (Gq/Gj), the cells in G2+M 
would not be synthesising DNA, and therefore would incorporate insignificant 
amounts of BrdU. However, in contrast to the cells in Gq/Gj, the cells in G2+M 
would be either in mitosis or preparing for it. Consequently, prior to cell division, by 
which each of the two daughter cells receives the full complement of genetic material, 
these cells in G2+M will contain twice the amount of DNA, i.e. "2n". So although the 
cells in Gq/Gj and the cells in G2+M cannot be distinguished on the basis of BrdU
152
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Figure 12
Specimen contour plot from FACScan showing the various phases of the cell cycle. 
(Taken from the Becton Dickinson Source Book)
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uptake (since neither incorporates it), they can he resolved hy the amount of PI 
staining which is proportional to the total DNA content.
The data from two experiments are presented in Table 23. These data were 
generated by analysing the various cell suspensions with the Consort software. An 
example is shown in Figure 13.
Both experiments demonstrate two main alterations to the cell cycle status of 
REL-C7 cells exposed to DMSO. Firstly, there is a decrease in the proportion of cells 
in S-phase, i.e. synthesising DNA. Secondly, there is an increase in the proportion of 
cells in Gp/Gp Between experiments, there appears to be some discrepancy in the 
actual numerical values obtained. The method used to prepare the cells for analysis is 
quite elaborate, requiring a lot of cell manipulation and processing. In addition, when 
the samples are actually analysed by flow cytometry, some subjective decisions have 
to be made, e.g. where to position the gates; in which defined area should paiticular 
events be included. These aspects of the method will introduce inaccuracies and make 
reproducibility between experiments rather difficult to achieve. In any event, 
individually, each experiment demonstrates that as the proportion of cells in S-phase 
declines, there is a corresponding increase in the proportion of cells in Gq/G j phase. 
As an aid to following these changes in cell cycle status, these data have been 
represented diagramatically (Figures 14A, 14B).
In experiment #1, the first appreciable shift was detected between 4 and 6 hr 
of DMSO exposure. The proportion of cells in S-phase dropped from 58% to 41% 
and the decline continued to 35% (8 hr exposure) and to 29% (24 hr exposure). 
Correspondingly, the proportion of cells in Gp/Gj increased from 30% (4 In-) to 47% 
(6 In) and this accumulation of cells in Gp/Gl j, continued to 54% (8 lu*) and to 60% 
(24 hr). Over the exposure times studied, the proportion of cells in G2+M remained 
largely unaltered, ranging from 8-14%. However, there was perhaps some evidence 
for changes in the level of G2+M cells. Over the earlier time points the proportion of 
cells in G2+M rose from 8% to 12% (1 hr) to 14% (2 lu and 3 hr) before declining to 
12% (4 hr and 6 lu) and to 10% (8 hr). These changes were, to say the least, modest
154
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Table 23
Effect of DMSO on the cell cycling status of REL-C7 cells. Percentage of REL-C7 
cells in the various phases of the cell cycle.
A. Experiment 1
DMSO Exposure (hr) Gq / G i S-phase G2 + M
Control 32 58 10
0 23 69 8
1 29 59 12
2 24 62 14
3 29 57 14
4 30 58 12
6 47 41 12
8 54 35 10
24 60 29 11
B. Experiment 2
DMSO Exposure (hr) Gq / G i S-phase G2 + M
Control 15 76 9
0 11 83 7
1 15 76 9
2 22 46 32
3 26 36 38
4 50 27 23
6 62 23 14
8 68 23 8
24 69 27 4
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Figure 13
Contour plot of REL-C7 cells exposed to DMSO for 4 hours. 
See text for method and interpretation.
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Figure 14A Experiment 1; Percentage of REL-C7 cells in various phases of the
cell cycle, following exposure to 1.5% DMSO.
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Figure 14B Experiment 2: Percentage of REL-C7 cells in various phases of the
40^ cell cycle, following exposure to 1.5% DMSO.
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and certainly did not provide convincing evidence of significant fluctuations in the 
levels of G2+ M cells. The major alterations were found in the levels of Gq/Gj cells
as the proportion of cells in S-phase declined, then the proportion of cells in Gq/Gj
Î
:and S-phase cells, and indeed, the changes tended to occur in a reciprocal fashion, i.e.
increased.
The same general pattern was demonstrated in experiment #2 and, in fact, the
alterations in the various phases of the cell cycle were more pronounced. Again, as
the proportion of cells in S-phase declined, then the proportion of cells in Gg/Gj
correspondingly increased. The first appreciable shift in S-phase cells was detected
between 1 and 2 lir of DMSO exposuie with a drop from 76% to 46%. This trend
.continued over the following time points: - 36% (3 hr) to 27% (4 lir) to 23% (6 hr) 
and more or less maintained at this level: 23% (8 hr) and 27% (24 hi’).
As the proportion of cells in S-phase declined, the proportion in Gq/Gj, 
steadily rose with increasing exposure to DMSO. Small, but detectable, alterations 
were seen even at the shortest DMSO exposure times. After 1 hr exposure to DMSO, 
the proportion of cells in Gq/Gj rose from 11% to 15% and subsequently to 22% (2 
hr) and to 26% (3 In'). Between 3 hi* and 4 lir exposure to DMSO, there was a marked 
elevation in Gq/G^ cells from 26% to 50% and this trend continued to 62% (6 In) to 
68% (8 In) to 69% (24 In).
Although in experiment #1 there were only marginal alterations in the levels 
of G2+M cells, in experiment #2 changes were far more obvious. Between 1 In and 2 
hi- exposure to DMSO, the proportion of cells in G2 + M rose markedly from 9% to
■ -432%. This rise continued to 38% with 3 In DMSO exposure and then started to 
decline to 23% (4 hr) to 24% (6 In) and back to baseline with 8% (8 In) and 4% (24 
hr).
Data are presented which demonstrate that relatively brief exposure to 
DMSO can bring about profound alterations in the cell cycling status of REL cells.
After between 4 and 6 hr exposure to DMSO a marked increase was detected in the 
proportion of cells in Gq/Gi . Over further time points, cells continued to accumulate
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in Gq/Gi reaching a maximum of 69%. This rise in Gq/Gj cells can be accounted 
for, mainly, by a fall in the proportion of cells in S-phase. In one of the experiments, 
this decrease in S-phase cells coincided with the increase in Gq/G^ cells, the most 
dramatic changes occurring after 4-6 In of DMSO exposure. In the other experiment, 
the same general trend was obtained although the inter-relationships between the 
various phases of the cell cycle were less clear cut. There was a marked decline in S- 
phase cells after 1-2 In DMSO exposure. This was accompanied by a 3.6 - fold 
increase in G2+M cells and a more modest increase in Gq/Gj cells. The proportion of 
S-phase cells continued to decline and after 3-4 In DMSO exposure the proportion of 
Gq/G^ cells increased markedly from 26% to 50%.
As has been demonstrated here and in previous sections, brief exposure of 
REL cells to DMSO can commit cells to differentiate with a concomitant down- 
regulation of proliferation. From grovrth curves it was shown that the rate of cell 
division decreases. From analyses of ^ H-thymidine incorporation, DNA synthesis 
was shown to be switched off. Cell cycle studies have indicated that the proportion of 
cells synthesising DNA declines because cells accumulate in Gq/G i • They seem to be 
unable to make the transition from G% into S-phase. Clearly, if there is no DNA 
synthesis, then there can be no cell division. It seems likely that DMSO (and other 
similar chemical inducers) exerts its effects, not by directly switching off DNA 
synthesis, but rather by preventing cells from passing from Gj into S-phase. This cell 
cycle "block" can be induced rapidly, requiring only a few hours exposure to DMSO.
3.5.7. Assessment of Cell Size
In preceding sections, experiments were set up to monitor the subtle changes 
that occurred when REL-C7 cells were induced to differentiate. In this (and the 
following) section, gross morphological aspects of differentiating REL-C7 cells were 
measured, e.g. cell size.
As outlined in the Materials and Methods (Section 2.12), cell size can be 
assessed by flow cytometric methods, e.g. FACS analyses. Using a FACS, the
160
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forward light scatter (FLS) properties of cells can be measured and, to all intents and 
purposes, this is proportional to cell size.
It is possible to measure accurately cell size by comparing the properties of a 
given cell population to those of reference beads of a defined precise diameter. In 
these studies, however, it was felt umiecessary to obtain the exact cell size. What was 
of interest was the relative changes that occurred between routinely proliferating REL- 
C7 cells and REL-C7 cells that had been exposed to DMSO.
REL-C7 cells were exposed to DMSO (1.5%) for various periods of time and 
were then analysed by FACS to assess their cell size. To allow direct comparison 
between individual samples, the histogram profiles were overlaid on one display 
(Figure 15).
It can be clearly seen that REL-C7 cells exposed to DMSO undergo a 
reduction in cell size. This reduction was detected after as little as 8 hr exposure to 
DMSO. A significant decrease in cell size was obtained after 24 hr exposure 
(p<0.001; Kolmogorov-Smirnov Two Sample Test (173)). With increasing exposure 
time, the cells continued to become smaller.
In Figme 15, the units on the x-axis are merely arbitrary units that do not 
relate to any absolute measurement. Nevertheless, the scale is proportional i.e. cells 
which have a peak at "800" are, on average, twice the diameter of cells with a peak at 
"400". For each cell population, the mean cell size (in arbitrary units) was assessed 
by estimating the peak value for each curve. Clearly, these values are not precise but 
at least they demonstrate the shift in cell size:-
DMSO 0 : 795 (arbitrary units)
Figure 15
REL-C7 cells exposed to DMSO for various periods of time. 
Effects on cell size as assessed by forward light scatter properties.
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In addition, as would be expected, there is a great deal of overlap between the 
curves. In any one population, the cells will not be all the one discrete size, but rather 
there will be a distribution of cell sizes. These histogram profiles show a shift in the 
size distribution curves. The decrease in cell size can be quite marked. This can be 
clearly seen by comparing the distributions for 0 hi' exposure and 96 hr exposure. 
There is very little overlap between the two distribution curves, i.e. the vast majority 
of cells exposed to DMSO for 96 In- are smaller than even the smallest cells in the 
DMSO 0 lir group.
3.5.8. Scanning Electron Microscopy (SEM)
SEM was kindly provided by Mr J Anderson, Department of Pathology, GRI.
As a further investigation into the morphological changes that may occur 
when REL-C7 cells are exposed to DMSO, the cell surface morphology was analysed 
by SEM. As before, REL-C7 cells were incubated with 1.5% DMSO for different 
periods of time; in this case 24 and 48 In'. The cells were prepar ed for SEM as 
described in Section 2.13.
Proliferating REL-C7 cells, cultured in MEM-0++ alone, taken from the 
logarithmic phase of growth, served as control cells. The cell surface had a 
convoluted appearance (Plate 5 A) and revealed many well defined microvilli and 
some longer string - like projections. Some short ridges appeared to run across the 
cell surface.
After 24 hr exposure to DMSO, some profound differences could be seen 
(Plate 5B). Some cells were similar to the controls. They still retained the rough, 
uneven surface with ridges running across the cell. However, other cells, with a much 
smoother morphology, were observed. These cells lacked the microvilli and ridges of 
control cells. The prominent feature of these cells was the appearances of pores or 
channels on the cell surface.
After 48 lir exposure to DMSO, a further shift in morphology was detected. 
Almost exclusively, all the cells observed showed the very smooth morphology. A
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representative sample is shown is shown in Plate 5C. Some pores/channels were still 
discernible.
In previous sections, data have been presented showing that exposure of 
REL-C7 cells to DMSO causes a down-regulation of DNA synthesis and a reduction 
in cell proliferation. A further investigation was set up whereby REL-C7 cells were 
taken from cultures in the stationary phase of growth, i.e. non-proliferating. These 
cells were cultured in the absence of any inducer, but were allowed to grow and divide 
until they reached the maximum cell density (approx 3 x lO^/ml) as shown in eaiiier 
growth curves.
These uninduced, non-proliferating cells were analysed by SEM (Plate 5D). 
Interestingly, they too had a generally smooth appearance with some deep 
pores/channels on the surface. There was a striking similarity between these cells 
and the smooth cells observed after 24 and 48 lir exposure to DMSO.
Although differentiation and proliferation seem to be closely related in an 
inverse fashion, the profound alterations to surface morphology induced by DMSO 
may reflect proliferation being dovm-regulated and the cells entering a proliferative 
stationary phase, rather than any great maturational progression.
It is also worth noting that the complete transformation of the cell surface 
from rough to smooth, can be effected within 24 hi’ of exposure to DMSO.
The data presented here also provide some corroboration of the results from 
the previous section where the size analyses were performed. From the scanning 
electronmicrographs, it was possible to estimate the actual diameter of cells. The non­
induced proliferating control cells measured some 11 pm in diameter. Following 
exposure to DMSO for 24 lir, cell diameter decreased slightly to about 10 pm. Cells 
that were exposed for 48 h were even smaller, about 8.5 pm in diameter. The non­
induced, non-proliferating control cells measured about 9.5 pm in diameter. Although 
these reductions may sound modest, if the cell volumes are calculated the differences
164
Plate 5A
Scanning Electron Micrograph of REL-C7 cells taken from the logarithmic 
phase of growth.
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Plate 5B
Scanning Electron Micrograph of REL-C7 cells exposed to 1.5% DMSO for 24 
hours.
?
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Plate 5C
Scanning Electron Micrograph of REL-C7 cells exposed to 1.5% DMSO for 48 
hours.
167
Plate 5D
Scanning Electron Micrograph of non-proliferating REL-C7 cells taken from the 
stationary phase of growth.
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are striking (Presume the cells are spherical; volume of a sphere = 4/3 n r^, Avhere n is 
a constant, 3.1416; and r = radius). Using the cell sizes from above, the non-induced 
proliferating control cells had a volume of 697 pm^. After 24hr of DMSO exposure, 
the cell volume had dropped to 524pm^- After 48 hi' of DMSO exposure, the cell 
volume decreased further to 322 pm^. For the non-induced, non-proliferating cells, 
the value was 449 pm^. Not withstanding the obvious inaccuracies of these 
calculations, the cell volume appeal's to be approximately halved following 48 In- 
exposure to DMSO - a profound reduction by any standards.
In brief summary, than, exposure of REL-C7 cells to 1.5% DMSO seems to 
induce a cascade of biological effects. It is proposed that, although maximum 
numbers of B+ve cells are obtained after 96 hr exposure to DMSO, an ordered 
sequence of events is initiated after only a few hours exposure to DMSO. DNA 
synthesis is down-regulated and cells start to come out of the proliferative cycle.
Cells begin to lose their ability to divide. Some cells become committed to 
differentiate. Gross morphological changes become apparent, e.g. reduction in cell 
size, profound alterations to the cell surface whereby the cells change from a rough 
appearance (by SEM) to a smooth one. Some time later, B+ve cells start to appear 
and by 96 lir exposure to DMSO, the proportion of B+ve cells is at its maximum. This 
sequence of events is represented diagrammatically in Figure 16.
3.6 Adaptation of REL-C7 cells to serum-free culture.
In the vast majority of tissue culture tecliniques, cells are propagated in a 
chemically defined medium which has been supplemented with serum. The source of 
serum can vary, but bovine and to a lesser extent, equine are probably the most 
commonly used. The obvious advantage of such serum supplemented media is that 
they provide optimum culture conditions for a wide variety of cells. The main 
disadvantage of these media is that they are chemically ill-defined. Serum constitutes 
a "soup" containing myriad activities. It is likely that these many, diverse activities 
will be able to elicit a whole range of biological effects, e.g. some stimulatory, some
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inliibitory. For a particular’ culture application it is necessary to pre-test batches of 
serum to determine if they are suitable. Some will be suitable, some will be rejected. 
This reflects our lack of understanding about the nature of serum and its role in tissue 
culture. The provision of reliable, chemically-defined, serum-free medium is 
currently an area of intense investigation by a number of the bioteclmology 
companies.
In previous sections, data were presented demonstrating that DMSO can 
induce REL-C7 cells to differentiate whereby they lose their proliferative ability and 
follow an erytliroid maturation programme. The aim of this part of the work was to 
identify biological activities that influenced the regulation of differentiation. Since 
serum contains so many undefined activities, it seemed inappropriate to use serum- 
supplemented media. The strategy was to prepare a basic culture medium in which all 
the constituents were chemically defined. By supplementing this medium with a 
particulai' growth factor or hormone, it may be possible to see what factors are able to 
modulate the differentiation process.
Serum-free media were prepared as outlined in Section 2.14. Over a period 
of time, REL-C7 cells were adapted to these various media. This was done by 
gradually replacing the sermii-containing medium with the appropriate serum-free 
medium. The cells readily adapted to these media.
To investigate if REL-C7 cells grew equally well in all the different media, 
growth curves were set up and doubling times calculated (Section 2.15). In addition, 
the cells were assessed for viability by Trypan Blue exclusion (Section 2.4.1). A 
representative example is shown in Figure 17.
All 3 serum-free medio, were, to a greater or lesser extent, sub-optimal.
The "in-house" medium, MEM-0±/ITS, BSA (MEM-0± supplemented with Insulin, 
Transferrin, Selenious Acid and Bovine Serum Albumin) was the best of the tlnee; 
SF-1 (Northumbria Biologicals) was the worst. MEM-0+/ITS, BSA most closely 
mirrored MEM-0++. Cells grown in MEM-0++ started to come out of exponential 
phase after ~ 64 hr of culture and reached a plateau in stationary phase at a cell
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concentration of 2.8 x 10^/ml. Cells grown in MEM-0±/ITS, BSA lagged behind 
somewhat, coming out of exponential phase after ~ 72 lir of culture, but nevertheless 
reaching a plateau at ~ 2.6 x 10^/ml after ~ 86 lir of culture. The rate of growth in 
both SF-1 and HPHM started to slow down after ~ 75 hr of culture and neither 
medium allowed the cell numbers to reach the level achieved with MEM-0++ (2.8 x 
10^/ml). SF-1 cultured cells reached a plateau at ~ 0.8 x 10^/ml, while HPHM 
cultured cells reached a plateau at ~1.4 x 10^/ml. In all the media tested, there was no 
difference in the cell viabilities, as assessed by Trypan Blue exclusion. In all 4 media, 
at all the time points shown, high viability was always obtained ( > 96%) (data not 
shown). Thus, SF-1 and HPHM media seemed to have no obviously deleterious 
effect on REL growth. Rather, these media seemed well capable of supporting cell 
growth, albeit at a sub-optimal level.
Doubling times were calculated (Section 2.15) and data from 6 experiments 
are summarised in Table 24. There was no significant difference between cells 
cultured in MEM-0++ and cells cultured in MEM-0+/ITS, BSA (P>0.1; student's t- 
test). There was, however, a significant difference in the doubling times of cells 
cultured in SF-1 or HPHM compared to MEM-0++ (SF-1, p<0.001; HPHM, p<0.02).
Thus, of the tluee serum fi-ee media examined, MEM-0+/ITS, BSA seemed 
superior, and this medium was used for most of the subsequent studies into DMSO - 
induced differentiation of REL-C7 cells cultured in serum-free conditions.
3.6.1. Differentiation of REL-C7 cells cultured in serum-free conditions.
REL-C7 cells, originally grown in MEM-0++, were adapted to serum-free 
culture as previous outlined in Section 2.14.
DMSO was used as the potential inducer of differentiation and experiments 
were set up as described in Sections 2.7 and 2.7.1. The extent of any erytliroid 
differentiation was measured by the benzidine reaction which detects haemoglobin )
(see Sections 2.8 and 2.8.2).
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Table 24
Doubling times of REL-C7 cells cultured in various media.
Results are expressed as mean ± SD of six experiments.
Culture Medium Doubling Time (hr) P-value
MEM-0++ 13.7±3.0 -
MEM-0/ ITS, BSA 14.8 + 1.8 P>0.1 NS
SF-1 22.0 ±3.7 P <  0.001
FIPHM 18.5 ± 8.6 0.01 < P < 0.02
NS =
not significant
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Briefly, tissue culture flasks containing 5 ml of appropriate medium were 
pre-equilibrated by incubating them at 37®C/5% C0 2 /humidifled atmosphere for 2-3 
hours prior to use. Routinely, cells were set up at a concentration of 0.01 x 10^/ml. 
Immediately before inoculating the flasks with cells, DMSO was added to a flnal 
concentration of 1.5% (75 pi —> 5ml). Obviously, cells adapted to a particular 
medium were set up in that medium supplemented with DMSO, e.g. cells cultured in 
SF-1 medium were set up in SF-1 medium/1.5% DMSO. After 4 days of incubation, 
cells from each flask were aspirated and analysed by the henzidine reaction. Data 
from 3 experiments are presented in Figure 18.
Only those cells cultured in MEM-0++ (i.e. serum- containing medium) 
were able to differentiate, reaching a maximum of 49% B+ve. By contrast, all three 
serum-free media produced <1% B+ve cells (in fact, on the slides examined, any 
B+ve cells were extremely rare events). This was a quite striking result, and further 
experiments were set up to try to establish what was required to allow differentiation 
to proceed.
3.6.2 Serum-supplemented "serum-free medium"
All the differentiation data presented so far have been obtained from REL-C7 
cells cultured in MEM-0++/DMS0. In the previous section, the lack of 
differentiation obtained in the serum-fi'ee culture may have been due to the change in 
basic medium rather than the absence of serum. For example, there may be some 
inlierent property of SF-1 medium that does not allow differentiation to proceed. To 
exclude this possibility, the three serum-free media were supplemented with FBS to a 
final concentration of 10%. Once the cells had adapted to these culture conditions, 
they were exposed to DMSO as described in the previous section. As before, the 
extent of erythroid differentiation was assessed by the benzidine reaction. Figure 19 
shows the results of tluee experiments.
In contrast to the results from the previous section, all three serum free 
media, when supplemented with FBS, were capable of supporting differentiation,
175
î
LU
Û
Nz:
a
co
T 30>
E
0)0)
E3k_0>V}
T30>
3O
CO
m do  C/)
O
LUDC
CO
.2+->c
(DCO
^  0) D)
iZ Q
lO
s
o
c o
Qk.
CL
0 )JC
g g g oco g o
<coCÛ
coH
+o
LU
X
co
++o
LU
2
QLU
LUDC
= >
Z)ü
(%) 9A+ 3 N ï a i z N a a
176
X I
T 3
u_
CL
LU
in
T 3 o
u_
C L 11.
T 3
LU
S o oC \i o oO )il Û 0A!i!Sod auipizuag
177
albeit to a reduced extent. Compared to the control (MEM-0++, mean =37% B+ve), 
all tlrree were inferior:- HPHM/10% FBS, mean =13%; SF-1/10% FBS, mean = 22% 
B+ve; and MEM-0+/ITS, BSA/10% FBS, mean = 30%. The observation that the 
serum-free media were inferior is not important. What is important is that, when 
supplemented with FBS, they were able to sustain an appreciable level of 
differentiation. This indicates that the basic media do not have any intrinsically 
adverse effects on differentiation, but rather it is the omission of FBS which is crucial, 
i.e. no FBS, no differentiation.
3.6.3 Effect of various FBS concentrations on REL-C7 differentiation
From the previous section, it appeared that FBS, or at least serum of some 
description, was necessary to sustain DMSO - induced differentiation. Routinely,
FBS was used at a concentration of 10%. Experiments were set up to "titre out" this 
FBS effect, i.e. what concentration of FBS will still sustain significant differentiation?
Several batches of medium were prepared, each supplemented with a 
different volume of FBS, i.e. MEM-0+ with FBS at 30%, 20%, 10%, 5%, 2.5%, 1.0% 
or 0.5%. REL cells that had routinely been maintained in MEM-0++ (i.e. 10% FBS) 
were adapted to each of these different FBS concentrations as outlined before (Section 
2.16). Following previously described methodologies, these cells were exposed to 
1.5% DMSO for 96 hr, and were then assessed for haemoglobin production by the 
benzidine reaction. Data from 4 experiments are presented in Figure 20.
The optimum range of FBS concentrations giving maximum numbers of 
B+ve cells was 5-15%. At concentrations higher than these, the proportion of B+ve 
cells declined, e.g. 30% FBS produced 38% B+ve cells; 20% FBS produced 37% 
B+ve cells; cf 10% FBS which produced 48% B+ve. Although there appeared to be 
some variation over the FBS range 5-30%, these differences were not significant 
(student's t-test).
When the FBS concentration was reduced to 2.5% a marked decline in B+ve 
cells was detected down to 17.5% (cf 48% B+ve at 10% FBS). This difference was
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statistically significant (P<0,01). Wlien the FBS concentration was further reduced to 
1.0%, the proportion of B+ve cells declined again (2% ± 1.8). This drop was 
significant (p<0.01).
Those cultures that had been set up with FBS at 0.5 % were uninterpretable. 
At this concentration of FBS, REL-C7 cells behaved in a peculiar fashion. Rather 
than remain in suspension during culture, the cells appeared to become adherent and 
their gross appearance was altered. This unusual observation was further investigated 
(see Section 3.7).
In summary, although the optimiun concentration of FBS was in the range 5- 
15%, significant levels of B+ve cells could still be obtained with FBS at 2.5%-30%. 
Only very low levels (e.g. 2%) of B+ve cells were observed at 1% FBS. Technical 
limitations prevented FBS concentrations below 1% being investigated. This is in 
broad agreement with the conclusions in an earlier section (section 3.1.2) in which 1% 
FBS was the lowest concentration of serum that was still able to support cell 
proliferation.
3.6.4 "Serum-free" medium supplemented with various sera
In all the previous differentiation studies, FBS has been used as the source of 
serum, and it has been demonstrated that FBS, at least, is necessary for differentiation 
to proceed.
Experiments were set up to see if the ability to support differentiation was 
unique to FBS or whether sera from other sources could substitute for it. Different 
sera were obtained from a variety of sources (see Section 2.16).Different batches of 
medium were prepared by supplementing MEM-0+ (i.e. no added serum) with one of 
the following sera;- (a) mouse,
(b) rat,
(c) rabbit,
(d) horse,
(e) human.
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As before, REL cells were adapted to these alternative culture media as 
described in Section 2.16.
To ensure that REL cells were well maintained in those media containing 
alternative sera, doubling times were calculated (Table 25). Data from 3 experiments 
showed that there was no significant difference between any of the sera tested with 
respect to REL cell proliferation.
These cells that had been adapted to grow in the presence of various sera 
were now exposed to DMSO to see if they could be induced to differentiate. As 
before, 5 ml of the appropriate medium were added to a tissue culture flask and 
allowed to equilibrate for several hours at 37°C/5% CO2 prior to the addition of 75p,l 
DMSO (i.e. 1.5%) and cells (to a concentration of 0.01 x 10^/ml). After 4d 
incubation, the cells were assessed by the benzidine stain for the production of 
haemoglobin. Data from 3 experiments are presented in Figure 21. Clearly, all 6 of 
the sera tested were able to sustain REL erytlnoid differentiation. Furthermore, there 
were no significant differences in the % B+ve cells between any of the sera. On the 
evidence presented here, FBS per se is not a requirement for differentiation, and in 
fact, a variety of sera can adequately substitute for FBS.
3.6.5 Heat treatment of FBS: Effects on REL growth and differentiation.
To investigate further the role of serum in REL differentiation, cells were 
grown in MEM-0+ supplemented with heat-treated FBS (see section 2.17). "Heat 
inactivated" (H.I.) serum was prepared by incubating aliquots of FBS at 56^C for 30 
mill. "Denatured" (D.N.) serum was prepared by boiling aliquots for FBS for 5 min.
As before, cells were adapted to grow in MEM-0+ supplemented with either 
FII-FBS or DN-FBS. Doubling times were calculated to see what effect, if any, these 
heat treatments had on REL proliferation (Table 26). HI-FBS was an adequate 
replacement for FBS. No significant difference was detected in the doubling times 
between FBS and HI-FBS supplemented MEM-0+. DN-FBS, on the other hand,
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Table 25
Doubling times of REL-C7 cells cultured in MEM-0+ supplemented with 
various sera.
Results are expressed as the mean ± SD of tlnee experiments.
Serum Supplement Doubling Time (hr) P-value
FBS 14.3 ±1.1 -
Mouse 12.8 + 0.6 0.5>P>0.1
Rat 13.9 + 1.9 P>0.5
Rabbit 14.8 + 0.6 P>0.5
Horse 14.0+1.4 P>0.5
Human 14.9+1.4 P>0.5
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Table 26
Doubling times of REL-C7 cells cultured in MEM-0± supplemented with heat- 
treated FBS.
Results are expressed as the mean ± SD of tliree experiments.
Serum Supplement Doubling Time (hr) P-value
FBS 13.7 + 1.2 -
HI-FBS 13.8 + 1.1 P>0.5
DN-FBS 21 + 1.0 P<0.01
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showed a significant extension to the doubling time compared to FBS (21 hr cf 13.7 
hr, p<0 .01, student's t-test).
As before, cells maintained under these culture conditions were exposed to 
DMSO to induce erytlu'oid differentiation. Data from 3 experiments are presented in 
Figure 22. Replacing FBS with HI-FBS had no deleterious effect on differentiation. 
On d.4 in MEM-0+/HI-FBS the percentage of B+ve cells was 53.3 + 7.1 (mean + 5.0) 
compared to 49.7 + 4.2 obtained in MEM-0++ (i.e. containing FBS). The values 
were not significantly different (0.5 >p >0.1, student's t-test). By contrast, replacing 
FBS with DN-FBS prevented any significant differentiation from taking place. In all 
3 experiments, the percentage of B+ve cells was always <1%.
Thus, heat inactivation of FBS affects neither its ability to support REL cell 
proliferation, nor its ability to allow differentiation to occur. On the other hand, heat 
dénaturation of FBS allows only sub-optimal REL cell proliferation and its ability to 
support differentiation is completely abrogated. It would appear that some serum 
factor (s) is required for differentiation to proceed, and that this activity is retained 
following mild heat treatment. However, following more severe heat treatment, this 
serum factor (s) loses its activity and differentiation cannot proceed. It is likely that 
this active serum factor (s) is proteinaceous.
3.6.6 Commitment to differentiation of REL-cells cultured in serum-free medium
Commitment has been defined as the ability to continue differentiation in the 
absence of inducing agent. It has previously been demonstrated that REL-C7 cells 
can be committed to differentiate with as little as 8 In exposure to DMSO, although it 
requires some 24-48hr to obtain significant commitment.
"Transfer-out" experiments were performed to investigate the role of FBS in 
commitment. The method used earlier (Section 2.9) was slightly modified. Briefly, 
REL cells cultured in MEM-0++ were inoculated into a pre-equilibrated tissue culture 
flask containing 5 ml MEM-0++ with DMSO at 1.5 % (final cell concentration 0.01 x
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10^/ml). After 24 lir incubation, the culture was poured into a centrifuge tube and the 
cells centrifuged at 100 g/5 min. The cells were washed twice with MEM-0++ (i.e. 
no DMSO) and resuspended in 5 ml of fresh, pre-equilibrated MEM-0++ in a second 
tissue culture flask. These secondary cultures were maintained for a further 72 lir (i.e. 
96 hr in total), then the cells were assessed for haemoglobin production by the 
benzidine reaction.
Similarly, parallel cultures were set up in which REL cells, maintained in 
MEM-0++, were exposed to DMSO as above. However, on this occasion, after 24 hi' 
of culture, the cells were washed twice with MEM-0+ /ITS, BSA to remove any 
residual DMSO, and also to remove/reduce any FBS. These cells were established in 
secondary cultures in MEMO-+/ITS, BSA (ie no DMSO and no FBS), and, after a 
further 72 ln', they were assessed for B+ve cells.
Lastly, further cultures were set up in which REL cells that had been 
maintained in MEM-0+/ITS, BSA (no FBS) were inoculated into a fresh flask of 5 ml 
of MEM-0+/ITS, BSA with 1.5% DMSO. After 24 hr incubation, the cells were 
washed free of any contaminating DMSO as before and re-established in a secondary 
culture flask containing MEM-0++ (i.e. serum-containing). After a further 72 hi' 
incubation, the cells were assessed for B+ve cells.
In Summary,
Cell cultured for 24 hr in Cells cultured for 72 hr in
transferred into
A. M[EM!-0++/DM!S0 —^  ^  ^  ^  ^  ^ —y —y M[EM[-0++
B. MEM-0++/DMS0 —+ —+ —y —y —y —+ —y —y —y MEM-0+/ITS, BSA
C. MEM-0+/ITS, BSA/DMSO ^  MEM-0++
The data from 3 experiments are summarised in Figure 23. A control culture 
was also set up in which REL cells were maintained in MEM-0++ supplemented with 
1.5% DMSO, uninterrupted for 96 In*.
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In the control culture, 43% (43 ± 4.6, mean ± SD) of the cells were B+ve. In 
test flask A (i.e. cells exposed to DMSO in the presence of FBS, then transferred to 
FBS- containing MEM-0), 45% (45 ± 6.1) of the cells were B+ve. This demonstrated 
that there was a high level of commitment to differentiate after 24 hi' exposure to 
DMSO. Although the test value of 45% B+ve was slightly higher than the control 
value of 43%, this difference was not significant (p>0.5, student's test).
Interestingly, in test flask B (i.e. cells exposed to DMSO in the presence of 
FBS, then transferred to serum-free MEM-0), 27% (27 + 4.6) of the cells were B+ve. 
Although this value of 27% is significantly lower than the control value of 43% (0.02 
> P>0.01, student's t-test), it still represents an appreciable amount of differentiation. 
Previously it was shown (Sections 3.6.1, 3.6.2) that serum, of some description, was 
necessary for differentiation to proceed. Here it has been demonstrated that once REL 
cells have been committed to differentiate, then, to some extent at least, serum is no 
longer required for differentiation. Thus, after 24 hi' exposure to DMSO in MEM- 
0 ++, many cells have already "made the decision" to differentiate and subsequent 
removal of serum does not affect the differentiation process.
The last combination that was set up (flask C), looked at cells that were 
exposed to DMSO in serum-free medium, and were then transferred to sermn- 
containing medium. Only very low, barely detectable, levels of B+ve cells were 
obtained, 2% ± 1.7. Obviously, this figure is highly significantly different from the 
control, and indeed from both of the other test cultures. It would appear that very few 
cells became committed to differentiation when exposed to DMSO in the absence of 
serum. In addition, these data indicate that serum may not be required to support the 
entire differentiation process, but rather it is necessary only in the critical stages of 
differentiation when cells became irreversibly committed to differentiate.
It is possible that the inability of REL cells to differentiate in the absence of 
serum may be due to some profound phenotypic change induced in the cells by serum- 
deprivation, i.e. they may have lost the capacity to differentiate. To test this 
possibility, cells that had been adapted to MEM-0+/ITS, BSA (i.e. serum-free) were
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"re-adapted" back to MEM-0++ (i.e. serum-containing). Subsequently, when these 
cells were exposed to DMSO, a significant, albeit sub-optimal, level of B+ve cells 
was obtained (Figure 24), 19% + 6.2 (cf control 43 + 4.6). This demonstrated that 
prolonged maintenance in serum-deprived conditions did not abrogate the ability of 
cells to differentiate. Cells inlierently retained this ability to differentiate and were 
able to express this under suitable culture conditions.
3.6.7. Addition of recombinant growth factors to serum-free culture. 
Effect on DMSO- induced differentiation
It has been clearly demonstrated that serum contains some activity(s) which 
is required to enable cells, in the presence of an inducer, to enter a differentiative 
phase in which they increasingly lose the capacity to proliferate and instead acquire a 
much more mature phenotype as demonstrated by morphology and the production of 
haemoglobin. More precisely, this activity seems to he necessary for the "decision­
making" process, i.e. commitment to differentiate. The required factor appears to be a 
common serum component whose activity is not affected by heat-inactivation, but 
whose activity is destroyed by heat dénaturation. In all likelihood, the factor is 
proteinaceous in nature. Wliat, then, is this activity?
The manner in which low molecular weight inducers (like DMSO) exert their 
effects has yet to be resolved. Similarly, the culture conditions that influence 
differentiation are ill-defined. A major impediment to this has been the necessary 
inclusion of serum in cell culture. The myriad activities present in serum make it 
impossible to delineate the factors that influence differentiation. Clearly, the use of a 
serum-free medium, in which all the constituents are defined, is an attractive 
proposition.
One strategy used to develop chemically-defined media is the so-called 
"unifying approach" (174), In effect, this involves designing a basic culture
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medium in which all the constituents are chemically-defined. By supplementing this 
basic medium with a particular hormone or growth factor (or combination of factors), 
it should be possible to see what influence, if any, they have on, say, differentiation.
A range of cytokines/growth factors (GF) was assessed for any effect on 
DMSO-induced differentiation: -
(a) Interleukin-6 (IL-6),
(b)Interleukin-11 (IL-11),
(c) Granulocyte colony stimulating factor (G-CSF),
(d)Macrophage colony stimulating factor (M-CSF),
(e) Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF),
(f)Kit Ligand (KLS),
(g)Macrophage Inflammatory Protein- l a  (MIP-la).
(see Section 2.18)
Stock MEM-0+/ITS, BSA was prepared. Aliquots of 20 mis were dispensed 
into Universal containers. Each cytokine/GF was studied at 3 different 
concentrations. Thus, to each aliquot of 20 ml was added one concentration of one 
cytokine/ GF. The concentration ranges were : -
(a) IL-6 : 2 , 20 , 200 ng/ml.
(b) IL-11 : 1, 10, 100 ng/ml.
(c) G-CSF : 1, 10, 50 pl/ml
(d) M-CSF : 1, 10, 100 ng/ml
(e) GM-CSF : 0.5, 5, 50 U/ml
(f) KLS : 2, 20, 50 pl/ml
(g) M IP-la : 20, 200, 500ng/ml.
Initial studies assessed the proliferative status of cells grown in the presence 
of a particular cytokine. Briefly, cultures were set up in 24-well Tissue culture plates
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(Costar). The 16 wells around the perimeter of the plate received 2ml sterile distilled 
water. The central 8 wells were used to establish cultures (Filling the outer wells with 
water minimises evaporation and reduces the tendency of the medium to become 
hypertonic). REL-C7 cells that had been adapted to MEM-0+/ITS, BSA were used to 
inoculate the well-cultures. Cells were set up at 1 x lO^/ml in a 2 ml volume. 
Doubling times were calculated as before (Section 2.15). Data from 2 experiments are 
shown in Table 27.
These data indicated that none of the cytokines/GF's appeared to have any 
great effect on REL-C7 proliferation, i.e. neither stimulatory nor inhibitory. All cells 
seemed to grow perfectly well, no matter what cytokine was added. For convenience, 
therefore, one concentration of each cytokine was selected for use in subsequent 
differentiation studies. The "middle" concentration (i.e. the recommended 
concentration) was chosen for each cytokine.
REL-C7 cells were set up at 1 x lO^/ml in tissue culture flasks in 5 ml of 
MEM-0+/ÏTS, BSA supplemented with a single cytokine and DMSO at 1.5%. After 
4 days the cells were assessed for haemoglobinazation (see Table 28).
As demonstrated before, MEM-0±/ITS, BSA was unable to support DMSO- 
induced differentiation ("No addition" in Table 28). Equally, when MEM-0+/ITS, 
BSA was supplemented with a single cytokine at the concentration indicated, no 
significant haemoglobinzation was detected. A few B+ve cells were observed but the 
numbers were small, not greater than the background level of spontaneous 
differentiation described in Section 3.5.2. As a positive control, a culture of REL-C7 
cells was set up in MEM-0++ with 1.5% DMSO. The subsequent level of 
haemoglobinization was satisfactory (38%+ 5.6, mean ± SD).
As a further investigation, some cytokine combinations were studied. Most 
of the GF's available are regarded as somewhat restricted in the lineages that they can 
influence. However, KLS (SCF) and M IP-la exert at least some of their effects on 
more primitive cells, often in synergy with other cytokines. The first part of the study 
combined KLS with each of the other cytokines listed. The second part of the study
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Table 27
MEM-0± / ITS, BSA supplemented with various cytokines. Effect on REL-C7 
doubling time.
Cytokine / Growth Factor Doubling Time (hr) Doubling Time (hr)
Experiment 1 Experiment 2
No addition 15.2 16.0
IL-6 2 ng/ml 16.1 15.7
20 14.8 14.8
200 14.2 16.0
IL-11 1 ng/ml 15.0 13.5
10 15.9 15.3
100 16.7 16.4
G-CSF I pl/ml 16.6 17.8
10 16.6 15.6
50 15.0 15.5
M-CSF 1 ng/ml 17.0 18.1
10 16.0 17.7
100 14.9 14.6
GM-CSF 0.5 U/ml 18.6 16.4
5.0 16.2 13.5
50 16.7 15.7
KLS 2 pl/ml 14.9 15.8
20 14.3 18.0
50 15.4 16.5
M IP-la 20 ng/ml 14.9 12.7
200 15.2 13.9
500 15.0 16.7
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Table 28
DMSO-induced differentiation of REL-C7 cells cultured in MEM-0± / ITS, BSA 
supplemented with various cytokines.
Results are expressed as the mean ± SD of three experiments
Cytokine Addition % B+ve
No addition <1
IL-6 (20ng/ml) < 1
IL-11 (lOng/ml) < 1
G-CSF (lOpl/ml) <1
M-CSF (lOng/ml) < 1
GM-CSF (5U/ml) < I
KLS (20pl/ml) < 1
M IP-la (200ng/ml) < 1
MEM-0++ Control 38 ±5.6
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combined M IP-la with each of the other cytokines. Again, REL-C7 cells were set 
up at IxlO^/ml in tissue cultine flasks in a 5 ml volume with DMSO at 1.5%. The 
proportion of cells staining B+ve was assessed as before. Data from 3 experiments 
are shown in Table 29. Clearly, the cytokine combinations listed were insufficient to 
support DMSO-induced differentiation. In fact, with all the cytokines used, the lack 
of effect was quite spectacular! No significant differentiation at all was detected. 
Consequently, no further cytokines or cytokine combinations were investigated, and 
the identity of the serum factor which supported differentiation remained unresolved. 
Considering the many and varied activities present in serum, this section of the work 
was something of a "fishing" exercise. Unfortunately, no fish were caught!
3.7 Phenotypic alterations in cultured REL-C7 cells
In a previous section (Section 3.6.2) it was shown that omission of FBS from 
the culture medium prevented cells from differentiating. To try to determine the 
lowest concentration of FBS that would still support differentiation, cultures were set 
up in which MEM-0+ was supplemented with a range of FBS concentrations from 
0.5 % - 30% (Section 3.6.3). An unexpected observation was that cells cultured in
0.5% FBS underwent a profound alteration in their gross morphology and in their 
growth characteristics.
3.7.1. Gross morphological changes
As outlined in Section 3.6.3, attempts were made to adapt REL-C7 cells to 
grow in culture medium supplemented with a range of FBS concentrations. As part of 
this investigation, cells that had previously been cultured in MEM-0+ /FBS 1% were 
seeded into flasks containing MEM-0+ /FBS 0.5%. Within 24 lir of initiation of 
these cultures, significant numbers of cells had adhered to the plastic surface of the 
tissue culture flask. At this stage, many cells were still in free suspension. Over the 
next few days of culture, the proportion of cells that were adherent increased
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Table 29
DMSO-iiiduced differentiation of REL-C7 cells cultured in MEM-0± / ITS, BSA 
supplemented with cytokine combinations.
Results are expressed as the mean ± SD of tlii’ee experiments.
Cytokine Combination % B+ve
No Addition < 1
K LS+IL -6 <1
+ IL-11 < 1
+ G-CSF < 1
+ M-CSF < 1
+ GM-CSF < 1
+ M IP-la <1
M IP-la + IL-6 < 1
+ IL-11 < 1
+ G-CSF <1
+ M-CSF < 1
+ GM-CSF < 1
MEM-0++ Control 44 ± 6.4
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progressively until by about day 4 of culture, relatively few cells remained in 
suspension.
Tbis adherent interaction with the plastic surface was very strong. Gentle, 
lateral rocking of the culture flasks failed to dislodge appreciable numbers of adherent 
cells. Even more vigorous physical agitation of the flasks left many cells still attached 
to the surface. Effective release of the cells from the plastic could, however, be 
achieved by drawing up some culture medium into a Pasteur pipette, and then forcibly 
expelling the liquid, in a fine jet, directly at the adherent cells. This resulted in the 
vast majority of cells being released into the supernatant. Interestingly, if such 
cultures were returned to the incubator (or fed and returned to the incubator) by the 
following day most of the cells had re-adhered.
It appeared that this plastic adherence was a response to a reduced FBS 
concentration. This was not strictly true. An additional batch of medium was 
prepared in which MEM-0± /FBS 0.5% was supplemented with BSA at a final 
concentration of 1% (see Section 2.14). Wlien REL cells were inoculated into this 
medium, the vast majority remained in suspension, although some cells, over a period 
of days, did show a tendency to adhere. These observations indicated that the 
adherent phenomenon was more likely due to reduction in protein concentration 
below a critical level, rather than a reduction in FBS per se. This is corroborated by 
the fact that REL cells could be maintained in suspension for weeks in medium that 
did not contain FBS, but did contain BSA (Section 3.6).
In addition to this shift from suspension culture to the formation of an adherent 
monolayer, the appearance of individual cells was also profoundly altered. Cells 
maintained in suspension culture appeared spheroid and light refractile with a smooth 
cell surface (Plate 6A). In contrast, adherent cells appeared "flattened" onto the 
plastic surface and were of irregular shape. Many cells had cytoplasmic extensions 
radiating out from the cell in all directions (pseudopodia) (Plate 6B). These cells were 
not dissimilar in appearance to peripheral blood, plastic-adherent, mononuclear cells
i.e. monocyte/macrophage cells.
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Plate 6
Magnification 400X.
A. Gross morphological appearance of REL-C7 cells grown in suspension 
culture.
O
<
" 0  -:4 O
o
«
B. Gross morphological appearance of REL-C7 cells grown as an adherent 
monolayer.
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3.7.2. Staining of adherent REL cells
Morphological analyses also showed profound alterations in adherent REL- 
C7 cells compared to the usual suspension culture cells. Adherent cells were released 
from the plastic surface hy vigourous pipetting and cytospin preparations were made 
(Section 2.19.4). The slides were allowed to air-dry and were then stained in Wright's 
stain. From Plate 7, it is obvious that these cells appear substantially different from 
REL-C7 cells maintained in suspension culture (in MEM-0++) (cf. Plate 4A), and 
from REL-C7 cells that have differentiated along an erythroid pathway (cf. Plate 4B). 
These adherent cells have the characteristic appearance of macrophages.
A range of specialised staining teclmiques was set up on these adherent cells 
in an attempt to characterise them (Section 2.19)
(a) Periodic acid-Schiff (PAS). This stain can be useful in identifying 
erytln'oid cells. Often, erythi'oblasts show heavy PAS positivity.
(b) Sudan Black B. A positive Sudan reaction is associated with myeloid 
cells, i.e. of the granulocyte and monocytic series.
(e) Alpha Naphthyl Acetate Esterase (a-NAE). This can be usefiil in 
identifying cells of the monocyte/macrophage series.
The results are presented in Table 30. Suspension culture REL-C7 cells were 
singularly unreactive with any of the stains that were set up. Although REL-C7 cells 
from adherent cultures were negative for PAS and Sudan Black, they were strongly 
positive with a-NAE (Plate 8), as indicated by the prominent black granulation.This 
positive result suggested a monocyte / macrophage lineage.
3.7.3. Immuiiopheiiotypic analyses by flow cytometry
From the gross morphological appearance of the cells and the pattern of 
staining with a-naphthyl acetate esterase, it seemed that these REL cells had begun to 
express characteristics associated with myeloid (monocyte/macrophage) 
differentiation. In an attempt to corroborate this, REL cells were stained with a panel 
of monoclonal antibodies
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Antibody Specificity
OX-1 rat leucocyte common antigen (LCA)
OX-4 rat la (immune associated)
OX-41 rat macrophage
OX-44 all rat myeloid, and peripheral lymphocytes
OX-45 rat surface glycoprotein on haematopoietic 
cells, and endothelial cells
ED-1 rat monocyte / macrophage
The choice of antihodies was somewhat arbitrary, the main limitation being 
the range of anti-rat antibodies which was available.
Prior to immunphenotypic analyses, adherent REL-C7 cells were recovered 
from tissue culture flasks by vigourous pipetting. For comparison, REL-C7 cells from 
suspension cultures were used, i.e. maintained in MEM-0++ under standard 
conditions. In addition, normal rat bone marrow cells were also analyzed to give an 
idea of the normal pattern of expression obtained from fresh haematopoietic material 
rather than established cell lines (the bone marrow cells were obtained by flushing out 
the contents of a rat femur).The staining procedure is outlined in Section 2.20. After 
staining, the percentage of cells expressing a particular antigen was determined by 
flow cytometry (FACScan, Becton Dickinson). Data from 2 experiments are shown in 
Table 31.
Virtually all normal rat bone marrow cells were positive for OX-1 and OX-45. 
In addition, the antigens associated with OX-41 and OX-44 were expressed on the 
majority of hone marrow cells (82% and 86% respectively). Only low levels of 
staining were obtained with OX-4 and ED-1 (17% and 15% repectively).
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rPlate 7
Morphology of REL-C7 cells from adherent monolayer cultures by Wright's 
stain.
Magnification lOOOX.
m
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Table 30
Cytochemical analyses of REL-C7 cells grown in suspension culture or in 
adherent monolayers.
Stain Suspension
Culture
Adherent
Culture
PAS -
Sudan Black -
a-NAE 4— H
= negative,
++++ = strongly positive.
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Plate 8
Magnification 400X.
A. a-naphthyl acetate esterase staining of REL-C7 cells grown in suspension 
culture.
B. a-naphthyl acetate esterase staining of REL-C7 cells grown as an
204
Table 31
Immunophenotypic analyses of varions cell populations.
Results are from two experiments.
Values are the means of the percentages of cells positive for that particular antibody.
Monoclonal
Antibody
Normal Rat Bone 
Marrow Cells
REL-C7 Suspension 
Culture
REL-C7 Adherent 
Monolayer
OX-1 >95 35 38
OX-4 17 <5 <5
OX-41 82 <5 63
OX-44 86 <5 <5
OX-45 >95 78 70
ED-1 15 <5 <5
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For the characterisation of REL-C7 cells, some of the antihodies were not 1
particularly informative. For example, antibodies OX-4, OX-44, and ED-1 were 
negative (<5% positive) for both suspension cells and adherent cells. With two other 
antibodies, some degree of positivity was obtained. The antigen identified by OX-1 
was expressed on 35% of suspension cells and 38% of adherent cells. The OX-45 
antigen was expressed at a higher level, with 78% of suspension cells and 70% of 
adherent cells being positive. The important point here is, not so much the degree of 
expression of the antigens, but rather the fact that there was no difference in 
expression between suspension cells and adherent cells.
OX-41, on the other hand, showed a significant difference. Suspension cells 
were negative (<5% positive) for OX-41. Adherent cells were strongly positive (63%) 
for expression of the antigen associated with OX-41. Since OX-41 identifies a 
macrophage marker, this observation provided further evidence that these adherent 
REL-C7 cells had developed myeloid (i.e. non-erythroid) characteristics.
3.7.4 Scanning Electron Microscopy (SEMI of adherent REL-C7 cells
It was previously demonstrated (Section 3.5.7) that profound alterations to the 
cell surface occurred when REL-C7 cells were induced to differentiate along an 
erythi'oid pathway following exposure to DMSO. The preceeding sections have
'i:
indicated that maintenance of REL-C7 cells in low protein culture conditions induced
the cells to mature along a myeloid pathway, or more precisely, a monocyte /
macrophage pathway.
Following the same procedure as before (Section 2.13), REL-C7 cells that had
.become adherent following maintenance in low protein culture medium (MEM-0± / 
FBS 0.5%) were prepared for scamiing electron microscopy. Striking differences were 
seen between suspension cells and adherent cells (Plate 9).
As before (Section 3.5.7), cells maintained in suspension culture appeared 
spheroid with a cell diameter of around 10-12pm. The suiface showed many
/I
,
protrusions and ridges. I
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Plate 9
Scanning electron microscopy of REL-C7 cells.
A. Suspension cells cultured in MEM-0-H-.
S377I89 "S2964 80KV X3.0K iHm JEOL
B. Adherent cells cultured in MEM-0±/FBS 0.5%.
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In contrast, adherent REL-C7 cells had a flat, angular appearance, often 
measuring greater than 20pm across. Numerous cytoplasmic extensions / pseudopodia 
were evident, stretching out from the cell to a distance of 3-4pm. The cell surface 
seemed to retain many of the small blebs evident on the suspension cells. In Plate 9B, 
as well as four flat angular cells, there is also one cell which has retained a spheroid 
appearance. A direct comparison demonstrates the profound alteration in morphology 
between suspension culture cells and adherent cells.
Interestingly, in Plate 9B, the two cells in the centre foreground appear to be 
closely associated with each other via their cytoplasmic extrusions. One can only 
speculate what information (if any) they are communicating.
In summary, a chance observation was made when experiments were set up to 
determine the lowest concentration of FBS that would support DMSO-induced 
erytlii'oid differentiation. Cells maintained in medium with the FBS concentration 
reduced to 0.5% (rather than the standard 10%) adhered to the plastic surface of 
culture flasks and their gross appearance changed markedly. Several strands of 
evidence indicated that these changes were a result of myeloid differentiation. Both 
light microscopy and scanning electron microscopy suggested that the appearance of 
these cells was consistent with cells of the monocyte / macrophage phenotype. In 
addition, specific staining with a-naphthyl acetate esterase demonstrated the presence 
of granulation, indicative of monocytic / macrophage cells. Furthermore, when these 
cells were analyzed with specific monoclonal antihodies, the adherent cells showed 
strong expression of a macrophage marker (identified by OX-41) that was not 
detectable on suspension cells.
Taken together, these data provide compelling evidence that REL cells can 
mature along a monocyte / macrophage pathway. These cell lines were named "REL" 
because of their capacity to undergo erytln'oid differentiation on exposure to DMSO 
(143), REL being an acronym for Rat ErythroLeukaemia cells. It would appear that 
these cells are not restricted to the erythroid lineage and, in fact, are far more versatile.
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The original leukaemia was elicited in Long Evans rats by the serial
....
administration of the poly cyclic aromatic hydrocarbon, 7,12-dimethylbenz(a)- 
antlimcene (DMBA). The majority of the leukaemias obtained (ca. 80%) were 
classified as erythi’oleukaemia (141). The erythroid nature of this leukaemia was re-
....inforced by the observation that leukaemic cell lines could be established and these 
cell lines could differentiate along an erytlrroid pathway. Data presented here,
however, contradict the assumption that these leukaemic cells are inherently erytlnoid.
It may be more accurate to regard these cells as being derived from a "stem cell" 
leukaemia.
1
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3.8 Cytogenetic analysis of REL-C7 cells
Tumour cells in general, and leukaemic cells in particular, can be characterised 
by cytogenetic abnormalities (175). It has been amply demonstrated that sites of 
consistent chromosomal rearrangements help to identify genes which may be critically 
involved in malignant transformation, and that these rearrangements themselves can 
subvert the normal functioning of these genes. The classic example of this is the so- 
called Philadelphia cliromosome found in patients with chronic myeloid leukaemia 
(CML) (176). Haematopoietic cells from the majority of patients with CML contain a 
reciprocal translocation of genetic material between chromosomes 9 and 22, t (9,22). 
This results in a chromosome 22 that is smaller than normal, called the Philadelphia 
chromosome (Plf) (named after the city in which this discovery was made).
Cytogenetic analyses of REL-C7 cells were set up to determine if any 
consistent chromosomal rearrangement could be detected (Section 2.21). The major 
chromosomal rearrangements detected were:-
(a) deletion, and presumptive loss, of a segment from the long arm of 
chromosome 1, namely (q51-55), which has no known mouse or human 
homology (177).
(b) a major portion of chromosome 3 (ql2-43) had translocated to 
chromosome 1 which had lost its terminal (q51-55) region (see(a)).
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See Figure 25.
Comparative mapping of genes between rat, mouse, and humans indicates 
some areas of homology. Although rat cliromosome 1 (q51-55) has no known 
homology with any mouse or human cliromosomes, rat chromosome 3 has a high 
degree of homology with mouse cliromosome 2 and a considerable length of human 
chromosome 9 (in fact, 9q 13-34). The breakpoint on rat cliromosome 3 has been 
mapped to position ql2 (177). Interestingly, this area also contains the proto­
oncogene, c-abl.
Earlier, by way of introduction, brief reference was made to the reciprocal 
translocation t (9,22) often detected in CML. More precisely, this translocation occurs 
at t (9,22)(q34, ql 1), i.e. the breakpoint on chromosome 9 is at band q34, and the 
breakpoint on chromosome 22 is at hand ql Lin humans, the c-abl proto-oncogene has 
been mapped to chromosome 9 (q34). Thus, as a result of this translocation, c-abl is 
transferred from clii'omosome 9 at band q34 to the her gene (breakpoint cluster 
region) at band 22ql 1. The formation of this hybrid gene is believed to be the crucial 
event in the malignant transformation of the haematopoietic (stem?) cell that 
subsequently manifests itself as CML.
It is tempting to speculate that a similar mechanism is in operation with REL- 
C l cells. It may be that the translocation of a segment of chromosome 3 (comprising 
the rat equivalent of c-abl) to chromosome 1, juxtaposes c-abl next to another gene or 
regulatory domain that can subvert the normal expression or activity of c-abl, 
conferring a proliferative advantage on these cells.
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Figure 25 The major chromosomal rearrangements detected in REL-C7 
cells.
R1 lost R1
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R3t
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SECTION 4
DISCUSSION
Almost thirty years ago, Huggins and Sugiyama (141) reported the 
induction of leukaemia in rats following repeated doses of a potent carcinogen, 
DMBA. The most common type of leukaemia that was produced appeared to he 
erytlii’oleukaemia. Subsequently, Kluge et al demonstrated that permanent cell lines 
(i.e. REL cells) could be established from leukaemic rat tissues and that these cells 
could be induced to differentiate along an erytlrroid lineage following exposure to 
DMSO (143).
In the intervening years, these REL cells have been largely neglected as tools 
to investigate the phenomenon of differentiation. To the best of the author's 
knowledge, the data submitted in this thesis represent the fullest characterisation to 
date of these erytlrroleukaemic cells.
The cell lines described were established by removing the spleen from a 
leukaemic rat and perfusing it with culture medium to release cells into free 
suspension. These suspensions gave rise to permanent cell lines. This is in contrast to 
an earlier report in which cell lines were established by injecting newborn rats with 
blood from leukaemic rats (143). Tumours developed in the newborn rats, and cells 
from these tumours were set up in culture medium and gave rise to permanent cell 
lines.
Suspension cultures were optimally maintained in culture medium 
supplemented with foetal bovine serum (FBS) at a final concentration of 10% (v/v). 
Although REL cells did not appear to he particularly fastidious in their FBS 
requirement, batches of FBS were pre-screened to identify the most suitable ones. In 
addition, the concentration of FBS could he varied between 5 and 20% without any 
deleterious effect on cell growth.
REL cells were readily grown in suspension culture and the time taken for the 
number of cells to increase by a factor of 2 (doubling time) was between 12 and 14 
hours. This short doubling time is indicative of the high level of proliferation of these
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cells. For eukaryotic cell lines, the doubling time is imlikely to be shorter. For 
example, murine erythroleukaemic cells (MELC / Friend cells) have been widely 
studied and their doubling time is of the order of 14 hours (178). Flowever, other 
established cell lines have a much slower rate of cell division. The HL-60 
promyelocytic cell line grow in suspension culture with a doubling time anywhere 
between 20 and 48 hours depending on the subline (179, 180). Similarly, K562 cells 
can have a doubling time between 24 and 32 hours (181, 182). Perhaps a rather 
extreme example is the HL-92 cell line (immature myeloid / monocyte) which has a 
doubling time of 90 - 100 hours (183).
Like other cell lines, it is possible to propagate and study REL cells in systems 
other than suspension culture. A particularly useful teclinique is the so-called 
clonogenic assay which exploits semi-solid culture media to immobilise cells to a 
discrete position in the culture system. Thus, the behaviour of individual cells and !
their progeny (i.e. clones) can be investigated. Agar gel has been used to isolate
• - Iclones of HL-60 cells (184), or, alternatively, methylcellulose has heen used to clone 
K562 cells (185).
REL cells could be readily cloned in methylcellulose-containing semi-solid 
culture medium. By this technique, the cloning efficiency of REL cultures was of the 
order of 60%. That is, in any population of REL cells, some 60% were proliferating 
and undergoing cell division to give rise to progeny. The remaining 40% of cells, 
presumably, failed to grow. This is an interesting phenomenon. The cells in this non- S:
.proliferating subpopulation were not obviously dead. For example, by Trypan Blue 
exclusion, cells maintained in MEM-0++ under standard conditions were consistently 
>99% viable. Despite this high viability, a significant proportion of the cells seemed 
unable to divide. The one caveat to this, is the reliability of the Trypan Blue exclusion 
test. The basis of the test is that live, viable cells will have an intact, functional outer
i:
membrane which prevents the penetration of the Trypan Blue dye into the interior of 
the cell. Conversely, dead or dying cells are likely to have an outer membrane whose 
integrity has been compromised in some way by whatever cellular insult caused the
213
fatal damage in the first place. In this case, Trypan Blue would be able to penetrate 
these cells. Thus, a cell which stains blue could be predicted, with some confidence, to 
be dead. On the other hand, the exclusion of the dye does not necessarily indicate that 
the cell is fully functional. It only indicates that the outer membrane is sufficiently 
intact to prevent penetration of the dye. In other words, it may indicate that a 
particular cell is viable, but it does not tell us "how viable" that cell is.
The cloning efficiency of REL cells was calculated from cultures set up in 
semi-solid medium rather than the standard liquid suspension culture. Could it be that 
this semi-solid culture system is suboptimal and that this may account for the inability 
of some of these cells to divide? From the single cell analyses (Section 3.5.1), this is 
unlikely. When REL cells were plated out at limiting dilution in liquid culture into the 
wells of a tissue culture plate, the resulting cloning efficiency (53-62%) was very 
close to the cloning efficiency obtained with the methylcellulose assay (55-59%) 
(Section 3.2). It would appear, therefore, that with the in vitro culture techniques 
available, a significant proportion of the cells lose the ability to divide. Nevertheless, 
this clonogenic assay is highly sensitive as demonstrated by the limiting dilution 
experiments. Even when cells were plated out at a dilution of 0.5 cell per well, the
1
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resulting cloning efficiency was similar to experiments when IxlO^cells were plated 
out in methylcellulose. Thus, these cloning teclmiques can be used to observe cell 
behaviour at the level of single cells.
Obviously, all these cell lines were derived from aberrant tissue from 
multicellular living organisms (i.e. rodents, humans). Although these cell lines are 
normally studied in vitro in tissue culture systems, it is nevertheless interesting to see i
if they have retained the crucial ability that allowed their isolation and propagation in 
the first place, namely their ability to grow in an dysregulated fashion in vivo. Clearly, 
with human cell lines, this option is not available. However, the malignant nature of 
cell lines can he retained. MEL cells can produce tumours when implanted into 
DBA/2 mice, the strain in which the tumours originated. Titration studies indicated 
that an inoculum of 500 cells would produce lai’ge tumours within 3 weeks (178). In a
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isimilar fashion, REL cells also retain their tumourogenic potential. The potency of the 
cells is demonstrated by the TD5Q (i.e. the numher of cells which will produce tumour 
in 50% of the recipient animals) which is remarkably low at a dose of 12 cells per 
recipient. Again, this indicates that the in vivo tumourogenic assay is a sensitive 
teclniique for measuring the malignant nature of REL cells.
Normal haematopiesis is a heirarchy whereby primitive stem cells can give 
rise to mature blood cells (186). These primitive cells consist of multipotential 
haematopoietic stem cells which possess extensive self-renewal capabilities (i.e. can 
give rise to new stem cells) and which can also generate progenitors that are 
programmed to differentiate. In turn, these progenitors become committed to a single 
lineage while retaining, at least some, proliferative ability. The progeny of these 
committed cells are mature blood cells which have specialised functions but have lost 
the ability to proliferate and have a limited lifespan. There is, therefore, a reciprocal 
relationship between maturation and proliferation in that the most primitive cells have 
extensive proliferative potential, while the most mature cells are incapable of cell 
division. It is the perturbation of this balance between maturation and proliferation 
that is the crucial event in leukaemogenesis. Thus, in normal haematopoiesis, as a 
particular cell differentiates towards a more mature phenotype, it will concommitantly 
lose its self-renewal potential. In leukaemia, however, there appears to be an 
uncoupling of maturation and proliferation so that immature cells, which are normally 
transitory, retain their self-renewal ability and accumulate in apparent maturation 
arrest (187). Can this maturation arrest be reversed? If the central defects in leukaemia 
are basically regulatory in nature, then it might be possible to induce terminal 
maturation. Clearly, then, it is necessary to understand how differentiation is regulated 
and how these aberrant differentiation programmes might be manipulated to
circumvent the maturational impasse. It has been shown that established leukaemic 
cell lines can be induced to differentiate and express characteristics of a more mature
'phenotype. These model systems, therefore, present an opportunity to devise 
strategies that can induce terminal maturation and thus exhaust the leukaemic clone.
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In the differentiation studies with REL cells, the majority of the data reported 
used DMSO as the chemical inducer. In a limited investigation, several other 
inducers were also identified (e.g. HMBA, ATRA), but DMSO was the most effective 
in this system. Studies with MELC cultures allowed the identification of a broad 
spectrmn of unrelated agents (188) some of which were strong inducers of 
differentiation, some of which were weak. The agents were diverse in their molecular 
structure, ranging from polar-planar compounds, to antibiotics, to fatty acids. It is 
worth noting that an inducer for one cell line is not necessarily an inducer for another 
cell line. For example, HMBA and DMSO are potent inducers of erythroid 
differentiation in MEL cells. However, both these compounds are ineffective in 
inducing erytln'oid differentiation in K562 cells (189). Conversely, hemin and butyric 
acid are potent inducers of K562 cells, but are, at best, weak inducers of MEL cells 
(188, 189). In addition, there are agents, such as bleomycin or 6-thioguanine, that are 
potent inducers for both K562 cells and MEL cells. These cell lines are all regarded as 
erytlnoleukaemic. The HL-60 is a promyelocytic leukaemia cell line. Some agents 
that are capable of inducing erythroid differentiation in K562 and/or MEL cells are 
also capable of inducing granulocytic differentiation in HL-60 cells, e.g. DMSO, 
HMBA, 6-thioguanine (190).
In Section 3.4 of this work experiments were set up to investigate chemically- ai
induced erythroid differentiation of REL-C7 cells. In the majority of the studies, 
DMSO was used as the inducer. When REL-C7 cells were incubated with DMSO, :
many of the cells differentiated to a more mature, erthioid morphology. This was 
.accompanied by a decline in the proliferative ability of these cells as demonstrated by
monitoring the changes in cell numbers over a period of 5 days. Wliereas control REL 
cells (i.e. no DMSO) had an average doubling time of 12 hours, cells cultured in the 
presence of DMSO had an extended doubling time. Over the first 48 hours of DMSO 
exposure the doubling time was 16 hours and this was further extended so that over a 
later 36 hour period (Time 601ir —> Time 96hr) the cell numbers increased only 'M:I
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modestly from 0.52 x 10^/ml to 0.70 x 10^/ml. Clearly, as these cells are induced to 
differentiate, their proliferative ability declines.
Alternative means for studying the proliferation of REL-C7 cells were the 
clonogenic assay and the tumourogenic assay. The clonogenic assay allows the 
observation of individual cells. Exposure of cells to DMSO had a profound effect on 
the ability of cells to form clones. After as little as 6 hours exposure to DMSO, a 
significant reduction in cloning efficiency was detected. This effect continued so that 
by 48 hours of exposure to DMSO, the cloning efficiency had declined to 0.325%. 
Along with the data from the growth curves, these results indicate that DMSO exerts 
its influence on REL cells immediately (i.e. no lag time). This proliferative down- 
regulation would appear to be an early event in DMSO-induced erythroid 
differentiation.
From the tumourogenic assay, it was shown that REL-C7 can retain their 
malignant potential. Indeed, it was calculated that an inoculum of as little as 12 cells 
would elicit tumour in 50% of the recipients. Groups of Long Evans babes received 
either control cells (no DMSO) or differentiated cells. Different groups received 
different doses, ranging from 1 x 10^ per recipient to 1 x 10  ^per recipient (Table 14). 
Although some 12 control cells seemed able to produce tumour in 50% of recipients, a 
dose o f  1 X  104 DMSO-treated cells elicited tumour in only 43% of recipients. This 
represents a reduction in tumourogenic potential of approximately 3 orders of 
magnitude.
If all the tumourogenic data from the controls are combined, 10 
undifferentiated cells would be expected to produce tumour in 50% of recipients. In 
those babes that received 1 x 10^ differentiated cells, a similar rate of tumour 
incidence was obtained, namely 43%. These data indicate that only a small proportion 
of DMSO-treated cells retained their tumourogenic potential. It may be that an 
inoculum o f  1 x 10^ differentiated cells contains of the order of 10 cells which still 
retain their ability to produce tumour, i.e. 1 cell in 1,000. This tends to corroborate the
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data from the clonogenic studies. Following exposure to DMSO for 48 hours, the 
cloning efficiency dropped to 0.325%, i.e. 3 cells in 1,000.
Thus, these data indicate that as DMSO induces REL-C7 cells to differentiate 
to phenotypically mature erythroid cells, there is a reciprocal loss of proliferative 
potential.
In these studies of DMSO-induced differentiation, down-regulation of 
proliferation seemed to be an early event. Some of the effects of DMSO could he
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detected after 6 hours exposure. This was in contrast to the length of time taken to
obtain significant levels of benzidine positive (B+ve) cells. Generally, B+ve cells S'
were first detected after some 72 hours of incubation in the presence of DMSO, rising 
to a maximum at about 96 houi's. These early events were analyzed by investigating 
the process of commitment to differentiation (commitment is defined as the ability to 
continue differentiation in the absence of inducing agent).
Obviously, the first observation was that REL cells could indeed become 
irreversibly committed to erytln'oid differentiation following exposure to DMSO for a
brief period of time (Tables 17A-G and Summary). Cells were incubated with DMSO 
for various periods of time. They were then washed to remove any residual DMSO 
and set up in inducer-free medium. Two trends were observed. First of all, as the 
length of exposure to DMSO increased, then so too did the proportion of B+ ve cells.
As little as 8 hours exposure to DMSO was sufficient to induce a small, but 
significant, proportion (2.1% B+ve) of the cells to differentiate. This increased 
progressively until, after 48 hours of exposure to DMSO, all the cells analyzed were 
B+ve. Similar results have been obtained with MEL cells and HL-60. With MEL 
cells, a period of about 12-18 hours exposure to inducer (in this case, HMBA) was 
required before committed cells begin to appear (191), while commitment of HL-60 
cells to terminal differentiation was initiated within 8-18 hours after exposm e of the
'cells to either DMSO or retinoic acid (192).
Secondly, with increasing exposure to DMSO, there was an increase in the 
incidence of colonies that contained B+ve cells. In control cells that had not been
à;
exposed to DMSO, 14 colonies were produced, 3 of which contained some B+ve cells
(3/14 = 21%). This is in good agreement with the results from Section 3.5.2 
. .(Spontaneous erythr oid differentiation) where, in the compai'able experiment, 23%
%(5/22) of the colonies contained some B+ve cells (Table 15 Summary). After 4 hours 
exposure to DMSO, there was no significant change in the proportion of colonies 
containing B+ve cells (22%) (4/18). However, after 8 hours exposure to DMSO, the 
proportion of colonies containing B+ve cells increased dramatically to 56% (10/18). 
This trend continued. After 16 hours of DMSO, 68% (13/19) of colonies contained 
B+ve cells; after 24 hours of DMSO, 78% (14/18) of colonies contained B+ve cells; 
after 32 hours of DMSO, 96% (22/23) of colonies contained B+ve cells; and after 48 
hours of DMSO, every colony contained B+ve cells. These data demonstrated the 
continual recruitment of REL cells to a differentiative programme with increasing 
exposure to DMSO.
These commitment studies with REL cells were done in limiting dilution 
assays. The advantage of this was that it allowed the behaviour of single cells to be 
observed, i.e. it was possible to study all the progeny from a single eell following 
exposure to DMSO. Considerable heterogeneity was observed in these colonies 
(Tables 17A-G, Tablet8). Some colonies contained no B+ve cells; others contained a 
mixture of B+ve and B-ve cells; others were exclusively B+ve. From the cells that 
received the shorter DMSO exposures (0 hr, 4 hr, 8 hr) a number of colonies were 
obtained which contained B+ve cells. However, none of these colonies were 
exclusively B+ve. All of these colonies were of the mixed type. It was only with 
increasing exposure to DMSO that colonies that were uniformily B+ve started to 
appear. For example, after 16 hours exposure to DMSO, of the 13 colonies that 
contained B+ve cells, only 2 were exclusively B+ve (15%). After 24 hours exposure 
to DMSO, of the 14 colonies that contained B+ve cells, 6 were exclusively B+ve 
(43%). This trend continued. After 32 hours exposui'e, 22 colonies were obtained, of 
which 17 (77%) were exclusively B+ve. After 48 hours exposure, all colonies were 
exclusively B+ve. These data demonstrated the continuing commitment of REL cells.
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Thus, increasing exposure to DMSO not only induces more cells to produce 
differentiated progeny (increase in the number of eolonies containing B+ve cells), but 
also induces cells to produce progeny that are increasingly B+ve (increase in the 
proportion of B+ve cells within any one colony).
A further demonstration of the down-regulatory effect that DMSO has on 
proliferation can be seen from an analysis of the cell numbers in individual colonies 
(Table 17 Summary). Cells that were not exposed to DMSO and cells that were 
exposed to DMSO for 4 hours both tended to produce large colonies with a median 
number of cells per colony of -1,000. As the DMSO exposure time increased, then 
the median number of cells per colony decreased. Thus, cells exposed to DMSO for 8 
hours produced colonies which had a median number of cells per colony of -625.
Cells exposed to DMSO for 16 hours produced colonies with a median number of 
cells per colony of 156. This inhibition of proliferation continued with the median 
number of cells per colony declining to 50 cells (24 hour exposure), 4 cells (32 hour 
exposure), and 2 cells (48 hour exposure).
Another interesting aspect of these studies is that, under these culture 
conditions, committed cells can give rise to both differentiated and undifferentiated 
progeny. From control cells that were not incubated with DMSO, 3 colonies (out of a 
total of 14) were obtained that were of the mixed phenotype. Since there was no 
DMSO exposure, one can safely assume that these cells differentiated spontaneously. 
From cells that were exposed to DMSO for 4 hom's, 4 mixed colonies (out of a total of 
18) were obtained. The differentiated cells in these colonies may have been 
committed by the presence of DMSO, or alternatively, they may have differentiated 
spontaneously. Cells exposed for 8 hours produced 10 mixed colonies (out of a total 
of 18). It is possible that some of the differentiated cells in these mixed colonies may 
have arisen spontaneously, but it is unlikely that spontaneous differentiation occurred 
in all 10 mixed colonies. At least some of these differentiated cells must have been 
induced by exposure to DMSO. So, individual cells that have been exposed to DMSO 
can produce progeny that are differentiated as well as progeny that have failed to
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When a cell divides, the two resulting daughter cells each receive the full 
complement of genetic material. Clearly, this requires the parental cell to duplicate the 
genetic material prior to cell division (mitosis). It has been loiown for many years that 
the process of eukaryotic cell proliferation can be divided up into discrete periods of
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differentiate. Similar heterogeneity of colony morphology has been reported with 
MEL cells (191).
The down-regulatory effect that DMSO had on REL proliferation was 
analyzed further by assessing the rate of DNA synthesis. This was done by incubating 
REL cells with DMSO for various periods of time and then measuring the 
incorporation of ^ H-thymidine into cellular DNA. Thus, those cells that are 
proliferating rapidly will have a high rate of DNA synthesis, and will therefore 
incorporate relatively lai'ge amounts of-^H-thymidine over a defined period of time. 
On the other hand, those cells in which proliferation has been down-regulated will 
have a slower rate of DNA synthesis, and will, therefore, incorporate a 
correspondingly lower amount of ^ H-thymidine over the same time interval.
Further corroboration was obtained that even brief exposure to DMSO can 
inhibit proliferation as measured by the amount of DNA synthesis. In two of the three 
experiments set up, a significant reduction in proliferation was detected after as little 
as 2 hours exposure to DMSO. In the other experiment, there was a reduction in DNA 
synthesis, hut not significantly so (Table 22). After 4 hours exposure to DMSO, all 
three experiments showed at least a significant reduction in DNA synthesis, and in 
two out of three experiments the difference was highly significant. After 6 hours 
exposure to DMSO, all three experiments showed a highly significant difference from 
the control cells. Thus, these data indicate that DNA synthesis can be down-regulated
after 2 hours exposure to DMSO. Previously (Section 3.5.3), it was shown that REL 
cells started to become committed to erytln'oid differentiation after a minimum of 8 
hours exposure to DMSO. It would appear, therefore, that this reduction in
:proliferation is an early event in the process of commitment to erythroid 
differentiation.
activity (193). Thus, DNA replication does not occur tliroughout the cell cycle, but 
rather it is restricted to a particular phase of it, called S-phase (S for synthetic). There 
is a post-synthetic, pre-mitotic period designated G2 (G for gap). This precedes 
mitosis. There then follows a post-mitotic, pre-synthetic period designated G\. 
Proliferating cells would proceed tlirough G% into S-phase, then into G2 , and then 
divide, thus completing the cell cycle:- G% S G2 M G% ->S, etc. In 
addition, under certain conditions, cells may opt out of this proliferative cycle and 
assume a stable, resting state in which cell division has ceased. Such cells are said to 
have entered a "Gq phase" of the cell cycle.
REL cells were exposed to DMSO for various periods of time and then 
subjected to cell cycle analyses to try to elucidate the manner in which their 
proliferative status was down-regulated. Both experiments (Table 23) were in broad 
agreement. In normally proliferating cells (i.e.MEM-0++ without DMSO), at any one 
time, the majority of cells were in S-phase (69% and 83% respectively) and relatively 
few cells were in Gq/Gj or G2+M. As cells were exposed to DMSO, a clear pattern 
developed. Generally speaking, with increasing exposure time to DMSO, there was a 
corresponding decrease in the proportion of cells in S-phase, i.e. the number of cells 
synthesizing DNA declined. In the first experiment, a reduction in the proportion of 
cells in S-phase could be detected after only 1 hour of DMSO exposure. However, the 
major decrease occurred between 4 and 6 hours exposure when the proportion of cells 
in S-phase dropped from 58% to 41%, with the trend continuing down to 35% (8 
hours exposure) and 29% (24 hours exposure). A similar pattern was seen in the
second experiment. Again, a reduction in the proportion of cells in S-phase could be
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detected after as little as 1 hour exposure to DMSO. However, in this experiment the 
major reduction was seen between 1 and 2 hours of DMSO exposure with the 
proportion of S-phase cells declining from 76% to 46%. This general trend continued 
so that after 24 hours exposure to DMSO, only 27% of cells were in S-phase.
As the proportion of S-phase cells declined, a corresponding increase in the 
proportion of cells in Gg/Gi could he detected. In the first experiment, the proportion
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of cells in G2+M remained fairly constant. Thus, any decline in S-phase cells could
largely be accounted for by the corresponding increase in Gq/G^ cells. For example,
between 4 and 6 hours DMSO exposme, there was the greatest decrease in S-phase
cells (58% to 41%) which directly coincided with the greatest increase in Gg/G^ cells
(30% to 47%). With increasing exposure times to DMSO, the propotion of cells inA
Gg/Gi continued to rise to 60% (24 hours). In the second experiment, although this 
reciprocal relationship between S-phase cells and Gg/Gi cells was still evident, the 
data were not quite so clear-cut. Although the major reduction in S-phase cells 
occurred between 1 and 2 hours of DMSO exposure (76% to 46%), the corresponding 
major increase in Gg/G% cells did not occur until between 3 and 4 hours of DMSO 
exposure (26% to 50%). This was largely due to an apparent increase in the 
proportion of cells in G2+M, unlike experiment 1 in which the level of G2+M cells 
remained relatively constant. Nevertheless, the same general trend was observed in 
that, with increasing exposure to DMSO, the proportion of cells in Gq/G| increased 
from 11% (no DMSO) to 69% (24 hours exposure).
These data corroborate the earlier findings that even brief exposure to DMSO 
can effect profound alterations in the proliferative status of REL cells. At a relatively 
gross level, it was shown by growth curves and the clonogenic assay, that cell division 
was down-regulated in the presence of DMSO. More precisely, DMSO seemed to 
inliibit cell division by inducing a reduction in DNA synthesis. More precisely still, 
DMSO appeared to cause this switch-off of DNA synthesis by preventing the cells 
from entering S-phase of the cell cycle. Instead, REL cells tended to accumulate in G\ 
phase, unable to make the transition to S-phase. Clearly, if cells cannot pass through 
S-phase, there can be no DNA synthesis and consequently no cell division.
Understanding the regulation of the cell cycle holds the key to imderstandiiig 
whether a cell will continue to proliferate, or alternatively, whether it will cease 
dividing and become committed to differentiate along a particular lineage to produce 
ftinctional end-cells. Not surprisingly, a great deal of attention has focused on events 
in the cell cycle to understand how inducers of differentiation exert their effects.
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Probably the most widely studied system is the MEL cell (Friend cell). In the 
earliest reports, several groups provided evidence that the inducer (DMSO) was 
required to be present during at least one, and possibly more, rounds of DNA 
synthesis to allow differentiation to proceed (194, 195), Further investigations 
indicated that DMSO (and some other inducers) delayed entry of cells into S-phase of 
the cell cycle, thus prolonging the length of G% phase (196). Subsequently, Pragnell et 
al reported that after 12 hours incubation with inducer (butyric acid), the numbers of 
cells entering S- and G2+M phases started to decline rapidly, and increasing numbers 
of cells accumulated in "Gj arrest" (197). When cells were sorted on the basis of their 
cell cycle status it was shown that, following induction with butyrate (197) or HMBA 
(198), only G% arrested cells were committed to differentiate. Furthermore, only G | 
cells synthesized globin mRNA, suggesting that commitment to differentiation and 
globin mRNA accumulation are linked events. Thus, the trigger to commitment and 
terminal differentiation only occurs during passage of cells tlirough G%. A further 
subtlety was reported by the Glasgow group exploiting MEL cells which were 
temperature-sensitive (ts) for growth (199). At permissive temperatures, ts cells 
replicated optimally and accumulated haemoglobin in response to inducer (HMBA). 
However, at a non-permissive temperature the cells were arrested in G% and, in the 
presence of inducer, did not accumulate haemoglobin or globin mRNA, nor did they 
undergo terminal differentiation. G% ts cells, treated with inducer, accumulated 
haemoglobin when released from growth arrest at the permissive temperature in the 
presence, but not in the absence, of inducer. These data indicated that there was a 
requirement for a cell cycle-dependent event prior to commitment to differentiation. 
The data obtained with REL cells are in broad agreement with the MEL story, but the 
mechanism outlined above is not necessarily the only one.
Although some reports have indicated that commitment to differentiation 
occurs in Gj phase and possibly early S-phase (194, 197), studies with HL-60 cells 
suggested that retinoic acid induces commitment preferentially during the S- or the 
S/G2 interphase (200). Furthermore, using DMSO as the inducer, the cell cycle
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pattern had no bearing on differentiation of HL-60 cells (201, 202). Thus it would 
appear that DMSO and retinoic acid initiate differentiation in HL-60 cells by different 
mechanisms (203, 204). Similar findings have been reported with K562 cells (205). 
Wliereas cells in late G% and early S phases were most sensitive to ara-C, hemin 
caused induction regai'dless of the cell cycle pattern. Indeed there was evidence that 
these agents could act synergistically to produce an earlier, more rapid increase in the 
number of induced cells, again reflecting the diverse mechanisms of action of these 
agents.
However, in REL cells, and other similar systems, the cell cycle status of cells 
appears to be the determining factor in commitment to differentiation. How then does 
the cell cycle influence the decision to either continue proliferation or, alternatively, to 
differentiate to a more mature phenotype with subsequent loss of proliferative 
potential?
Over the last few years, great progress has been made in our understanding of 
the regulation of the events in the cell cycle. Due to the delay in the submission of this 
thesis, some of the aspects of the IŒL studies presented have been overtaken 
somewhat by these developments. Nevertheless, it is important to put the REL data in 
perspective with current thinking.
Control of the cell cycle involves an integrated cascade of regulatory proteins 
which includes cyclins and cyclin dependent kinases (CDK). Gy dins are synthesized 
and activated in a cell cycle-dependent manner and function as regulatory subunits of 
CDK's. CDK's phosphorylate transcription factors to control cell cycle-regulated 
genes and proteins that support proliferation. For example, growth factor-induced cell 
proliferation is mediated by D-type cyclins (Dl, D2, D3) which are synthesized in G\ 
in response to growth factor stimulation (206). While the levels of cyclins tend to 
oscillate with the phases of the cell cycle, CDK's are present at similar levels 
throughout. The activities of these CDK's are controlled by these specific cyclins and 
by a series of recently described cdk inliibitors (CDKI) (207, 208). In particular, in 
cellular proliferation, the initiation of the cell cycle is mediated largely by complexes
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of the D-type cyclins with CDK4 and CDK6 (209). Thus, interference with cyclin Dl 
function by either antibodies or antisense oligonucleotides can prevent cells from 
progressing into S-phase (210).
It has recently been shown that D-type cyclins can complex with CDK4 and 
CDK6 and bind to the retinoblastoma gene product pRb (211). The retinoblastoma 
gene is regarded as a tumour suppressor gene (or anti-oncogene) in that mutation or 
loss of both copies of the gene is associated with a number of human cancers (212). 
pRb is thought to have a pivotal role in cell cycle progression and cell division.
During early G j, the hypophosphorylated form of pRb binds and inactivates the E2F 
transcription factor, resulting in suppressed transcription of E2F-regulated genes (213, 
214). Among these are the genes for DNA polymerase a , dihydrofolate reductase, and 
thymidylate synthetase which are required for DNA replication (215). D-type cyclins 
can form complexes with CDK4 or CDK6 to phosphorylate pRb. When pRb is in the 
hyperphosphorylated form, it dissociates from E2F, allowing the released E2F to 
promote the transcription of genes associated with DNA replication (Figure 26). 
Subsequent progression through G% into S-phase is controlled by another complex, 
Cyclin E / CDK2 (216).
In MEL cells undergoing HMBA-mediated commitment to differentiation, 
hypophosphorylated forms of pRb accumulate, accompanied by an increasing amount 
of total pRb (217). These hypophosphorylated forms of pRb are likely to bind E2F, 
thus preventing the transcription of a range of genes associated with DNA replication, 
i.e. proliferation would be down-regulated. These data suggested that pRb may play a 
role in the recruitment of cells to terminal differentiation. Subsequently, it was shown 
that HMB A-induced differentiation of MEL cells involved a rapid decrease in the 
level of CDK4 protein, thus suppressing the kinase activity of CDK4 (218). In 
addition, the level of cyclin D3 was increased by HMBA, and this protein formed 
complexes with pRb and E2F as the cells were progressively committed to 
differentiation. Further evidence for the critical role of CDK4 was supplied by DNA 
transfection studies which showed that forced overexpression of CDK4 protein
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Figure 26
Schematic representation of the interrelationships between cell cycle regulatory 
proteins (Abridged from Ref. 209) .
Abbreviations : cyclin D (cln D); cyclin dependent kinase (cdk); retinoblastoma 
protein (pRb); transcription factor E2F (E2F).
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-:=l.suppressed the recruitment of MEL cells to terminal differentiation. These 
observations suggest that chemically-induced differentiation of MEL cells involves 
the modulation of cyclins, CDK's, transcription factors (e.g. E2F), and molecular 
intermediates (e.g. pRb) 'which together can down-regulate proliferation and direct the 
expression of differentiation-specific genes.
In addition to these proliferative alterations, commitment and differentiation 
elicited some gross changes to REL cells. For example, REL cells undergo a 
progressive reduction in cell size with increasing exposure to DMSO, as measured by
a
flow cytometry. Although thew appeared to be a decrease in cell volume after as little 
as 8 hours exposure to DMSO, it was only after 24 hours exposure that a significant 
reduction was observed (Figure 15). A linear relationship was obtained between the 
duration of exposure to DMSO and the mean cell size. A similar decrease in cell size 
during differentiation has been reported with HL-60 cells (219) and with MEL cells 
(220). In particular, in MEL cells the changes in cell size appeared to follow a bi- 
phasic pattern, with the first volume reduction occmring during the initial 10 hours of 
DMSO exposure (i.e. early), and the second volume reduction occurring after
approximately 60 hours of DMSO (i.e. late). This was corroborated and extended by 
Zucker et al who also reported a correlation between the decrease in mean cell volume 
and the increase in the proportion of Gj cells in the early time period (221). In their 
hands, these changes in cell volume were a rapid monitor to determine the early 
events of the differentiation process. Unlike this MEL differentiation, REL 
differentiation did not produce any evidence for a bi-phasic pattern of cell volume 
reduction, although, like the MEL system, a reduction in cell volume could be 
observed after a brief exposure to DMSO.
.Scanning electron microscopy (SEM) was performed on induced REL cells to 
see if any further gross morphological changes could be detected. REL cells, 
proliferating under standard conditions, revealed a cell surface that had many well- 
defined microvilli. Some short ridges and some ruffles seemed to run across the cell 
surface. After 24 hours of exposure to DMSO, although some cells were identical to
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the control cells, other cells presented a surface that was markedly altered. These 
altered cells did not have the microvilli and ridges of control cells, but rather they had 
a generally smooth surface appearance with pores and channels discernible. This trend 
continued with increasing exposure time to DMSO. After 48 hours of DMSO 
exposure, virtually all the cells had acquired this smooth surface appearance. It has 
previously been demonstrated in this work that, after 48 hours of exposme to DMSO, 
REL cells are largely non-proliferative. Uninduced, non-proliferating REL cells were 
also analyzed by SEM. They, too, had a generally smooth appearance with pores and 
chamiels on the surface. There was a remarkable resemblence between these 
uninduced, non-proliferating cells and the DMSO-induced, non-proliferating cells. 
These surface alterations occur over the same period of time as do the proliferative 
changes. The appearance of the more mature phenotype (e.g. accumulation of 
haemoglobin) is a much later event. Thus, these profound alterations to the cell 
surface may reflect the down-regulation of proliferation and the cells entering a 
proliferative stationary phase, rather than any maturational progression.
Similar SEM studies have been reported for MEL cells (222). Cells taken from 
the logarithmic phase of growth had short microvilli scattered uniformly around the 
cell with some ruffles evident. After 48 hours of DMSO exposure, the cells had a 
blebby appearance. With cells that had differentiated further (e.g. 5 days of incubation 
with DMSO), a polarization phenomenon was seen whereby one half of the cell was 
blebby while the other half, which was separated by an equatorial cord, had a smooth 
membrane. This process resembled the enucleation process of untransformed 
erythroid cells.
This dissection of the process of differentiation of REL cells allowed a 
sequence of events to be proposed (Figure 16). After 4 hours exposure to DMSO, a 
significant reduction in DNA synthesis could be detected and cells began to 
accumulate in Gg/G^ phase of the cell cycle. After 6 hours of DMSO, DNA synthesis 
continued to decline and cells continued to accumulate in Gq/G^ . A significant 
number of cells were no longer capable of cell division as demonstrated by the
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reduction in cloning efficiency. After 8 hours of DMSO, some cells had now become 
irreversibly committed to erythroid differentiation. As the duration of DMSO 
exposure increased, then the switch-off of proliferation became more pronounced and 
the number of committed cells correspondingly increased. Gross morphological 
changes could now be detected. A decrease in cell volume could be measured after 24 
hours of DMSO and this was accompanied by the appearance of cells with a smooth 
surface rather than a surface with microvilli and ridges. The cells continued to 
decrease in size and by 48 hours of DMSO virtually all the cells had acquired a 
smooth surface. By 72 hours of DMSO, the first haemoglobin-producing cells 
appeared and these numbers rose to a maximum after 96 hours of DMSO.
To try to identify what biological activities were involved in the process of 
commitment to differentiation, attempts were made to adapt REL cells to a i1chemically-defined medium and then induce them to differentiate by the addition of 
known growth factors/cytokines. In effect, this meant propagating REL cells in 
serum-free medium. REL cells were readily adapted to serum-free conditions and 
their growth kinetics were only slightly inferior compared to the usual serum- 
containing medium. Attempts to induce REL cells to differentiate in serum-free 
medium were invariably unsuccessful. It appeared that there was some activity in 
serum that was required for differentiation to proceed.
In fact, further investigation revealed that this serum activity was required for 
commitment to differentiation. This was shown by "transfer-out" experiments.
"Me
Briefly, REL cells were incubated with DMSO for 24 hours, transferred to DMSO- 
free medium, incubated for a further 72 hours (i.e. 96 hours in total), and then 
assessed for haemoglobin production by the benzidine reaction. These transfers were 
carried out between different combinations of serum-containing medium and serum- 
free medium. For example, cells were exposed to DMSO in serum-containing 
medium, and then transferred to serum-containing medium that did not contain 
DMSO. These cells subsequently generated high numbers of B+ve cells, indicating
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that extensive commitment had occurred in the initial 24 horn’ culture in the presence 
of DM S O (and serum).
A further combination was set up in which cells REL cells were again 
cultured with DMSO for 24 hours in serum-containing medium. On this occasion they 
were transferred to serum-free medium that did not contain DMSO. Although 
previous experiments had indicated that serum-Eee conditions could not support 
differentiation, these transferred cells did produce significant numbers of 
differentiated progeny (Figure 23). The proportion of B+ve cells in this second 
experiment (serum-containing -+ serum-free) was less than the proportion of B+ve 
cells found in the first experiment (serum-containing -+ serum-containing). This 
difference probably reflects that, after 24 hours exposure to DMSO, although a 
significant proportion of the cells had become committed to differentiate, commitment
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was still incomplete, i.e. some cells had still not been recruited to commitment. If the 
exposure time to DMSO had been extended to, say 48 hours, then it is likely that more 
cells would have become committed and, therefore, a greater proportion of the cells 
would have been B+ve. In any event, these data demonstrate that serum is not 
necessarily required for the entire process of differentiation, but rather it is required 
only over the crucial commitment period. At least to some extent, once cells have 
been committed to differentiate, then serum is longer required for the rest of the 
differentiation programme to be expressed.
In the final combination that was set up, cells were initially exposed to DMSO
.in serum-free medium and were then transferred to serum-containing medium . Only 
very low levels (2%) of B+ve cells were obtained. It appeared that very few cells 
became committed to differentiation in the initial serum-free incubation. The low 
level of cells that were B+ve could possibly be accounted for by some carry-over of 
DMSO firom the initial serum-free incubation to the the subsequent serum-containing 
incubation, although the cells were washed thoroughly. Perhaps this combination of 
serum with some contaminating DMSO enabled a small number of cells to become
committed to differentiate. An additional contribution may have come from cells that 
had undergone spontaneous differentiation.
Although cells cultured in serum-free medium could not be induced to 
differentiate, they still retained the potential to do so, provided that the appropriate 
conditions were available. This was demonstrated by "re-adapting" cells from serum- 
free medium back to serum-containing medium. When these cells were incubated with 
DMSO, a significant proportion of the cells were B+ve. Thus, prolonged maintenance 
in serum-deprived conditions did not abrogate the cell's ability to express a 
differentiative programme.
Some preliminary experiments were set up in which serum-free medium was 
supplemented with a selected growth factor or combination of growth factors (IL-6, 
IL-11, G-CSF, M-CSF, GM-CSF, KLS, MIP-la). At the concentrations prepared, 
none of the growth factors appeared to exert any appreciable effect on cell 
proliferation - neither stimulatory nor inhibitory (Table 27). When cells that had been 
adapted to these cytokine-supplemented serum-free media were incubated with 
DMSO, the proportion of cells that became B+ve was invariably <1% (Table 28).
These attempts to try to identify the factor(s) in serum that allowed 
commitment to proceed were, to say the least, speculative. It is a feature of 
haematopoietic regulation that cytokines tend to exert their effects in combinations, 
rather than in isolation. It is likely that a similar situation pertains to REL 
differentiation. Several, as yet unidentified, cytokines may act together in a synergistic 
manner to promote DMSO-induced differentiation.
Serum-fi*ee conditions have been used to study differentiation in other cell 
lines. MEL cells were readily adapted to serum-free medium with no impairment of 
cell proliferation (223). On subsequent exposure to a variety of inducers (DMSO, 
HMBA, hemin) a significant proportion of the cells were B+ve. In this respect, serum- 
free medium was inferior to serum-containing medium with all tliree inducers. For 
example, using DMSO as the inducer, semm-containing cultures were approximately 
70% B+ve, while serum-free cultures were about 40% B+ve. These data suggested
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that factors present in serum could play a role in modulating erythroid differentiation 
in MEL cells. K562 cells have also been induced to differentiate in serum-free 
medium (224), although some sub-lines have been selected that are unable to 
differentiate in serum-free conditions (225). Interestingly, in this last report, newborn 
bovine serum (NBS) was found to be significantly inferior to FBS in its ability to 
support differentiation. They concluded that K562 cells required a factor found in 
FBS to undergo erythroid differentiation. In contrast, REL cells were able to 
differentiate with a variety of sera.
The nature of the factor(s) in serum which is required to allow REL cells to 
differentiate remains to be resolved.
REL cells are regarded as being erythroid in nature because of their ability to 
differentiate along an erytlnoid pathway and because they possess some 
morphologically erythroid features. While studying the effects of reduced FBS 
concentrations on REL proliferation and differentiation, some REL cells underwent 
gross morphological changes. When cultured in medium with FBS at a concentration 
of 0.5% (v/v), cells became plastic adherent, rather than the usual suspension cultures 
observed when the medium contained FBS at 10% (v/v). These cells resembled 
peripheral blood, plastic-adherent, mononuclear cells; i.e.monocyte/macrophage cells. 
Further evidence of the monocy te/macrophage natur e of these cells was provided by 
morphological anaysis using Wright's stain. The resulting preparations were 
consistent with monocyte/macrophage cells. Furthermore, cytochemical analyses with 
a-naplithyl acetate esterase staining gave a strong positive result, indicating the 
monocyte/macrophage nature of these adherent cells.
Adherent cells were also analysed with a range of monoclonal antibodies, each 
recognizing a specific cell surface antigen. There was little difference in the pattern of 
the reactions between suspension cells and adherent cells. The only difference 
observed was with monoclonal antibody OX-41, which recognises an antigen 
associated with monocyte/macrophage cells. Suspension cells were negative for this
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antibody, adherent cells were strongly positive. These data provided additional 
evidence that these adherent cells were indeed monocyte/macrophage.
To illustrate the point further, SEM's were prepared on suspension cells and 
adherent cells. Striking differences were observed (Plate 9). Suspension cells were 
generally spheroid, about 10-12pm in diameter with surface microvilli and ridges. 
Adherent cells, on the other hand, were flat, angular cells measuring over 20pm in 
diameter with numerous cytoplasmic extensions stretching out from the body of the 
cell. It would seem safe to conclude that these adherent cells are indeed of the 
monocyte/macrophage lineage.
Similar multi-potentialities have been reported in other cell lines. As 
mentioned earlies, HL-60 cells can be induced to differentiate to granulocytic cells 
(151, 152) or macrophage-like cells (153), depending on the inducer. Furthermore, a 
minor population of HL-60 cells appeared to express some eosinophilic characteristics 
(155). This eosinophilic potential of HL-60 cells was supported by subcloning 
experiments which allowed the establishment of HL-60 sublines which were restricted 
to the eosinophilic lineage (226). Other data on the multipotential nature of cell lines 
is less convincing. For example, MEL cells have been reported to express both 
erytlii’opoietic and granulopoietic lineage markers following induction with DMSO 
(227). Similarly, K562 cells have reported to express megakaryocytic antigens (228), 
myeloid antigens (229), and even B-lymphocytic antigens (230). This aberrant 
expression of surface antigens may reflect the phenomenon of lineage infidelity (93) 
in which individual cells co-express markers which are normally restricted to a single 
lineage.
The data presented here on the REL cells provides compelling evidence for 
their true bi-potentiality. Evidence is not restricted merely to expression of non- 
erytlrroid surface markers. Morphological and cytochemical data clearly show that 
these so-called erytliroleukaemic cells are capable of developing along a monocyte / 
macrophage pathway. Perhaps this cell line should be regarded as a "stem cell" 
leukaemia.
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The data presented in this thesis constitute the most extensive investigation to 
date into this rat erythroleukaemic cell line. Initial studies described the growth 
characteristics of the cells using a variety of culture techniques. The main thrust of 
this work focused on the ability of these cells to undergo erytlnoid differentiation 
following induction by a variety of chemicals. A sequence of events was described in 
which the proliferative potential of the cells was progressively diminished as the cells 
became increasingly committed to differentiation. The bi-potential nature of REL 
cells was also established when, under unusual culture conditions, REL cells were 
shown to develope into cells of the monocyte/macrophage series.
Although many characteristics of REL cells were investigated, there were 
some important aspects that were not addressed. Over the last decade in particular, 
molecular biological techniques have become increasingly powerful tools in our 
understanding of cellular regulation. Many genes have been implicated in the cellular 
dysregulation that ultimately manifests itself as neoplastic tissue. In this thesis, data 
were presented on cell biological aspects of commitment and differentiation. Clearly, 
this could have been a fertile area for molecular biological analyses of differentiation. 
Although REL cells have not been studied in this context, other cell lines have 
provided some insight into the regulation of differentiation at the molecular level.
As before, the MEL cell line is amongst the most extensively studied. 
Differentiation of MEL cells is associated with dramatic changes in the expression of 
various genes. For example, treatment with HMBA or DMSO can cause an early 
decrease in the expression of the proto-oncogenes c-myc and c~myb, and in the tumour 
suppressor gene p53, while the expression of c-fos increases rapidly (231, 232). The 
decrease in c-myc and c-myb mRNA and protein reflects decreased transcription of 
these genes. The down-regulation of p53 appears to be due to regulation at a post- 
transcriptional level. Constitutive expression of an exogenous c-myc cDNA inhibits 
inducer-mediated differentiation of MEL cells (233, 234, 235). Furthermore, 
constitutive expression of c-myc antisense RNA accelerates inducer-mediated 
differentiation in MEL cells (236). Cells with depressed levels of c-myc, due to
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expression of c-myc antisense, arrest at an early point in phase of the cell cycle.
These data imply that these changes in gene expression are among the steps necessary 
for inducer-mediated terminal differentiation. Likewise, constitutive expression of 
exogenous c-myb cDNA inhibits inducer-mediated MEL differentiation (237).
Similar data have come Eom HL-60 studies. The c-myc gene is markedly 
amplified in uninduced HL-60 cells (238), but is rapidly inactivated during 
granulocytic differentiation induced by retinoic acid (239).
Clearly, it would have been of interest to analyse REL commitment and 
differentiation at the molecular level. The patterns of expression of various proto­
oncogenes could have been investigated and any subsequent information could have
.  ■ •been integrated into the cascade of events that is initiated when REL cells are exposed 
to DMSO. These studies could have been extended to include REL culture in serum- 
free medium. Although REL cells were able to proliferate adequately in serum-free 
conditions, they could not be induced to differentiate. It may have been of value to 
investigate the pattern of proto-oncogene expression in cells cultured in serum-free 
medium to try to identify any significant differences from cells cultured with serum.
Preliminary cytogenetic information was provided, identifying the major 
cliromosomal rearrangements in REL cells. Tantalisingly, the translocation between 
chromosome 1 and chromosome 3 involved that part of chromosome 3 that contained 
the c-abl proto-oncogene. One could only speculate that this translocation might 
subvert the normal function of c-abl and thus contribute to the proliferative 
dysregulation of REL cells. Molecular analyses may have been able to identify an 
altered form of the c-abl gene.
An exciting area of biological research is the regulation of cell cycle events.
This, too, would merit some molecular investigation. As well as looking at the 
modulation of oncogene expression during commitment and differentiation, analyses 
of the expression of the cyclins and cyclin dependent kinases would provide a 
fascinating insight into mechanisms that subtly control the cell cycle.
:
I
-if:.
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With a greater understanding of the regulation of differentiation, it may be 
possible, in the fulness of time, to apply these experimental findings to devising 
strategies that may have some real clinical impact in the treatment of haematological 
malignancies.
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